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ABSTRACT
I. Total Synthesis of All Class III Galbulimima Alkaloids
We describe the total synthesis of (+)- and (-)-galbulimima alkaloid 13, (-)-himgaline
anad (-)-himbadine. The absolute stereochemistry of natural (-)-galbulimima alkaloid 13 is
revised to 2S. Sequential use of catalytic cross-coupling and cross-metathesis reactions followed
by an intramolecular Diels-Alder reaction provided the required trans-decalin AB-ring system
and masked the Cl 6-carbonyl as an N-vinyl carbamate for late stage unveiling in the form of the
necessary C16-enone. A vinyl-radical cyclization secured the C-ring while successful execution
of our strategy for introduction of the CDE-ring system in complex galbulimima alkaloids
provided the target pentacycle with complete diastereoselection.
II. Total Synthesis of (-)-Himandrine
We describe the first total synthesis of (-)-himandrine, a member of the class II
galbulimima alkaloids. Noteworthy features of this chemistry include a diastereoselective Diels-
Alder reaction in the rapid synthesis of the tricycle ABC-ring system in enantiomerically
enriched form, the use of a formal [3+3] annulation strategy to secure the CDE-ring system with
complete diastereoselection, and successful implementation of our biogenetically inspired
oxidative spirocyclization of an advanced intermediate. The successful and direct late-stage
formation of the F-ring in the hexacyclic core of himandrine drew on the power of biogenetic
considerations and fully utilized the inherent chemistry of a plausible biosynthetic intermediate.
Thesis Supervisor: Professor Mohammad Movassaghi
Title: Associate Professor of Chemistry
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Abbreviations
A angstrom
[a] specific rotation
Ac acetyl
AIBN 2,2' -azobisisobutyronitrile
anis anisaldehyde
aq aqueous
atm atmosphere
br broad
brsm yield based on recovered starting material
Bu butyl
"C degree Celcius
calcd calculated
CAM ceric ammonium molybdate
cm centimeter
cm1  wavenumber
COSY correlation spectroscopy
d doublet
d deuterium
6 parts per million
DEAD diethyl azodicarboxylate
diam diameter
DMAP 4-dimethylaminopyridine
DMF NN-dimethylformamide
DMSO dimethylsulfoxide
DTBMP 2,6-di-tert-butyl-4-methylpyridine
dr diastereomeric ratio
ee enantiomeric excess
El electron ionization
equiv equivalent
ESI electronspray ionization
Et ethyl
FT Fourier transform
g gram
g gradient
GB galbulimima
GC gas chromatography
h hour
ht height
hv photochemical irradiation
HMBC heteronuclear multiple bond correlation
HPLC high performance liquid chromatography
HRMS high resolution mass spectroscopy
HSQC heteronuclear single quantum correlation
Hz Hertz
1 iso
IBX 2-iodoxybenzoic acid
IR infrared
J coupling constant
kcal kilocalorie
KHMDS potassium hexamethyldislylamide
L liter
LAH lithium aluminum hydride
LDA lithium diisopropylamide
LHMDS lithium hexadislylamide
lit. literature value
m medium
m multiplet
M molar
micro
Me methyl
mg milligram
MHz megahertz
min minute
mL mililiter
mm millimeter
mmol millimole
ptmol micromole
mol mole
MS mass spectrometry
m/z mass to charge ratio
n normal
NBS N-bromosucinnimide
NCS N-chlorosucinnimide
nm nanometer
NMR nuclear magnetic resonance
nOe nuclear Overhauser effect
NOESY nuclear Overhauser effect spectroscopy
o.d. outer diameter
p para
Ph phenyl
PMA phosphomolybdic acid
ppm parts per million
PPTS pyridinium p-toluenesulfonate
Pr propyl
Pyr pyridine
q quartet
Rf retention factor
ROESY rotating frame Overhauser effect spectroscopy
s singlet
s strong
str stretch
t triplet
TBAF tetra-n-butylammonium fluoride
TBS tert-butyldimethylsilyl
TFA trifluoroacetic acid
THF tetrahydrofuran
TLC thin layer chromatography
TMS trimethyl silyl
UV ultraviolet
W weak
Z benzylcarbamate
Chapter I.
Total Synthesis of All Class III Galbulimima Alkaloids
Introduction and Background
The galbulimima alkaloids are a family of structurally fascinating polycyclic compounds
isolated from the bark of Galbulimima belgraveana, a tree native to northern Australia and
Papua New Guinea (Figure 1).' These alkaloids are classified into three distinct groups (classes
1-111) based on the amount of alkaloids isolated from the bark of trees with class I compounds as
the most dominant and class III compounds as the most rare (class 1:111, 100: 1). The biological
activity 2 of himbacine (1), a potential treatment for Alzheimer's disease, has prompted several
inventive syntheses of in this area.3' Our laboratory is interested in the class II and class III
galbulimima alkaloids because of their molecular complexity. In this chapter, we describe the
total synthesis of all class III galbulimima alkaloids: (+)- and (-)-GB 13 (2),5 (-)-himgaline (3)
and (-)-himbadine (4), allowing revision of their absolute stereochemical assignment.
Me-N2 Me HHO H HO HO
H H *H HHO
H HHH
HH -H H- H-'HMe H \~ A HN
0H H 6NH N H . HN
H H Me 06 Me HO HH H Me 01-
Himbacine (1) Galbulimima Alkaloid 13 (2) Himgaline (3) Himbadine (4)
Figure 1. Representative galbulimima alkaloids."
Hypothesis for the Biosynthesis of Galbulimima alkaloids:
A compelling hypothesis by Mander, Ritchie and Taylor in 1967 linked various
galbulimima alkaloids to a common polyacetate derived precursor: nine-acetate unit, a pyruvate,
and NH 3 5 (Scheme 1).ld They postulated that bicycle 6 could be the point of divergence to the
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Scheme 1. Carbon mapping of Galbulimima alkaloids proposed by Mander, Ritchie and Taylor.
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Scheme 2. Our biosynthetic hypothesis of class II and class III galbulimima alkaloids.
condensation,
tautomerization
conjugate addition.
C-ring formation
enamine
formation
12, R = H or Me
class II (himandrine and himandridine) and class III (galbulimima alkaloid 13, himbadine, and
himgaline). Conversion of bicycle 6 to pentacycle 7 would provide access to the class III
galbulimima alkaloids. Oxidation at Cl 3 followed by N-C9 bond formation of pentacyclic ester
8 would afford the class II GB alkaloids.
Based on Mander, Ritchie and Taylor's consideration on the biosynthesis of galbulimima
alkaloids described above,Id we developed a unified biosynthetic hypothesis of Class II and
Class III galbulimima alkaloids specifying stereochemical control and timing of events (Scheme
2).5 In particular, we envisioned the pentacyclic amino ketoester 16 to be the point of divergence
to access class II and class III galbulimima alkaloids. We postulated that intramolecular
conjugate addition of the enol tautomer of the C20-ketone of 11 to the unsaturated iminium ion
would result in formation of tetracycle 12 that would be subject to rapid C6-enamine addition to
the C20-carbonyl giving the pentacyclic imine 14. Imine reduction followed by enone formation
to give pentacyclic aminoketoester 16 would then set the stage for decarboxylation for the Class
III alkaloids (GB 13, himbadine and himgaline). Alternatively, tautomerization of pentacyclic
amino ketoester 16 and C17-hydroxylation, followed by an intramolecular allylic displacement
by the amine would give the N-C9 bond present in Class II alkaloids (see chapter II). This
refined biosynthetic hypothesis guided the first enantioselective total syntheses of both class II
and class III alkaloids as described in the remainder of this thesis.
During our studies directed toward the synthesis of Class II and Class III alkaloids,
Baldwin and co-workers reported the total synthesis of himbacine and himandravine, members
of the Class I alkaloids, employing their independent biomimetic route that was distinct from
Me Me,. Me,
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Scheme 3. Baldwin's biosynthetic hypothesis of galbulimima alkaloids.
ours. 3d'e In their report, they also proposed the biosynthetic hypothesis of class II and class III Gb
alkaloids starting from the tricycle 24 derived from intramolecular Diels Alder reaction of the
tetraene precursor (Scheme 3). Conjugate addition of enol tautomer of methyl ketone 24 to the
iminium moiety would give the tetracycle 25. Tautomerization of the enamine 25 followed by
double bond migration produced enone 26 which would undergo Michael addition first to give
the spirocycle 27. At this point, 1,2 addition of the enamine 27 provided the hexacyclic 28,
which upon imminium reduction was proposed to give the hexacyclic amino alcohol 29, their
speculated intermediate in the biosynthesis of class II and III galbulimima alkaloids. However,
our mechanistic and methodological studies did not support the sequence of events described in
conversion of 25 to 28.
Review of Prior Synthetic Studies of Class III Galbulimima alkaloids:
An overview of the literature concerning the class III galbulimima alkaloids is presented
in this section. Mander reported the first total synthesis of (±)-GB 13 in 2003.4a The key steps in
the synthesis involved a Diels-Alder cycloaddition and elaboration of the benzenoid moiety to
MeO ,,, 2H M O ONH2 MeO
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HO MOMO MOMO OTBS
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Scheme 4. Mander's total synthesis of (±)-GB 13. Conditions: (a) AcOH, H20, 89%. (b) MOM-Cl, DMAP, 'PrNEt,
DCM, 97%. (c) NaH, EtOCHO; NEt3, CH3CN, pNO 2C6H4 SO2N3; hv, THF, ((CH 3)3Si)2NH, 0 "C, H30, 68% (3
steps). (d) Cl3CCOC, NEt3, 98%. (e) KDA, Ph 2Se2; H20 2 , THF, 74%. (f) 33, Yb(thd)3, 110 "C, 87%. (g) TBAF,
THF, 74%. (h) LiAlH4, THF, 94%. (i) MOM-Cl, DMAP, 'PrNEt, DCM, 96%. (j) Li, NH3; HCI, MeOH, THF, 55%.
(k) LiAlH4, THF; MCPBA, DCM; DMP, NaHCO3, 77% (3 steps). (1) pNO2ArSO 2NHNH2, py, EtOH, THF, 76%.
(m) H2NOH-HCl, py, 100 "C. (n) ZrC14, NaBH4; Zn, AcOH, Et 20; TFAA, NEt3, DCM, 32% (4 steps). (o) dil. HCl;
DMP, DCM; MOM-Cl, DMAP, 'PrNEt, DCM, 57% (3 steps). (p) LDA, TMSCl, THF; Pd(OAc) 2, DMSO, CH3CN,
82% (2 steps). (q) K2CO 3 , H2 0, 60 C, 90%. (r) dil. HCl, acetone, 37%.
afford the piperidine ring of GB 13 (Scheme 4). The synthesis began with [3.3.1 ]bicyclononane
30 which underwent decarboxylation of P-keto acid followed by protection of alcohol, and
Wolff ring contraction6 of the corresponding diazoketone to provide amide 31. At this point,
dehydration of the amide moiety of 31 provided the corresponding nitrile in high yield followed
by selenoxide elimination to afford alkene 32, which underwent Diels-Alder reaction with diene
33 in the presence of ytterbium tris(2,2,6,6-tetramethyl-3,5-heptane-dionate) (Yb(thd)3) at 110
'C to provide the desired endo adduct 34 in excellent yield. Hydrolysis of silyl enol ether 34,
followed by reduction of the resulting ketone, protection of the corresponding alcohol as the
methoxymethyl ether, and Birch reduction 7 afforded the desired enone 35. Enone 35 then
underwent a 3-step sequence to provide the corresponding epoxy ketone 36, which was subjected
to Eschenmoser fragmentation8 to afford the alkynyl ketone 37. Treatment of alkynyl ketone 37
with excess hydroxylamine in pyridine gave bis-oxime 38, which was subjected to reductive
cyclization in the presence of zirconium tetrachloride and sodium borohydride to provide the
corresponding N-hydroxypiperidine, which, upon reduction and protection, produced the
pentacylic amine 39 with the desired all-cis-piperidine ring stereochemistry required for the
synthesis of GB 13. Introduction of enone moiety on the B-ring via Saegusa oxidatian,9 followed
by global deprotection completed the total synthesis of (±)-GB 13.
At that time. the absolute streochemical assignment of GB 13 remained ambiguous, and
in 2006, our laboratory reported the first total syntheses of both (+)- and (-)-GB 13 (2), allowing
unequivocal revision of their absolute stereochemical assignment.5 The first enantioselective
total synthesis of (+)- and (-)-GB 13 (2) is outlined in the following page of this chapter. We
reported our first total syntheses of (+)- and (-)-galbulimima alkaloid 13, 2-epi-galbulimima
alkaloid 13, (-)-himbadine, 2-epi-oxohimgaline, 2-epi-himgaline, oxohimgaline, and (-)-
himgaline in the Organic Syntheses symposium at MIT on May 1 8 th, 2006. Subsequent to our
reports, our structural revision was further supported by total syntheses from Shah,10 Evans," in
addition to further X-ray analysis by Mander.12
In 2006, Shah and co-workers reported the total synthesis of (-)-GB 13 which involved
diastereoselective Diels-Alder reaction, radical cyclization, reductive amination, and aza-
Michael reaction as the key steps in their synthesis (Scheme 5).10 The synthesis started with the
previously reported alkene 40'1 (synthesized in 10 steps from (R)-3-butyn-2-ol) which underwent
lactone reduction, protection and oxidation to give the corresponding methyl ketone, followed by
OTIPS H HO H H H HH H
a-b TIPSO HH c d-eHOH H - H H
O i43
Me H 40  Me 41 H 42
COOBn BnOOC P
S 0 H O H H O H H
I | A j-k H H h-i 0 H H(-)-2 --- 0 O 0--
c H H, H
46 45 44
N'H N'H 0
COCF 3  COCF 3  0
Scheme 5. Shah's total synthesis of (-)-GB 13. Conditions: (a) LiAlH 4, THF; Et3N, TIPSOTf, CH2Cl2 , -60 "C;
Dess-Martin, CH2Cl2, 0 "C, 90% (3 steps). (b) 03, Zn/AcOH, cat. AgNO 3, CH2Cl2; BnOCOCH 2P(O)(OEt)2,
NaHMDS, THF, 78% (2 steps). (c) TMSOTf, Et3N; NBS, THF; "Bu3SnH, AIBN, PhH, reflux, 56% (3 steps). (d)
H2/Pd-C, EtOAc; DCC, DMAP, Meldrum's acid; BnOH, PhH, reflux, 74% (3 steps). (e) HCl (aq.), THF, 85%. (f)
Zn(OTf)2 , CHCl3, reflux, 82%. (g) Methyl vinyl ketone, NaOEt, toluene, 0 "C; H2/Pd-C; EtOH, H30, 65 "C, 77% (2
steps). (h) (R)-c-methylbenzylamine, MeOH; Na(CN)BH 3, MeOH, AcOH; HCO 2NH 4, MeOH, Pd(OH) 2, reflux;
Na(CN)BH 3, MeOH, AcOH; (CF 3CO)20, Et3N, CH2Cl2, 61% (5 steps). (i) NaIO4, RuCl 3 '3H20, CCl4:MeCN:H 20,
86%. (j) LHMDS, THF, 0 "C, Me 2S2; NaIO4, MeOH; toluene, 100 "C, 65% (3 steps). (k) NBS, AIBN, CCl 4, 80 "C;
AgOCOCF3, DMF; NaHCO3 (aq.), THF; Dess Martin, 77% (4 steps). (1) HCI (6N), microwave, lh, 80%.
ozonolysis and Horner-Wadsworth-Emmons reaction to provide alkene 41. Methyl ketone 41
was subjected to a-bromination followed by highly diastreoselective radical ring closure to
afford tricyclic ketone 42 (ABC ring system). Formation of the D ring was achieved through
Lewis acid catalyzed intramolecular cyclization of p-keto ester 43 followed by conjugate
addition with methyl vinyl ketone to provide diketone 44. At this point, selective reductive
amination, protection of the amine, and ruthenium oxide mediated oxidation provided the
hexacylic amino lactone 45. Introduction of enone moiety on the B ring was achieved through
sulfoxide elimination, allylic bromination and displacement, followed by hydrolysis and
oxidation to afford enone 46. Decarboxylative unraveling of lactone 46 completed the total
synthesis of (-)-GB 13.
In 2007, Evans and co-workers disclosed an elegant total synthesis of (+)-GB 13." Their
key transformations included the asymmetric intramolecular Diels Alder reaction, Michael and
Aldol reaction (Scheme 6). The synthesis began with the Horner-Wadsworth-Emmons
olefination of trans decalin aldehyde 48 (synthesized via intramolecular Diels Alder reaction)
NBnBoc
r+ - HHn 
H HeNBnBoc
~ H H H .~- H N M
ACbzN 4N H H'M
Me H Me 52 H)<0 51
H0  54 H 0  53 H 0  Me Me
Scheme 6. Evan's total synthesis of (+)-GB 13. Conditions: LiClO 4 , 'Pr 2Net, CH3CN, 50 'C, 85%. (b) DIBAL-H,
PhMe, -90 'C. (c) TBAF, HOAc, THF, 87% (2 steps). (d) TBSOTf, 2,6-lutidine; NaH, BnBr; TBAF 85% (3 steps).
(e) DMP, NaHCO3, CH 2Cl2. (f) allyldiazoacetate, SnC12. (g) LiOMe, LiC1O 4, Et2 0, 0* 4 23 'C, 62% (3 steps). (h)
Pd(PPh 3)4, morpholine, THF, 86%. (i) DBU, PhH. (j) Pd(OH)2, H2, THF. (k) DMP, NaHCO 3, CH 2C12 , 72% (3
steps). 1) 20% TFA/CH 2CI2, 0 *C, aq. NaHCO 3 workup; 4 A MS, PhH. (m) HOAc, THF, 00 -> 23 'C. (n)
NaBH 3CN, EtOH, 0 -C. (o) DMP, NaHCO 3, CH2Cl2. (p) benzyl chloroformate, Na 2 CO 3, CH2Cl2/H20, 00 4 23 *C,
39% (5 steps). (q) IBX, TsOH-H 20, DMSO/PhH, 65 'C. (r) TMS-I, CH 2C12 , 0 'C; HCl; NaOH, 23 'C, 81% (2
steps).
using the previously reported (R)-s-ketophosphonate 473e to afford the corresponding
unsaturated ketone followed by reduction and deprotection to give the allylic alcohol 49. Diol 49
was oxidized, and the resulting aldehyde was selectively subjected to Roskamp reaction1 to
introduce the necessary p-ketoester for the planned Michael reaction; however, under the
reaction condition, the isolated product was enol ester 50. The undesired formation of enol ester
50 can be reversed under basic condition followed by decarboxylation to afford the tricyclic
ketone 51. The C16 ketone was introduced through DBU promoted elimination of the acetonide,
hydrogenation and oxidation of the corresponding alcohol. The E ring of 52 was formed through
deprotection of the amine under acidic condition and dehydration to the corresponding imine.
Under acidic condition, imine 52 underwent aldol addition to give the desired pentacycle as its
imminium ion 53. Reduction of imminium 53 followed by regeneration of the C16-ketone and
protection of amine provided the corresponding pentacyclic amino alcohol. At this point, we
were delighted to see application of the final stages strategy in our synthesis was used in this
solution. Unsaturated ketone on the A ring was introduced through IBX oxidation1 5 , and the
benzyl carbamate was removed with TMS-I16 to afford (+)-GB 13.
In 2009, Sarpong and co-workers reported another total synthesis of galbulimima
alkaloid- 13 in racemic form which involved the Rh(I)-catalyzed ketone hydroarylation reaction
HO0 H OH HMe, NOMe a N b-c OH N OMe
+s " /OMe- .""~H
H'1TBSO O OBe O 58Oe
55 (.)-56 57
Cbz H 0
Me 7N H(.2 1H h Ne-gHH Me N OMe
0 i~ -; ~ 0- I \MeOH NOe
HHO HO 0-61 60 H 59
Scheme 7. Sarpong's total synthesis of (±)-GB 13. Conditions: (a) LDA, THF, 78 'C, 56; HCI, THF/MeOH, 0 'C;
K2CO 3, 23 'C, 58% (2 steps). (b) S03-pyr, DMSO, pyridine, CH 2 C12, 23 *C; KHPO4/NaOH buffer, 60 *C, 55% (2
steps). (c) H2 , cat. PtO2, Na 2CO 3, EtOAc, 0 *C, 93%. (d) (Bpin) 2, cat. Pd 2(dba) 3-CHCl 3, cat. PCy 3HBF4, KOAc,
DMF, 80 'C, 65%. (e) DMP, CH 2Cl2 ; Et3N, SiO 2 , CH 2Cl 2, 78% (2 steps). (f) cat. [Rh(cod)(MeCN) 2]*BF4~, Et3N,
PhMe, 80 'C, 77%. (g) NaSEt, DMF, 120 *C; Tf2O, pyridine, 0 'C; AlMe 3, cat. Pd(Ph 3)4, THF, 54% (3 steps). (h)
cat. Rh/A120 3, H2 (1000 psi), EtOH; BnOCOCI, aq. NaHCO 3/PhMe; IBX, TsOH, DMSO/PhH, 65 'C, 60% (3
steps). (i) TMS-I, CH 2 Cl 2, 0 'C; HCl, NaOH, 79%.
(Scheme 7).17 The synthesis started with coupling between cyclopentenone 56 and lithioanion of
bromomethoxypicoline 55 to provide allylic alcohol 57. 1,3 Allylic transposition of 57 could be
accomplished using modified Parikh-Doering Swern conditions' 8 followed by selective
hydrogenation to give alcohol 58. Introduction of boronic ester moiety proceeded in good yield
to provide intermediate 59. Oxidation of alcohol 59, epimerization to the cis [6-5] ring fusion,
treatment of the corresponding pinacolboronic ester with the Rh(I) catalyst to undergo 1,2
addition, and installation of the pyridinyl methyl group provided the desired pentacycle 60.
Hydrogenation of the pyridine ring provided the desired piperidine moiety. At this point,
application of the final stages strategy in our synthesis was used to complete the total synthesis
of (±)-GB-13. Cbz protection, and IBX oxidation 5 afforded the desired enone 61. Removal of
the Cbz group with TMS-I' 6 gave (±)-GB 13.
Results and Discussion
Our goals in the study and total synthesis of galbulimima alkaloids were to develop the
first enantioselective synthesis of (+)- and (-)-GB 13 (2) and to confirm the absolute
streochemical assignment of class II and III GB alkaloids. Furthermore, we wanted to explore
our own biosynthetic hypothesis of class II and III GB alkaloids and to chemically validate our
proposal for their biogenesis. Guided by our original biosynthetic hypothesis, 5 we envisioned a
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Scheme 8. Retrosynthetic analysis of (-)-GB 13.
strategic C5-C20 bond disconnection to greatly simplify the structure of 2 to the tetracyclic
precursor 62 (Scheme 8). We expected to obtain the imino-ketone 62 from the unsaturated imine
63, in turn prepared by condensation of the iminium chloride 64 with aldehyde 65. Given the
uncertainty in the absolute stereochemistry of natural (-)-GB 13 (2), the coupling of the readily
available (+)- or (-)-iminium chloride 64 with (±)-aldehyde 65 provided an expedient route to
both enantiomers of advanced intermediates and alkaloid 2.
An efficient synthesis of trans-decalin aldehyde 65 is outlined in Scheme 9. Suzuki cross-
coupling'9 of readily available dibromide 66 and vinyl boronic acid 70 using thallium
carbonate20 provided cis-vinyl bromide 68 in 75% yield. Efforts to substitute thallium carbonate
Me
-- TBSO
Pd(PPh3 )4 (10 mol %) Me/T1 2CO3, KOH
BrB-Br O Me THF, H 20 TBSO
Br Me 23 *C
Me Me
66 (±)-67 (±)-68
OTBS
Me
+ |
Me'
OTBS
(±)-69
entry T12CO3 (equiv) KOH (equiv) yield ratio (±)-68:(±)-69a
1 1 none 70% 3:1
2 0.5 1.5 59% 2:1
3 0.25 1.75 39% 1:1
4 0.1 1.9 19% 1:1
5 0.1 4 38% 1:1
aRatio determined by crude 1H NMR.
Table 1. Optimization of Suzuki coupling for reduction of thallium carbonate
Br
Br a Me b Me66 -~ -
TBSO TBSO 6
Me B(OH) 2  (±)-68 Br (±)-71 N
OTBS (±)-70 O
OHC C 1
8CHO
H
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Scheme 9. Diastereoselective synthesis of (±)-aldehyde 65. Conditions: (a) Pd(PPh3)4, T12 CO3, THF, H20, 23 *C,
75%. (b) Cul, K2C0 3 , oxazolidin-2-one, (MeNHCH 2)2, toluene, 110 *C, 95%. (c) 1. TBAF, THF, 95%. 2. MnO2,
CH 2C12, 92%. 3. TBSOTf, Et 3N, CH 2Cl2 , -78 *C, 93%. (d) 4,5-DihydrolMesCl 2Ru=CH(o-'PrO)Ph (10 mol%),
acrolein, CH 2Cl 2, 23 'C, 85%. (e) toluene, 90 *C, 82%, ('>20:1, endo:exo).
with potassium hydroxide were unsuccessful, resulting in no improvement in the yield. In
addition, unwanted dimerization of the boronate 69 ocurred when less T12CO 3 was used (Table
1). Use of palladium acetate and SPhos ligand developed by Buchwald2 1 produced 1:1 mixture of
the desired vinyl bromide 68 and dimer 69.
Subsequent copper-catalyzed coupling of bromodiene 68 with oxazolidin-2-one afforded
the desired triene 71 in excellent yield2 2 and proved an effective strategy for masking the C16-
carbonyl. Conversion of the C20-silyl ether of triene 71 to the C20-silyl enol ether gave tetraene
72 (Scheme 9). Selective functionalization of the C9-C1O alkene of 72 to the corresponding
unsaturated aldehyde 73 (C9-E:Z, >20:1) was achieved via an olefin cross-metathesis reaction
with acrolein using the 4,5-dihydroMesCl 2Ru=CH(o-'PrO)Ph23 catalyst. Heating a solution of
tetraenal 73 in toluene at 90 'C afforded the desired trans-decalin aldehyde 65 in good yield
(82%, >20:1, endo:exo).
Having access to the trans-decalin aldehyde (±)-65, we proceeded to the synthesis of
enantiomerically enriched iminium salt (S)-64 and (R)-64 in multi-gram scale (Scheme 10).
Amino alcohol 74 derived from L-alanine was iodinated to provide alkyl halide 75. Radical
addition with methyl vinyl ketone afforded the desired amino ketone (+)-76. Deprotection of the
Boc group under acidic conditions resulted in cyclization to give the desired iminium salt (-)-(S)-
64. The enantioselecitivity of the iminium salt (-)-(S)-64 was measured to be >99% ee by chiral
HPLC analysis of the corresponding benzylated derivative. The corresponding enantiomer,
iminium chloride (+)-(R)-64 was prepared using the same route, starting with amino alcohol ent-
Me 0 Me CI Me
HO NHBoc NHBoc Me NHBoc H
74 61% 75 53% (+)-(S)-76 81% Me
(-)-(S)-64
Me Me 0 Me CIMe
HO NHBoc NHBoc b Me NHBoc H -
ent-74 60% ent-75 59% (-)-(R)-76 81% Me
(+)-(R)-64
Scheme 10. Synthesis of iminium salt (-)-(S)-64 and (+)-(R)-64. Conditions: (a) 12, PPh 3, Imidazole, THF, 0 0C. (b)
methyl vinyl ketone, "Bu3SnH, AIBN, toluene, reflux. (c) HCl (aq.), 23 *C.
74 derived from D-alanine.
Deprotonation of the (-)-iminium chloride 64 (>99% ee, Scheme 11) with "butyl lithium
gave the corresponding lithiated enamine,24 which upon addition to a cold solution of aldehyde
65 provided the corresponding p-hydroxy imines in 85% yield. Dehydration using the Martin
sulfurane reagent 25 afforded the desired (7E)-as-unsaturated imine 63 (Scheme 11) and the
corresponding 2-epi-enantiomer (not shown in Scheme 11) as a 1:1 mixture of inseparable
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Scheme 11. Concise total synthesis of (-)-GB 13 (2). Conditions: (a) "BuLi, THF, -78 *C, 5 min, 85%. (b) Martin
sulfurane, benzene, 23 0C, 81%. (c) NBS, NaHCO3, THF, 0 *C; "Bu3SnH, AIBN, benzene, 60-9O0 *C, 55% (2-
steps). (d) Et3N-(HF) 3, THF, 23 *C; NaBH4, EtOH, 0 *C, 70% (2 steps). (e) CICO 2Bn, Na2CO3, H20, CH 2Cl 2, 65%.
(f) IBX, TsOHeH20, benzene, DMSO, 65 0C, 10 h, 80%. (g) TMSI, CH2Cl2, 0 *C; HCl; NaOH, 23 *C, 89%. For
brevity, the corresponding ent-2-epi-isomer of compounds 63 and 77-80 are not shown.
diastereomers in 81% yield. The diastereomers were chromatographically separated after the
next two steps. Diastereoselective introduction of the C21-C8 bond in tetracycle 79 was
accomplished via a 5-exo-trig vinyl-radical cyclization. 26 Conversion of silyl enol ether 63 to the
vinyl bromide 77 (Scheme 11, 1:1.5 mixture of C20-olefin isomers), followed by heating of the
crude vinyl bromide 77 with excess tributyltin hydride and AIBN provided the desired tetracycle
79 along with the C2-epi-enantiomer in 55% yield. Treatment of enol ether 79 with
triethylamine-trihydrofluoride resulted in C5-C6 enamine addition to the unmasked C20
carbonyl, directly providing the corresponding pentacyclic imine. Removal of the volatiles under
reduced pressure and introduction of sodium borohydride in ethanol resulted in
diastereoselective C6-imine reduction, affording the corresponding stable pentacyclic amine in a
one-pot process (Scheme 11). Optically active pentacyclic amine (-)-81 (36%) and the
corresponding 2-epi-enantiomer, amine (+)-82 (34%), were readily separated by flash column
chromatography. Remarkably, formation of the C8 stereocenter during the radical cyclization as
well as the introduction of the three contiguous stereocenters (C20, C5, and C6) in the
conversion of silyl enol ether 79 to pentacyclic amine (-)-81 occur with a high level of
diastereoselection. To date, no other diastereomers have been detected. Introduction of the enone
was accomplished by treatment of N-vinyl carbamate (-)-83 with excess p-TsOHeH 2O and
IBX15 in benzene-DMSO at 65 'C for 10 h to provide carbamate (-)-84 in 80% yield.
Subsequent deprotection of (-)-N-Cbz GB 13 (84) with trimethylsilyl iodide (TMSI)' 6 followed
by an aqueous work-up provided synthetic GB 13 (2) in 89% yield (Scheme 11). All
spectroscopic data for our enantiomerically enriched (-)-2 matched literature data.1,a The sign of
rotation for our synthetic 2 ([a] 22D = -64 (c 0.06, CHCl3)), was consistent with that reported for
the natural enantiomer ([c] = -84 (CHCl3)Ib), unambiguously securing the absolute
stereochemistry. Synthesis of (+)-GB 13 (ent-2, [C] 22 D +66 (c 0.07, CHCl 3)) using (+)-64
(>99% ee) via the route described above confirmed our absolute stereochemical assignment.
Interestingly, intramolecular amine conjugate addition at C19 was observed upon N-deprotection
of 84 and acidic treatment. This conjugate addition was subject to reversion on mild base
treatment (1N NaOHaq, 1 h).
With access to pentacyclic amines (+)- and (-)-81 (Scheme 11), we explored the
synthesis of optically active 2-epi-GB 13 (2-epi-2) (Scheme 12). Interestingly, removal of the
HO HO HO HHO
H H H 
H H OH 
H
H HH H6 HN Ff\'\ \cN, 1N, 17HkNH H-~ N H'Me H RHMe2 H Cbz H mew me\  M 2  6leH R HH 0 HH 0 H H
O (-)-2-epi-84 2-epi-galbulimima (-)-2-epi-1 6-oxohimgaline
a R = H, (-)-82 alkaloid 13 (2-epi-2) (2-epi-21)R = Cbz, (-)-2-epi-83
Scheme 12. Synthesis of (-)-2-epi-16-oxohimgaline (2-epi-21). Conditions: (a) ClCO2Bn, Na2CO 3, H20, CH2Cl 2,
54%. (b) IBX, TsOHeH 20, benzene, DMSO, 65 *C, 10 h, 59%. (c) TMSI, CH 2Cl 2, O *C; HCl; NaOH, 23 *C, 93%.
nitrogen-protective group of (-)-2-epi-N-Cbz GB 13 (2-epi-84, Scheme 12), under identical
conditions to those described for N-Cbz GB 13 (84), led to exclusive isolation of (-)-2-epi- 16-
oxohimgaline (2-epi-21, Scheme 12, [a]2 2D - -24 (c 0.085, CH 2Cl 2)) even after treatment with
base. Similarly, (+)-2-epi-16-oxohimgaline ([a] 22D = +24 (c 0.07, CH 2Cl 2)) was prepared from
(+)-2-epi-84. The more facile conjugate addition observed with 2-epi-GB 13 (2-epi-2),
compared to that seen with GB 13 (2, Scheme 11) is likely due to decreased steric interactions
between the C2-substituent and the C17-methine in the 2-epi series. This observation further
supports the hypothesis for the biosynthesis of himgaline (3) via sequential conjugate addition
and carbonyl reduction of GB 13 (2).
Immediately after we completed the total synthesis of (+)- and (-)-GB 13 (2), in Spring
2006, we synthesized (-)-himgaline (3) by converting (-)-galbulimima alkaloid 13 (2) to (-)-
himgaline (3) in the presence of sodium triacetoxyborohydride and acetic acid (Scheme 13). In
the event, intramolecular conjugate addition of the nitrogen onto the C17-C19 alkene occurred
rapidly in the presence of acetic acid to provide the oxohimgaline intermediate 85. Subsequent
reduction with sodium triacetoxyborohydride 27 effected C16 carbonyl reduction
diasteroselectively through intramolecular hydride delivery to give the (-)-himgaline (3) in 73%
yield. All spectroscopic data for our enantiomerically enriched (-)-himgaline matched literature
data.' The sign of rotation of our synthetic (-)-himgaline [a]22 D = - 82 (c 0.11, CHCl3) , was
HHO H HHO HHO
OAc
(-)-Galbulimima Alkaloid 13 (2) 85 (-)-Himgaline (3)
Scheme 13. Total Synthesis of (-)-himgaline. Conditions: (a) NaBH(OAc)3, CH3CN, AcOH, 23 0 C, 5 min, 73%.
consistent with that reported for the natural enantiomer [a]= - 76 (CHCl 3).'
Conversion of (-)-galbulimima alkaloid 13 (2) to (-)-himbadine (4) was achieved via
reductive methylation in the presence of formalin and sodium triacetoxyborohydride. All
spectroscopic data for our enantiomerically enriched (-)-himbadine matched literature data.' The
sign of rotation of our synthetic (-)-himbadine [a] 22 D = - 47 (c 0.045, CHCl3) , was consistent
with that reported for the natural enantiomer [a] 60 (CHCl3). 1
H HO H H HO H
?HH _'H H
a
H \NH .
H NHH NMeH
Me 0 H Me 0
(-)-Galbulimima Alkaloid 13 (2) (-)-Himbadine (4)
Scheme 14. Total synthesis of (-)-himbadine. Conditions: Formalin, CH 3CN, NaBH(OAc) 3, 50% (2 steps).
Conclusion
The total synthesis of all class III galbulimima alkaloids: (+)- and (-)-GB 13 (2), (-)-
himgaline (3), and (-)-himbadine (4) has been described. The absolute stereochemistry of natural
(-)-2 is revised to 2S. Noteworthy features of this chemistry include a vinyl-radical cyclization
strategy to secure the C-ring and the successful execution of our biomimetically inspired strategy
for introduction of the CDE-ring system in 2 (79--81, Scheme 11).
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Experimental Section
General Procedures. All reactions were performed in oven-dried or flame-dried round
bottomed flasks or modified Schlenk (Kjeldahl shape) flasks. The flasks were fitted with rubber
septa and reactions were conducted under a positive pressure of argon. Stainless steel syringes
or cannulae were used to transfer air- and moisture-sensitive liquids. Flash column
chromatography was performed as described by Still et al. using silica gel (60-A pore size,
32-63 ptm, standard grade, Sorbent Technologies).' Where necessary (so noted), silica gel was
neutralized by treatment of the silica gel pior to chromatography with the eluent containing 1%
triethylamine. Analytical thin-layer chromatography was performed using glass plates pre-
coated with 0.25 mm 230-400 mesh silica gel impregnated with a fluorescent indicator (254
nm). Where necessary (so noted), silica gel plates were neutralized by treatment with a solution
of 5% triethylamine in dichloromethane followed by heating on a hot plate (~250 'C). Thin
layer chromatography plates were visualized by exposure to ultraviolet light and/or by exposure
to an ethanolic phosphomolybdic acid (PMA), an acidic solution of p-anisaldehyde (anis), an
aqueous solution of ceric ammonium molybdate (CAM), an aqueous solution of potassium
permanganate (KMnO4) or an ethanolic solution of ninhydrin followed by heating (<1 min) on a
hot plate (-250 C). Organic solutions were concentrated on Buchi R-200 rotary evaporators at
-20 Torr at 25-35 0C, then at -1 Torr unless otherwise indicated.
Materials. Commercial reagents and solvents were used as received with the following
exceptions: dichloromethane, diethyl ether, tetrahydrofuran, acetonitrile, and toluene were
purchased from J.T. Baker (Cycletainer TM) and were purified by the method of Grubbs et al.
under positive argon pressure.2 Triethylamine, diisopropylethylamine, and benzene were
distilled over calcium hydride immediately before use. Acrolein was distilled over calcium
sulfate immediately before use. Methyl vinyl ketone was distilled over potassium carbonate and
calcium chloride immediately prior to use. Martin sulfurane was purchased from Aldrich and
stored in a glove box under nitrogen atmosphere. N-Bromosuccinimide (NBS) was
recrystallized from boiling water prior to use. 2-Iodoxybenzoic acid (IBX) was prepared
according to literature procedure. 3 Activated y-manganese dioxide (MnO 2) was prepared
according to literature procedure. 4 The molarity of n-butyllithium solutions was determined by
titration using diphenylacetic acid as an indicator (average of three determinations).5 Ammonia
saturated dichloromethane was obtained by agitation of dichloromethane in the presence of
ammonium hydroxide followed by drying over anhydrous sodium sulfate. Where necessary (so
noted) solutions were deoxygenated by alternate freeze (liquid nitrogen)/evacuation/argon-
flush/thaw cycles (FPT, three iterations) or degassed by purging with argon for several minutes.
Instrumentation. Proton nuclear magnetic resonance ('H NMR) spectra were recorded with a
Varian 300 Mercury or a Varian inverse probe 500 INOVA spectrometer or a Bruker inverse
probe 600 Avance spectrometer. Chemical shifts are recorded in parts per million from internal
Still, W. C.; Kahn, M.; Mitra, A. J. Org. Chem. 1978, 43, 2923.
2 Pangborn, A. B.; Giardello, M. A.; Grubbs, R. H.; Rosen, R. K.; Timmers, F. J. Organometallics 1996, 15, 1518.
3 Frigerio, M.; Santagostino, M.; Sputore, S. J. Org. Chem. 1999, 64, 4537.
4 Fatiadi, A. J., Synthesis 1976, 65.
5 Kofron, W. G.; Baclawski, L. M. J. Org. Chem. 1976, 41, 1879.
tetramethylsilane on the 6 scale and are referenced from the residual protium in the NMR solvent
(CHCl 3: 6 7.27, C6 D5 H: 67.16). Data is reported as follows: chemical shift [multiplicity (s =
singlet, d = doublet, t = triplet, q = quartet, m = multiplet, app = apparent, br = broad), coupling
constant(s) in Hertz, integration, assignment]. Carbon- 13 nuclear magnetic resonance (1 3C NMR)
spectra were recorded with a Varian 500 INOVA spectrometer or a Bruker 400 spectrometer with
a Magnex Scientific superconducting magnet and are recorded in parts per million from internal
tetramethylsilane on the 8 scale and are referenced from the carbon resonances of the solvent
(CDCl 3: 6 77.2, benzene-d: 6 128.4). Infrared data were obtained with a Perkin-Elmer 2000
FTIR and are reported as follows: [frequency of absorption (cm ), intensity of absorption (s =
strong, m = medium, w = weak, br = broad), assignment]. Gas chromatography was performed on
an Agilent Technologies 6890N Network GC System with a HP-5 5% Phenyl Methyl Siloxane
column (50 'C, 6 min; 25 'C/min to 250 'C; 250 'C, 6 min). We are grateful to Dr. Li Li for
obtaining the mass spectroscopic data at the Department of Chemistry's Instrumentation Facility,
Massachusetts Institute of Technology. High-resolution mass spectra (HRMS) were recorded on
a Bruker APEX 4.7 Tesler FTMS spectrometer using electronspray ion source (ESI) or
electronspray (ES).
Compound Numbering. For compounds 2, 63, 65, 79, 81, 82, 83, 84, 2-epi-83, 2-epi-21, the
atom numbering system used is consistent with correlated atoms in the final product as numbered
in the isolation papers of the natural alkaloids.6
6 Ritchie, E.; Taylor, W. C. In The Alkaloids; Manske, R. H. F., Ed.; Academic Press: New York, 1967; Vol. 9,
Chapter 14.
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( I)-trans-2-[3-(tert-Butyl-dimethyl-silanyloxy)-but-1-enyll-4,4,5,5-tetramethyl-[1,3,2]dioxaborolane
Terminal alkyne Si7 (4.70 g, 25.5 mmol, 1 equiv) was added dropwise via syringe to a
solution of freshly prepared pinacolborane8 in dichloromethane (5 M, 10 mL, 50.2 mmol, 2.00
equiv) at 0*C. The solution was stirred and allowed to warm to ambient temperature. After 24 h,
the solution was partitioned between diethyl ether (300 mL) and saturated aqueous ammonium
chloride solution (150 mL). The aqueous phase was extracted with diethyl ether (2 x 150 mL)
and the combined organic phases were washed with saturated aqueous ammonium chloride
solution (100 mL), were washed with brine (80 mL), were dried over anhydrous sodium sulfate,
were filtered, and were concentrated under reduced pressure. Purification of the resulting oil by
flash column chromatography (silica gel: diam. 9 cm, ht. 10 cm; eluent: hexanes:EtOAc [95:5] to
hexanes:EtOAc [80:20]) provided boronate (±)-67 (5.40 g, 68%) as a colorless oil.
IH NMR (500 MHz, CDCl 3, 20'C):
13C NMR (125 MHz, CDCl 3, 20*C):
6.60 (dd, J= 18, 4.0 Hz, 1H, CH=CHB), 5.63 (dd, J
= 18, 1.7 Hz, 1H, CH=CHB), 4.37-4.32 (m, 1H,
CH 3CHCH=CH), 1.28 (s, 6H, BOC(CH 3)CH 3),
1.28 (s, 6H, BOC(CH 3)CH3), 1.22 (d, J= 6.7 Hz,
3H, CHCH 3), 0.91 (s, 9H, SiC(CH 3)3), 0.05 (s, 6H,
Si(CH 3)2).
157.2 (BC=C), 83.3 (BC=C), 70.0 ((Me) 2C), 26.1,
25.0, 24.9, 23.9, 18.5, -4.5 (SiCH 3), -4.6 (SiCH 3).
FTIR (thin film) cm- :
HRMS (ESI):
GC, tR:
2929 (m), 1996 (w), 1611
1146 (w).
calcd for C16H33BNaO3Si
found: 335.2177.
(w), 1370 (w), 1337 (w),
[M+Na]*: 335.2184,
11.73 min
TLC (20% EtOAc in hexanes), Rf: 0.63 (KMnO4)
7 Prepared from 3-butynol, tert-butyldimethylsilylchloride, imidazole, dimethylformamide, 23 'C, 12h; see:
Cotterill, A. S.; Gill, M.; Gimenez, A.; Milanovic N. M. J. Chem. Soc., Perkin Trans. 11994, 22, 3269.
8 Pinacolborane was prepared according to Tucker, C. E.; Davidson, J.; Knochel, P. J. Org. Chem. 1992, 57, 3482.
S2
CBr4, PPh3
CH2CI2, 0 *C
82%
Br
Br
66
1,1-Dibromo-octa-1,7-diene (66):
Triphenylphosphine (6.34 g, 24.2 mmol, 2.40 equiv) was added in three portions to a
solution of carbon tetrabromide (4.00 g, 12.1 mmol, 1.20 equiv) in dichloromethane (30 mL) at
0 C in an ice bath to produce a yellow-orange solution. The solution was stirred at 0 'C for 10
min. A solution of aldehyde S29 (1.12 g, 10.0 mmol, 1 equiv) in dichloromethane (6 mL) was
introduced via cannula to the cold reaction mixture. The transfer was completed using a second
4-mL portion of dichloromethane and the mixture was vigorously stirred at 0"C. The solution
became dark orange and white solid precipitated. After 1 h, excess dibromophosphorane was
quenched by sequential addition of triethylamine (3.4 mL, 24 mmol, 2.4 equiv) and methanol
(1.0 mL, 25 mmol, 2.5 equiv). The solution was allowed to warm to room temperature,
transferred to a separatory funnel and added dropwise to a solution of "pentane-diethyl ether
(5:1, 300 mL), resulting in precipitation of triphenylphosphine oxide. The resulting light brown
solid was removed by filtration and washed with "pentane (100 mL). The combined organic
filtrate was concentrated and purified by flash column chromatography (silica gel: diam. 5 cm,
ht. 10 cm; eluent: hexanes:EtOAc [90:10]) to yield dibromide 66 as a colorless oil (2.21 g, 82%).
'H NMR (500 MHz, CDCl 3, 20'C):
13C NMR (125 MHz, CDCl 3, 20'C):
6.40 (t, J= 7.4 Hz, 1H, Br 2C=CH), 5.85-5.76 (m,
1H, HC=CH2), 5.02 (app-dq, J= 17, 1.5 Hz, 1H,
trans-HC=CH2), 4.97 (m, 1H, cis-HC=CH2), 2.14-
2.05 (m, 4H, Br2C=CHCH 2, H2C=CHCH2), 1.47-
1.41 (in, 4H, CH 2(CH 2)2CH 2).
138.9, 138.7, 114.9 (HC=CH2), 88.9 (Br 2C=CH),
33.6, 33.0, 28.4, 27.4.
FTIR (thin film) cm': 2928 (s), 2857 (m), 1641 (m), 911 (s),
(m).
804 (m), 780
HRMS-EI (m/z): calcd for CsH 3Br 2 [M+H]*: 265.9300,
found: 265.9324.
GC, tR. 10.16 min
TLC (40% EtOAc in hexanes), RfJ S2, 0.64 (KMnO4)
66, 0.75 (UV, KMnO4)
9 6-Heptenal was prepared from 7-octene-1,2-diol (commercially available), sodium metaperiodate, diethyl ether,
water, lh, 93%. Spectroscopic data matched published data; see: Taylor, R. E.; Galvin, G. M.; Hilfiker, K. A.;
Chen, Y. J. Org. Chem. 1998, 63, 9580.
Br
Br
66
TBSO
Me B'O Me
(±)-67 - Me
Mee
NalO4NH40Ac
2300C
acetone, water
95%
Pd(PPh3)4,T12CO3
THF, H20
23 00, dark
75%
BSO
e B(OH) 2
(±)-70 (used crude)
(±)-68
(±)-(2E,4Z)-(4-Bromo-1-methyl-undeca-2,4,10-trienyloxy)-tert-butyl-dimethyl-silane (68):
To a solution of boronate (+)-67 (0.94 g, 3.0 mmol, 1 equiv) in acetone and water (30
mL, 2:1) was added sodium metaperiodate (2.0 g, 9.4 mmol, 3.1 equiv) and ammonium acetate
(0.71 g, 9.2 mmol, 3.0 equiv). The resulting cloudy solution was stirred at ambient temperature.
After 48 h, the reaction mixture was placed under reduced pressure to remove acetone, was
diluted with ethyl acetate (100 mL) and the phases separated. The aqueous layer was extracted
with ethyl acetate (100 mL) and the combined organic layers were washed with brine (50 mL),
were dried over anhydrous sodium sulfate, were filtered, and were concentrated under reduced
pressure to provide boronic acid (±)-70 as a light brown oil (0.66 g, 95%). Dibromide 66 (150
mg, 0.56 mmol, 1 equiv) and crude boronic acid (+)-70 (160 mg, 0.69 mmol, 1.2 equiv) were
combined, dissolved in THF-water (3:1, 11 mL), and the solution was degassed thoroughly
(FPT). Tetrakis(triphenylphosphine)palladium (33 mg, 0.028 mmol, 0.050 equiv) was added as
a solid, light was excluded, and the resulting clear yellow solution was stirred for 5 min.
Thallium carbonate (0.53 g, 1.1 mmol, 2.0 equiv) was added as a solid, and the resulting
heterogeneous yellow-white mixture was stirred in the dark. After 25 h, the light tan reaction
mixture was diluted with ethyl acetate and passed through a silica plug and the clear solution was
concentrated. The resulting brown oil was purified by flash column chromatography (silica gel:
diam. 2.5 cm, ht. 4 cm; eluent: hexanes:EtOAc [98:2] to hexanes:EtOAc [96:4]) to provide triene
(±)-68 as a yellow oil (156 mg, 75%).
'H NMR (500 MHz, CDCl 3, 200C):
3C NMR (125 MHz, CDCl 3, 20'C):
FTIR (thin film) cm-':
6.19 (d, J= 14.6 Hz, 1H, BrCCH=CH), 6.03 (dd, J
- 14.6, 4.8 Hz, 1H, BrCCH=CH), 5.91-5.75 (m,
2H, BrC=CH; CH2=CH), 5.06-4.93 (m, 2H,
CH 2=CH), 4.44 (m, 1H, TBSOCHCH 3), 2.35-2.28
(m, 2H, BrC=CHCH 2), 2.10-2.06 (m, 2H,
CH 2=CHCH 2), 1.49-1.43 (m, 4H, (CH 2)2), 1.25 (d,
J= 6.4 Hz, 3H, CH 3), 0.92 (s, 9H, SiC(CH 3)3), 0.08
(s, 3H, SiCH 3), 0.07 (s, 3H, SiCH 3).
138.9, 138.3, 133.7, 127.5, 125.2, 114.7, 68.5
(TBSOCH), 33.8, 31.6, 28.7, 28.1, 26.1 (C(CH 3)3),
24.8, 18.5, -4.4 (SiCH 3), -4.5 (SiCH 3).
2955 (s), 2929 (s), 2857 (s), 1472 (w), 1462 (w),
1255 (m), 1149 (m), 1089 (m), 835 (s), 776 (s).
HRMS (ESI): caled for C18H33NaBrOSi [M+Na]*: 395.1376,
found: 395.1365.
TLC (40% EtOAc in hexanes), Rf- 70, 0.26 (KMnO4)
68, 0.83 (UV, KMnO4)
oxazolidin-2-one
MeNHCH 2CH2NHMe MeMe _______
Cul, K2CO3,110 *C TBSOTBSO toluene, 21 h N-,
(±)-68 Br (±)-71
95% 0
(±)-3-{(1Z)-1-[(E)-3-(tert-Butyl-dimethyl-silanyloxy)-but-1-enyll-octa-1,7-dienyll-oxazolidin-2-one
Vinyl bromide (±)-68 (3.10 g, 8.30 mmol, 1 equiv) was transferred in dry toluene to a
flame-dried Schlenk pressure vessel, the solvent was removed under reduced pressure, and the
vessel filled with argon. Oxazolidin-2-one (869 mg, 9.96 mmol, 1.20 equiv), copper iodide (790
mg, 4.15 mmol, 0.500 equiv), and potassium carbonate (2.29 g, 16.6 mmol, 2.00 equiv) were
added under argon, and the vessel was evacuated and back-filled with argon three times.
Dimethylethylenediamine (2.23 mL, 20.8 mmol, 2.50 equiv) and toluene (33 mL) were added.
The reaction vessel was sealed under argon atmosphere and the green-gray heterogeneous
mixture was heated to 110 'C. The solution turned slate-blue after five minutes, then light
yellow-green. After 21 h, the solution was cooled to ambient temperature and partitioned
between ethyl acetate (200 mL) and water (100 mL). The blue aqueous layer was extracted with
ethyl acetate (3 x 150 mL), and the combined yellow organic layers were washed with brine (50
mL), were dried over anhydrous sodium sulfate, were filtered, and were concentrated under
reduced pressure. The resulting brown oil was purified by flash column chromatography (silica
gel: diam. 7 cm, ht. 10 cm; eluent: CH 2Cl 2:acetone [99:1] to CH 2Cl2:acetone [96:4] to
CH 2Cl2:acetone [85:15]) to provide triene (±)-71 as a light yellow oil (2.98 g, 95%).
'H NMR (500 MHz, C6D6, 20'C):
"C NMR (125 MHz, C6D6, 20'C):
FTIR (thin film) cm-:
HRMS (ESI):
6.09 (dd, J= 15.4, 1.0 Hz, 1H,
(TBSO)CHCH=CH), 5.77-5.69 (m, 1H, CH=CH 2),
5.63 (dd, J= 15.6, 5.5 Hz, 1H,
(TBSO)CHCH=CH), 5.46 (t, J= 7.4 Hz, 1H,
(N)C=CH), 5.04-4.97 (m, 2H, CH=CH2), 4.27 (app-
p, J= 6.1 Hz, iH, (TBSO)CH), 3.55-3.51 (m, 2H,
OCH 2CH 2N), 3.02-2.91 (m, 2H, OCH 2CH 2N),
2.04-1.98 (m, 2H, CH 2CH=CH2), 1.94-1.90 (m, 2H,(N)C=CHCH 2), 1.28-1.24 (m, 4H, (CH 2)2), 1.21 (d,
J= 6.3 Hz, 3H, TBSOCHCH 3), 1.01 (s, 9H,
SiC(CH 3)3), 0.11 (s, 3H, Si(CH 3)2), 0.10 (s, 3H,
Si(CH 3)2).
156.2 (O=C), 139.2, 134.5, 134.1, 134.0, 125.6,
115.1, 69.5, 61.9, 46.2, 34.3, 29.3, 28.8, 28.3, 26.5,
(C(CH 3)3), 25.2, 18.8, -4.0 (SiCH 3), -4.2 (SiCH3).
2928 (w), 2856 (w), 1758 (s), 1414 (m), 1251 (w),
834 (m).
caled for C21H37NaNO 3Si [M+Na]*: 402.2435,
found: 402.2444.
TLC (3% acetone in CH 2C12), Rf- 68, 0.89 (UV, CAM)
71, 0.54 (UV, CAM)
Me
TBSO
N0
(*)-71 O- 
-
TBAF, THF, Me
0-23 C HO \ /
(±)-S3 0 D
(+)-3-[(1Z)-1-((E)-3-Hydroxy-but-1-enyl)-octa-1,7-dienyll-oxazolidin-2-one (S3):
A solution of tetrabutylammonium fluoride in THF (IM, 1.9 mL, 1.9 mmol, 1.5 equiv)
was added to a solution of silyl ether (±)-71 (487 mg, 1.28 mmol, 1 equiv) in THF (10 mL) at 0
0C. The resulting light yellow solution was vigourously stirred and allowed to warm to ambient
temperature. After 3.5 h, the reaction mixture was diluted with ethyl acetate (50 mL), water (5
mL), and saturated aqueous ammonium chloride solution (25 mL). The aqueous layer was
extracted with ethyl acetate (3 x 50 ml), and the combined organic layers were washed with
brine (25 mL), were dried over anhydrous sodium sulfate, were filtered, and were concentrated
under reduced pressure. The resulting yellow oil was purified by flash column chromatography
(silica gel: diam. 2.5 cm, ht. 6.5 cm; eluent: CH 2Cl 2:acetone [95:5] to CH 2Cl2:acetone [80:20] to
CH2Cl2:acetone [50:50]) to provide the alcohol (±)-S3 as a clear oil (321 mg, 95%).
'H NMR (500 MHz, C6D6, 20*C):
3 C NMR (125 MHz, C6D6, 20'C):
FTIR (thin film) cm-':
HRMS (ESI):
TLC (10% acetone in CH 2Cl 2), Rf
5.99 (d, J= 15.6 Hz, 1H, MeC(OH)CH=CH), 5.8 1-
5.71 (in, 1H, CH=CH 2), 5.64 (dd, J= 15.6, 5.5 Hz,
1H, MeC(OH)CH=CH), 5.41 (t, J= 7.4 Hz, 1H,
(N)C=CH), 5.07-4.97 (in, 2H, CH=CH2), 4.24 (br-
s, 1H, CHOH), 3.67-3.57 (in, 2H, OCH2CH 2N),
2.97 (t, J= 8.0 Hz, 2H, OCH 2CH2N), 2.36-2.18 (br-
s, OH), 2.03-1.91 (m, 4H, (allylic CH 2), 1.32-1.25
(in, 4H, (CH 2)2, 1.23 (d, J = 6.3 Hz, 3H, CH 3).
156.7 (O=C), 139.2 (C=CN), 134.5, 134.1, 128.7,
126.1, 115.1 (HC=CH2), 68.3, 62.2, 46.2, 34.3,
29.3, 28.9, 28.2, 24.0.
3421 (br-m, OH), 2973 (w), 2927 (m), 2857 (w),
1741 (s, C=O), 1419 (s), 1247 (in), 1037 (in).
calcd for Ci5H23NaNO 3 [M+Na]+: 288.1572,
found: 288.1572.
71, 0.75 (UV, CAM)
S3, 0.16 (UV, CAM)
Me
HO
(*)-S3 0
MnO 2  , Me
CH2Cl2, 23 *C O
92% (±)-S4
0
(±)-3-[(1Z)-1-((E)-3-Oxo-but-l-enyl)-octa-1,7-dienyll-oxazolidin-2-one (S4):
y-Manganese dioxide (1.21 g, 13.9 mmol, 11.7 equiv) was added under an argon
atmosphere in one portion to a solution of alcohol (±)-S3 (317 mg, 1.20 mmol, 1 equiv) in
dichloromethane (6 mL) and the mixture was stirred at ambient temperature. After 19.5 h, the
reaction mixture was diluted with dichloromethane and passed through celite. The resulting
solution was concentrated under reduced pressure to provide spectroscopically clean ketone (±)-
S4 as a clear oil (289 mg, 92%). If desired, purification of ketone (±)-S4 could be achieved via
flash column chromatography (silica gel, eluent: CH 2Cl 2:acetone [98:2] to CH 2Cl2:acetone
[90:10]).
'H NMR (500 MHz, C6D6, 20'C):
3C NMR (125 MHz, C6D6, 20'C):
FTIR (thin film) cm-:
HRMS (ESI):
TLC (10% acetone in CH 2Cl 2), RfI
6.77 (d, J= 15.8 Hz, 1H, MeCOCH=CH), 6.00 (d, J
= 15.8 Hz, 1H, MeCOCH=CH), 5.78-5.70 (m, 1H,
CH=CH2), 5.52 (t, J= 7.6 Hz, 1H, (N)C=CH),
5.06-4.99 (m, 2H, CH=CH 2), 3.47 (app-t, J= 7.8
Hz, 2H, OCH 2CH2N), 2.73 (app-t, J= 7.8 Hz, 2H,
OCH2CH 2N), 1.94-1.90 (m, 7H, allylic-CH 2,
allylic-CH 2, Me), 1.21-1.20 (m, 4H, (CH 2)2).
196.6 (ketone-C=O), 156.1 (carbamate-C=O),
143.7, 140.2, 139.0, 134.1, 126.6, 115.3, 62.2
(OCH 2CH 2N), 46.0 (OCH 2CH2N), 34.2, 29.3, 28.8,
28.3, 27.9.
2924 (m), 1754 (s, C=O), 1746 (s, C=O), 1666 (m),
1631 (m), 1599 (m), 1414 (s), 1251 (m).
calcd for Ci5H21NaNO3 [M+Na]*: 286.1414,
found: 286.1421.
S3, 0.16 (UV, CAM)
S4, 0.42 (UV, CAM)
Me.
0
(±)-S4 N
0
TBSOTf, NEt3
CH2CI2, -78 *C
93%
TBSO
72
3-{1Z)-1-[(Z)-3-(tert-Butyl-dimethyl-silanyloxy)-but-1,3 dienyll-octa-1,7-dienyll-oxazolidin-2-one
(72h
Triethylamine (860 [tL, 6.12 mmol, 1.50 equiv) was added to a solution of ketone (±)-S4
(1.07 g, 4.08 mmol, 1 equiv) in dichloromethane (20 mL) at -78 "C, followed by dropwise
addition of TBSOTf (1.12 mL, 4.89 mmol, 1.20 equiv). After 15 min, the excess silylating agent
was quenched by the addition of saturated aqueous sodium bicarbonate solution (5 mL) and
allowed to warm to ambient temperature. The reaction mixture was diluted with ethyl acetate
(80 mL) and washed with saturated aqueous sodium bicarbonate solution (30 mL). The aqueous
phase was extracted with ethyl acetate (4 x 75 mL), and the combined organic layers were
washed with brine (20 mL), were dried over anhydrous sodium sulfate, were filtered, and were
concentrated under reduced pressure. The resulting oil was purified by flash column
chromatography (neutralized silica gel: diam. 5 cm, ht. 9 cm; eluent: CH 2Cl 2:acetone [97:3]) to
provide the silyl enol ether 72 as a white solid (1.44 g, 93%).
'H NMR (500 MHz, C6D6, 200C):
13C NMR (125 MHz, C6D6, 20'C):
FTIR (thin film) cm-1:
HRMS (ESI):
6.80 (d, J= 15.3 Hz, 1H, HC=CHCOTBS), 6.06 (d,
J= 15.3 Hz, 1H, HC=CHCOTBS), 5.76-5.68 (m,
1H, CH=CH 2), 5.60 (t, J= 7.4 Hz, 1H, (N)C=CH),
5.03-4.96 (m, 2H, CH=CH 2), 4.42 (s, 1H,
CH 2=CHOTBS), 4.33 (s, 1H, CH2=CHOTBS), 3.51
(app-t, J= 7.6 Hz. 2H, OCH 2CH2N), 2.89 (app-t, J
= 8.0 Hz, 2H, OCH 2CH 2N), 2.03-1.99 (m, 2H,
CH 2CH=CH 2), 1.95-1.85 (m, 2H, (N)C=CHCH 2),
1.24-1.21 (m, 4H, (CH 2)2), 1.02 (s, 9H,
SiC(CH 3)3), 0.18 (s, 6H, Si(CH 3)2).
156.3, 155.6, 139.2, 136.1, 134.8, 127.3, 126.5,
115.1, 97.4, 62.1, 46.3, 34.2, 29.3, 28.7, 28.6, 26.4,
18.9, -4.2.
2930 (s), 2858 (s), 1759 (s, C=O), 1415 (m), 1316
(m), 1254 (m), 1030 (m), 840 (m).
calcd for C2 1H36NO3Si [M+H]*: 378.2459,
found: 378.2465.
TLC, Rf
(10% acetone in CH 2Cl2, neutralized plates): S4, 0.58 (UV, CAM)
72, 0.79 (UV, CAM)
TBSO
72 0
0
acrolein,
4,5-DihydrolMES-
Cl2Ru=CH(o-O'Pr)Ph(10 mol%)
CH2Cl2, 23 *C
85%
OHC
TBSO
73 
O
0
(2E,8Z,10E)-12-(tert-Butyl-dimethyl-silanyloxy)-9-(2-oxo-oxazolidin-3-yl)-trideca-2,8,10,12-tetraen-
1-al (73):
To a solution of silyl enol ether 72 (500 mg, 1.32 mmol, 1 equiv) in dichloromethane (6.6
mL) was added freshly distilled acrolein (354 [tL, 5.30 mmol, 4.00 equiv, no stabilizer present),
followed by 4,5-(DihydroIMES)Cl2Ru=CH(o-O'Pr)Pho (82 mg, 0.13 mmol, 0.10 equiv). The
green solution was stirred at ambient temperature for 10 minutes, then purified immediately
without concentration via flash column chromatography (neutralized silica gel: diam. 5 cm, ht. 8
cm; eluent: CH 2Cl2:acetone:NEt 3 [98:1:1]) to provide the tetraene 73 as a tan solid (455 mg,
85%).
'H NMR (500 MHz, C6D6, 20*C):
3C NMR (125 MHz, C6D6, 20'C):
FTIR (thin film) cm-':
HRMS (ESI):
TLC, Rf
(3% acetone in CH 2Cl2, neutralized plates)
9.34 (d, J= 7.6 Hz, 1H, CHO), 6.71 (d, J= 15.3 Hz,
1H, HC=CHCOTBS) 6.07 (d, J= 15.3 Hz, 1H,
HC=CHCOTBS), 6.01 (dd, J= 15.6, 6.6 Hz, 1H,
CH=CHCHO), 5.90 (dd, J= 15.6, 7.6 Hz, 1H,
CH=CHCHO), 5.55 (t, J= 7.4 Hz, 1H, (N)C=CH),
4.43 (s, 1H, CH 2=CHOTBS), 4.34 (s, 1H,
CH 2=CHOTBS), 3.55 (app-t, J= 7.9 Hz, 2H,
OCH 2CH 2N), 2.90 (app-t, J= 7.4 Hz, 2H,
OCH 2CH2N), 1.93 (app-q, J= 7.2 Hz, 2H,
CH 2CH=CH2), 1.67 (app-q, J= 6.9 Hz, 2H,
(N)C=CHCH 2), 1.11-0.94 (m, 13H, (CH 2)2 ,
SiC(CH 3)3), 0.18 (s, 6H, Si(CH 3)2).
193.2 (CHO), 157.5, 156.4, 155.5, 135.5, 135.0,
133.6, 127.0, 126.8, 97.5, 62.2, 46.3, 32.6, 28.5,
28.3, 27.9, 26.3, 18.8, -4.2.
2951 (s), 2930 (s), 2858 (m), 1753 (s), 1689 (s),
1414 (m), 1253 (m), 840 (m).
calcd for C22H35NaNO 4Si [M+Na]*: 428.2228,
found: 428.2226.
72, 0.63 (UV, CAM)
73, 0.30 (UV, CAM)
10 Garber, S. B.; Kingsbury, J. S.; Gray, B. L.; Hoveyda, A. H. J. Am. Chem. Soc. 2000, 122, 8168. Grubbs' GI and
G2 Ru-catalysts required above ambient temperatures found to be incompatible with the sensitive tetraene product
73.
90 *C TBSO
-. 0. w"19 10
toluene
TBSO 82% N O
73 (±)-65 0
(±)-(9S, 10R, 15R, 19S)-trans-Decalin aldehyde (65):
A flame-dried Schlenk flask was charged with tetraene 73 (279 mg, 0.688 mmol, 1 equiv)
and toluene (34 mL) and sealed under argon atmosphere. The vessel was heated to 90 "C. After
13 h, the solvent was removed under reduced pressure and the resulting oil was purified by flash
column chromatography (neutralized silica gel: diam. 2.5 cm, ht. 8 cm; eluent:
CH 2Cl2:acetone:NEt 3 [94:5:1]) to provide the (±)-trans-decalin aldehyde 65 as a yellow oil (228
mg, 82%).
'H NMR (500 MHz, C6D6, 200C):
"C NMR (125 MHz, C6D6, 20'C):
nOe data (500 MHz, C6D6, 200C):
FTIR (thin film) cm-1:
HRMS (ESI):
9.66 (d, J= 5.2 Hz, 1H, CHO), 5.01 (dd, J= 5.2,
2.1 Hz, 1H, NC=CH), 4.37 (d, J= 1.1 Hz, 1H,
C=CH2), 4.34 (d, J= 1.0 Hz, 1H, C=CH 2), 3.42-
3.33 (in, 2H, OCH 2CH 2N), 2.98-2.95 (m, 1H,
CHCOTBS), 2.79 (q, J= 8.6 Hz, 1H, OCH 2CH 2N),
2.50-2.45 (m, 1H, OCH 2CH 2N), 2.33-2.28 (m, 1H,
HCC(N)CH), 2.26-2.21 (in, 1H, CHOCH), 2.04-
1.97 (m, 2H, CHOCHCH), 1.67-1.62 (m, 2H,
(CH 2)4), 1.54-1.52 (m, 1H, (CH 2)4), 1.26 (qt, J=
13.2, 3.8 Hz, 1H, (CH 2)4), 1.17-1.09 (in, 1H,(CH 2)4), 1.03-0.92 (in, 1H, (CH 2)4), 0.97 (s, 9H,
SiC(CH 3)3), 0.83 (qd, J= 3.8, 12.6 Hz, 1H, (CH 2)4),
0.14 (s, 3H, SiCH 3), 0.12 (s, 3H, SiCH 3).
203.6 (CHO), 158.2 (carbamate-C=O), 156.2,
140.8, 117.8, 95.4, 62.0 (OCH 2CH 2N), 53.9, 46.7
(OCH2CH2N), 44.4, 42.7, 37.4, 30.9, 27.2, 27.0,
26.4 (SiC(CH 3)3, 18.8, -3.9 (SiCH 3), -4.3 (SiCH 3).
2929 (s), 2857 (m), 1756 (s), 1724 (s), 1408 (m),
1255 (m), 1220 (m), 837 (s).
calcd for C22H36NO4 Si [M+H]*: 406.2408,
found: 406.2403.
TLC, Rf
(30% acetone in hexanes, neutralized plates) 73, 0.26 (UV, CAM)
65, 0.33 (CAM)
Me(C=O)CH=CH2
AIBN, "Bu3SnH
iPr2NEt, toluene
reflux
0 Me
Me O eNHBoc
(+)-(S)-76
53%
(+)-(S)-(1-Methyl-5-oxo-hexyl)-carbamic acid tert-butyl ester (76):
A solution of alkyl iodide (S)-75" (5.10 g, 17.7 mmol, 1 equiv) in toluene (95 mL) was
treated sequentially with methyl vinyl ketone (9.40 mL, 115 mmol, 6.50 equiv) and
diisopropylethylamine (10.0 mL, 88.5 mmol, 3.00 equiv). The reaction mixture was heated to
reflux and a solution of tributyltin hydride (7.5 mL, 28 mmol, 1.6 equiv) and AIBN (0.40 g, 2.4
mmol, 0.15 equiv) in toluene (30 mL) was added via cannula. After heating at reflux for 1 h, the
reaction mixture was cooled to ambient temperature and triethylamine (10 mL) was added.
Excess tributyltin hydride was quenched by dropwise addition of a solution of iodine in toluene
(0.2 M, 0.5 mL) until an orange color persisted. The orange solution was stirred for 10 min, then
a solution of potassium fluoride (5.2 g) in water (40 mL) was added, and the resulting suspension
was stirred for 1.5 h. The reaction mixture was filtered through celite, and the filtrate was
partitioned between diethyl ether (100 mL) and water (50 mL). The aqueous layer was extracted
with diethyl ether (3 x 100 mL) and the combined organic layers were washed sequentially with
saturated aqueous sodium bicarbonate solution (20 mL) and brine (20 mL). The organic phases
were dried over anhydrous sodium sulfate, were filtered and were concentrated under reduced
pressure. Purification of the yellow residue by flash chromatography (silica gel: diam. 7, ht. 15
cm; eluent: hexanes:EtOAc [1:1]) afforded the ketone (+)-(S)- 76 as a brown solid (2.2 g, 53%,
[a] 2 2D = +3 (c 0.5, EtOAc)).
The corresponding enantiomer, ketone (-)-(R)-76 (6.9 g, 59%, [a] 22D = -3 (c 0.5,
EtOAc)), was prepared using the same procedure and starting with alkyl iodide (R)-75.
'H NMR (500 MHz, CDCl 3, 20'C):
13C NMR (125 MHz, CDCl 3, 200C):
FTIR (thin film), cm-1:
HRMS (El):
TLC (50% EtOAc in hexane):
4.33 (br-s, 1H, NHBoc), 3.65 (br-s, 1H,
(CH 3)CHNH), 2.52-2.40 (m, 2H, C(O)CH 2), 2.14
(s, 3H, CH 3C(O), 1.66-1.54 (in, 3H, CH 2C(CH3),(CH3)CHCH 2CH2), 1.45 (s, 9H, C(CH 3)3), 1.44-
1.38 (in, 1H, CH 2C(CH3)), 1.12 (d, 3H, J= 6.6 Hz,
CH(CH 3)).
209.1, 155.6, 79.2, 46.3, 43.4, 36.7, 30.2, 28.6, 21.4,
20.3.
3351 (m, N-H), 2975 (m), 1710 (br-s, C=O), 1523
(m), 1172 (in).
calcd for C12H24NO3 [M+H]*: 230.1751,
found: 230.1752.
75, 0.73 (ninhydrin, UV)
76, 0.52 (ninhydrin, anis)
" Prepared from L-alaninol; see: Caputo, R.; Cassano, E.; Longobardo, L.; Palumbo, G. Tetrahedron 1995, 51,
12337.
Me
I '.NHBoc
(S)-75
0 Me
Me O eNHBoc
(+)-(S)-76
CI- Me
H C I, H 20 M
69% Me
(-)-(2S)-64
(-)-(2S)-2,6-Dimethyl-2,3,4,5-tetrahydro-pyridinium chloride (64):
The N-Boc ketone (+)-(S)-76 (3.40 g, 14.9 mmol, 1 equiv) was dissolved in aqueous
hydrochloric acid (1 OM, 60.0 mL). After stirring for 12 h, the reaction mixture was concentrated
under reduced pressure (1 Torr) to give a dark brown oil. This residue was triturated from THF
(2 x 10 mL) to provide the iminium chloride (-)-(2S)-64 as a beige solid (1.5 g, 69%, [a]2 2 D
-19 (c 0.5, EtOAc)) and vigorously dried. 12 The optical activity of (-)-64 was measured to be
>99% ee by chiral HPLC analysis of the corresponding benzylated derivative13 [(SS)-Whelk-O;
3.0 mL/min; 13% 'PrOH in hexanes; tR(major) = 19.53 min; tR(minor, not seen) - 17.64 min].
The corresponding enantiomer, iminium chloride (+)-(2R)-64 (0.4 g, 81%, [a] 2 2D = +19
(c 0.5, EtOAc)), was prepared using the same procedure and starting with N-Boc ketone (-)-(R)-
76. The optical activity of (+)-64 was measured to be >99% ee by chiral HPLC analysis of the
corresponding benzylated derivative' 3 [(S,S)-Whelk-O; 3.0 mL/min; 13% 'PrOH in hexanes;
tR(major) = 17.64 min; tR(minor, not seen) = 19.53 min]'.
'H NMR (500 MHz, CDCl 3, 200C):
'
3 C NMR (125 MHz, CDCl3, 20"C):
FTIR (thin film), cm-:
HRMS (El):
15.24 (m, 1H, C=NH*), 3.97 (br-s, 1H,
NH*CH(CH 3)CH 2), 2.64 (br-s, 5H, (CH 3)CNH*=C,
CH 3CCH 2), 2.08-2.02 (m, 1H, (CH 3)CCH 2), 1.97-
1.90 (m, 1H, (CH 3)CCH 2), 1.84-1.76 (m, 1H,
HN*=CCH 2CH2), 1.61 (d, 3H, J= 6.8 Hz, C(CH 3),
1.58-1.55 (m, 1H, HN*=CCH 2CH 2).
186.6, 51.9, 31.6, 27.5, 24.4, 20.1, 16.0.
3406 (br-s, N-H), 2936 (m), 2839 (m), 1686 (m),
1457 (w), 1386 (w).
calcd for C7H1 4N [M-Cl]*: 112.1121,
found: 112.1120.
12 Iminium chloride 64 was highly hygroscopic and required handling under inert atmosphere for optimal results.
13 Iminium chloride 64 was lithiated and acylated with benzoyl chloride to give the corresponding vinylogous amide.
14 Additionally, to ensure elution of the major compound after the minor compound, the (R,R)-Whelk-O was also
used: [(R,R)-Whelk-0; 3.0 mL/min; 13% 'PrOH in hexanes; tR(major) = 20.34 min; IR(minor, not seen) = 19.39
min].
,Me ,Me Me
Ci Me
'CHO H O  7 8 7
2 H Me H Martin's 20 H H
TBSO H" (-)-64 TBSO HV sulfurane TBSO H' +' OTBSHHH "- H + "H OB
H - 9BuLi, THF H k benzene H H16 H -78*C H 23*C H H
85% S5 O O 81% O O
(±)-65 (mixture of 63 ent-2-epi-63
diastereomers) 1 1
3-{3-[1-tert-Butyl-dimethyvl-silanyloxy)-vinyll-4-[2-(6-methyl-3,4,5,6-tetrahydro-pyvridin-2-yl)-vinyll-
3,4,4a,5,6,8,8s-octahydro-naphthalene-1-yl}-oxazolidin-2-one (63):
To a suspension of iminium chloride (-)-(2S)-64 (101 mg, 0.68 mmol, 2.00 equiv) in
THF at -78 0C and sealed under argon" was added a solution of n-butyllithium in hexanes (2.53
M, 520 [tL, 1.32 mmol, 3.87 equiv). The resulting brown solution was maintained at -78 0C for
30 min, was warmed to 0 'C for 10 min, then cooled to -78 'C. A sample of aldehyde (+)-65
(137 mg, 0.34 mmol, 1 equiv) in a round-bottomed flask was azeotropically dried from toluene
(2 x 4 mL), the flask was evacuated and backfilled with argon three times, charged with THF
(700 [tL), and cooled to -78 'C. The lithiated enamine solution was transferred cold via cannula
to the cold aldehyde solution. After ten minutes excess anion was quenched at -78 'C by the
addition of saturated aqueous ammonium chloride solution (2 mL) and the reaction mixture was
allowed to warm to room temperature. The reaction mixture was diluted with ethyl acetate (40
mL) and saturated aqueous ammonium chloride solution (15 mL) and the layers separated. The
aqueous layer was extracted with ethyl acetate (2 x 40 mL) and the combined organic layers
were washed with brine (15 mL), were dried over anhydrous sodium sulfate, were filtered, and
were concentrated under reduced pressure. The resulting yellow oil was purified by flash
column chromatography (neutralized silica gel: diam. 2.5 cm, ht. 10 cm; eluent:
CH 2Cl 2:acetone:NEt 3 [98:1:1] to CH 2Cl 2:acetone:NEt 3 [97:2:1] to CH 2Cl2:acetone:NEt 3 [96:3:1])
to provide p-hydroxyimine S5 (168 mg, 85%, equal mixture of 4 diastereomers) as a light
yellow oil. Additionally, the starting aldehyde (+)-65 was recovered (8.1 mg, 6%).
A solution of Martin sulfurane (219 mg, 0.326 mmol, 1.18 equiv) in benzene (2 mL)
under argon atmosphere,' 5 was transferred via cannula to a solution of p-hydroxyimine S5 (153
mg, 0.276 mmol, 1 equiv) in benzene (4 mL) at 23 'C. After 25 min, the reaction mixture was
concentrated under reduced pressure, and the resulting oil was purified by flash column
chromatography (neutralized silica gel: diam. 5 cm, ht. 18 cm; eluent: hexanes:acetone:NEt 3[89:10:1] to acetone:hexanes:NEt [84:15:1] to acetone:hexanes:NEt 3 [74:25:1] to
acetone:hexanes:NEt 3 [64:35:1]) to provide the a,p-unsaturated imines (119 mg, 81%, 63:ent-2-
epi-63, ~1:1) as a yellow oil.
The corresponding enantiomers of the p-hydroxyimine (203 mg, 70%, equal mixture of 4
diastereomers) and the cp-unsaturated imine (167 mg, 85%, ent-63:2-epi-63, -1:1) were
prepared using the same procedure and the imine salt (+)-(2R)-64.
15 Rigorous inert atmosphere and anhydrous conditions were required for optimal results.
'H NMR (500 MHz, C6D6, 20C, equal mixture of two diastereomers, 63:ent-2-epi-63, 1:1):
6.46 (d, J= 4.6 Hz, 1H, C7-H), 6.43 (d, J= 4.6 Hz,
1H, C7-H), 6.13-6.05 (m, 2H, C8-H, C8-H), 5.14-
5.11 (m, 2H, C17-H, C17-H), 4.29 (br-s, 2H, C21-
H, C21-H), 3.62-3.52 (m, 2H, C2-H, C2-H), 3.46-
3.41 (m, 4H, OCH 2CH 2N, OCH 2CH2N), 2.95-2.89
(m, 2H, OCH2CH 2N, OCH 2CH 2N), 2.79-2.75 (m,
2H, C19-H, C19-H), 2.65-2.60 (m, 2H,
OCH 2CH 2N, OCH2CH 2N), 2.40-2.31 (m, 4H, C5-
H, C5-H, C15-H, C15-H), 2.19-2.07 (m, 6H, C5-H,
C5-H, C9-H, C9-H, CH 2, CH 2), 2.01-1.94 (m, 2H,
C1O-H, C1O-H), 1.86-1.71 (m, 8H, CH 2, CH 2),
1.57-1.49 (m, 8H, C3-H, C3-H, C4-H, C4-H), 1.39
(br-s, 3H, Cl-H), 1.38 (br-s, 3H, Cl-H), 1.36-1.21
(m, 6H, CH 2 , CH 2), 0.97 (br-s, 18H, SiC(CH3)3),
0.19 (br-s, 3H, Si(CH 3)2), 0.18 (br-s, 3H, Si(CH 3)2),
0.17 (br-s, 3H, Si(CH 3)2), 0.17 (br-s, 3H, Si(CH 3)2).
3 C NMR (125 MHz, C6D6, 20C, equal mixture of two diastereomers, 63:ent-2-epi-63, ~1:1):
163.99, 163.98, 159.64, 159.63, 156.01, 155.99,
140.46 (br-s, 2 carbons), 137.99 (C8), 137.95 (C8),
136.26 (C7), 136.19 (C7), 119.44 (C17), 119.25
(C 17), 94.39 (C21), 94.34 (C21), 61.80 (br-s, 2
carbons, OCH2CH 2N, OCH2CH 2N), 54.53, 54.41,
48.05 (C19), 48.04 (C19), 46.82 (OCH 2CH2N),
46.78 (OCH2CH 2N), 46.63 (C9), 46.60 (C9), 43.21
(C15), 43.16 (C15), 40.39 (C10), 40.36 (C10),
31.74 (C11), 31.67 (C11), 30.65 (C14), 30.61
(C14), 30.42, 30.37, 27.39, 27.36, 27.11 (br-s, 2
carbons), 26.31, 26.29, 25.88, 25.85, 24.30, 24.26,
19.66, 19.47, 18.69 (SiC(CH3)3), -4.03
(Si(CH 3)2),-4.05 (Si(CH 3)2), -4.17 (Si(CH 3)2),
-4.23 (Si(CH 3)2).
FTIR (thin film, equal mixture of two diastereomers, 63:ent-2-epi-63, ~1:1) cm: 2929 (s), 2856
(m), 1756 (s), 1615 (m), 1406 (m), 1259 (m), 1215
(m), 839 (s).
HRMS (ESI, S5): calcd for C29H47N20 4 Si [M+H]*: 517.3456,
found: 517.3464.
HRMS (ESI, 63:ent-2-epi-63, -1:1): caled for C29H 46N2O3 Si [M]*: 499.3351,
found: 499.3354.
TLC Rf (neutralized plates):
(CH 2Cl 2:acetone:NEt 3 [96:3:1])
(hexanes:acetone:NEt 3 [69:30:1])
65, 0.59 (CAM)
S5, 0.21 (CAM)
S5, 0.40 (UV, CAM)
63 and ent-2-epi-63, 0.44 (UV, CAM)
2'Me Me 2 ,Me
N Ns N
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20 H H 0 I H
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63 ent-2-epi-63 isomeric mixture
TBSO OTBS Bu3SnH, AIBN
H + H benzene, 60-90 *C
H H 55% (two steps)
H2 H H N Me
Me NH HN H
79 0 0 ent-2-epi-79
1 1
3-[3-(tert-Butvl-dimethvl-silanyloxy)-1-(6-methyl-3,4,5,6-tetrahydro-pyridin-2-ylmethyl)-
3a,5a,6,7,8,9,9a,9b-octahydro-1H-cyclopentalalnaphthalen-5-yll-oxazolidin-2-one (79 and ent-2-epi-
79):
A solution of a,p-unsaturated imine 63 (119 mg, 0.238 mmol, 1 equiv, equal mixture of
63 and ent-2-epi-63) in THF (12 mL) was degassed via an argon purge. To this solution was
added solid sodium bicarbonate (106 mg, 1.26 mmol, 5.29 equiv) under argon. The reaction
mixture was cooled to 0 'C, light was excluded, and NBS (50.5 mg, 0.284 mmol, 1.19 equiv)
was added as a solid. The reaction mixture was maintained at 0 'C for ten minutes, then diluted
with hexanes:acetone:NEt 3 ([50:50:1], 10 mL), was filtered cold through a silica plug (diam. 1
cm, ht. 2.5 cm) and the filtrate was concentrated under reduced pressure to produce an orange-
brown foam. This residue was dissolved in benzene and filtered to remove excess insoluble
succinimide. It was then concentrated and placed under reduced pressure (- 0.5 Torr) for 1 h.
The resulting brominated product was used crude for the cyclization step.
The crude vinyl bromide was dissolved in benzene-d 1 6 (4.8 mL), was degassed via an
argon purge, and was charged with tributyltin hydride (192 [tL, 0.722 mmol, 3.00 equiv). A
solution of AIBN in benzene-d (0.30M) was prepared in a flame-dried flask, degassed via
bubbling argon, and a portion 17 (200 [L, 0.060 mmol, 0.25 equiv) was transferred to the reaction
mixture. The reaction solution was placed in a pre-heated 60 'C oil bath and heated to 90 'C over
20 min. After 30 min, the reaction mixture was cooled, an additional portion of AIBN was
added (200 [tL, 0.060 mmol, 0.25 equiv), and the mixture was returned to 90 'C. After a
subsequent 20 min, the solution was cooled, additional tributyltin hydride (96 [tL, 0.36 mmol,
1.5 equiv) and AIBN (400 [tL, 0.030 mmol, 0.50 equiv) were added, and the reaction was
returned to 90 'C. After 20 min, the reaction was cooled, a final portion of AIBN was added
(400 [tL, 0.030 mmol, 0.50 equiv), and the mixture was returned to 90 'C. After an additional 20
min at 90 'C, the reaction appeared complete by direct 'H NMR spectral analysis. The reaction
solution was cooled, triethylamine (1 mL) was added to neutralize adventitious hydrobromic
16 Deuterated solvent was used to facilitate evaluation of reaction progress by direct 1 H NMR monitoring.
17 Sequential addition of the reagents was necessary for optimal results.
acid, and the solution was concentrated to -400 [tL under reduced pressure. The resulting brown
oil was purified via flash column chromatography (neutralized silica gel: diam. 2.5 cm, ht. 10
cm; eluent: hexanes:acetone:NEt 3 [97:2:1] to acetone:hexanes:NEt 3 [95:4:1] to
acetone:hexanes:NEt 3 [92:7:1] to acetone:hexanes:NEt [84:15:1]) to provide an equal mixture of
two diastereomeric tetracycles 79 and ent-2-epi-79 as a tan foam (65.7 mg, 55% (two steps)).
The corresponding enantiomers, tetracycles ent-79 and 2-epi-79 (90 mg, 54% (two steps),
(~1:1)) were prepared using the same procedure and starting with a,p-unsaturated imines ent-
63:2-epi-63, (~1:1)).
'H NMR (500 MHz, C6D6, 20C, equal mixture of two diastereomers, 79:ent-2-epi-79, -1:1):
5.66-5.63 (m, 2H, C17-H, C17-H), 4.83 (app-t, J=
2.9 Hz, 1H, C21-H), 4.70 (app-t, J= 2.9 Hz, 1H,
C21-H), 3.46-3.35 (m, 8H, OCH 2CH 2N,
OCH 2CH 2N, C2-H, C2-H, C19-H, C19-H), 3.11-
3.05 (m, 2H, OCH2CH 2N, OCH 2CH 2N), 2.99-2.94
(m, 1H, C8-H), 2.94-2.88 (m, 1H, C8-H), 2.74-2.69
(m, 2H, OCH2CH 2N, OCH 2CH 2N), 2.50-2.44 (m,
2H, C15-H, C15-H), 2.21-2.15 (m, 4H, C7-H, C7-
H, CH 2, CH 2), 2.15-2.09 (m, 2H, CH 2, CH 2), 2.09-
2.02 (m, 2H, CH 2 ,CH 2), 1.79-1.65 (m, 8H, C9-H,
C9-H, CH 2, CH 2), 1.56-1.43 (m, 4H, CH 2, CH 2),
1.43-1.26 (m, 4H, C1O-H, C1O-H, CH 2, CH 2), 1.36
(d, J = 6.7 Hz, 3H, Cl-H), 1.35 (d, J= 6.7 Hz, 3H,
Cl-H), 1.24-1.11 (m, 4H, CH 2 , CH 2), 1.01 (br-s,
18H, SiC(CH 3)3), 0.99-0.83 (m, 8H, CH 2, CH 2),
0.21 (s, 3H, SiCH 3)2), 0.20 (s, 3H, SiCH 3)2), 0.19
(s, 3H, SiCH 3)2), 0.18 (s, 3H, SiCH 3)2).
3 C NMR (125 MHz, C6D6, 20'C, equal mixture of two diastereomers, 79:ent-2-epi-79, -1:1):
167.31, 167.16, 156.35 (br-s, 2 carbons), 155.48,
155.24, 139.62 (br-s, 2 carbons), 128.93 (br-s, 2
carbons), 118.02, 117.96, 105.25, 104.82, 61.89 (br-
s, 2 carbons), 53.97, 53.84, 47.27, 47.24, 46.95,
46.82, 44.87, 44.76, 43.99, 43.95, 43.63 (br-s, 2
carbons), 32.10, 32.01, 30.36 (br-s, 2 carbons),
30.29, 30.24, 30.14, 30.05, 27.38 (br-s, 2 carbons),
27.36, 27.34, 26.34, 26.32, 24.42, 24.38, 19.84,
19.67, 18.76, 18.73, -4.17, -4.18, -4.20, -4.21.
FTIR (thin film, equal mixture of two diastereomers, 79:ent-2-epi-79, ~1:1) cm-1: 3397 (br-w),
2928 (s), 2856 (m), 1758 (s, C=O), 1650 (m), 1408
(m), 1254 (m), 1212 (w), 865 (m), 841 (m), 782
(w).
calcd for C29H47N20 3Si [M+H]*: 499.3351,
found: 499.3357.
HRMS (ESI):
TLC, Rf
(30% acetone in hexanes, neutralized plates) 79, 0.44 (UV, CAM)
ent-2-epi-79, 0.51 (UV, CAM)
OTBS
+ HI
Me
H N H
CO,4--O ent-2-epi-79
Et3N(HF)3, THF
23 C, 3h;
NaBH4, EIOH
0 0C, 15min
HO OHH HH
H H 19+ , H *HNH HH H 17 H7/H Me
Me NC HN 0 H
00
(-)-81, 36% (+)-82, 34%
Pentacyclic amines (-)-81 and (+)-82:
To a solution of tetracycle 79 (65.7 mg, 0.132 mmol, 1 equiv, equal mixture of 79 and
ent-2-epi-79) in THF (13 mL) at 23 'C was added triethylamine trihydrogen fluoride (107 [tL,
0.660 mmol, 5.00 equiv). After 3 h, the solution was cooled to 0 'C and the volatiles were
removed under reduced pressure on a manifold and allowed to warm to ambient temperature (3
h). The crude reaction mixture was dissolved in ethanol (10 mL) and cooled to 0 'C. A
suspension of sodium borohydride (10 mg, 0.26 mmol, 2.0 equiv) in ethanol (2 mL) was added
dropwise to the cold reaction mixture under an argon atmosphere. The resulting solution was
stirred at 0 'C for ten minutes, then excess hydride was quenched at 0 'C by the addition of
ethanolic hydrochloric acid (0.5 M, 1.5 mL) and the solution was vigorously stirred for five
minutes. The reaction mixture was neutralized by the addition of triethylamine (2 mL), was
stirred for five minutes, and the volatiles were removed under reduced pressure on a manifold (1
h). The resulting white solid was dissolved in ethyl acetate (50 mL), saturated aqueous sodium
bicarbonate solution (25 mL) and water (5 mL). The layers were separated and the aqueous
layer was extracted with ethyl acetate (3 x 50 mL). The combined organic layers were washed
with brine (10 mL), were dried over anhydrous sodium sulfate, were filtered, and were
concentrated under reduced pressure. Purification of the resulting yellow oil via flash column
chromatography (neutralized silica gel: diam. 1 cm, ht. 10 cm; eluent: CH 2Cl2:methanol [95:5] to
ammonia saturated CH 2Cl 2:methanol [92:8]) afforded the readily separable pentacyclic amines
(-)-81 (18.4 mg, 36%, [c] 22 D = -29 (c 0.44, CH2Cl2)) and (+)-82 (17.3 mg, 34%, [a] 2 D = +65 (c
0.43, CH 2Cl 2)).
The corresponding enantiomeric amines, (+)-81 and (-)-82 (20.0 mg and 25.0 mg,
respectively, 66%), were obtained using the same procedure and starting with a mixture of ent-79
and 2-epi-79 (-1:1).
'H NMR (500 MHz, C6D6, 20'C):
'H NMR (500 MHz, C6D6, 20'C):
Pentacyclic amine (-)-81: 6.09 (br-s, 1H, C17-H),
3.85-3.80 (in, 1H, C19-H), 3.50 (app-q, J= 7.4 Hz,
1H, OCH 2CH2N), 3.44 (app-q, J= 6.6 Hz, 1H,
OCH2CH 2N), 3.02-2.91 (in, 2H, OCH 2CH 2N),
2.79-2.71 (in, 2H, OCH2CH 2N), 2.42-2.33 (in, 1H),
2.13 (t, J= 9.8 Hz, IH), 2.00-1.94 (in, 1H), 1.90-
1.84 (in, 2H), 1.74 (ddd, J= 14.0, 6.2, 3.6 Hz, 1H),
1.71-1.61 (in, 2H), 1.56-1.46 (in, 2H), 1.44-1.31 (m,
3H), 1.23-1.09 (in, 6H), 0.98-0.88 (m, 2H) 0.85 (d,
J= 6.2 Hz, 3H, Cl-H).
Pentacyclic amine (+)-82: 6.00 (br-s, 1H, C17-H),
3.70-3.65 (in, 1H, C19-H), 3.56-3.46 (in, 2H,
OCH 2CH2N), 3.26 (t, J= 6.1 Hz, 1H, C6-H), 3.07
(app-q, J= 6.3 Hz, 1H, C2-H), 3.04-2.96 (in, 1H,
13C NMR (125 MHz, C6D6, 20'C):
13C NMR (125 MHz, C6D6, 20'C):
FTIR (thin film) cm-:
FTIR (thin film) cm-':
HRMS (ESI):
HRMS (ESI):
TLC, Rf
(10% MeOH:NH3 satd CH 2Cl2)
OCH 2CH 2N), 2.77 (app-q, J= 6.5 Hz, 1H,
OCH 2CH 2N), 2.07-1.67 (m, 1 1H), 1.30-1.09 (m,
6H), 1.09-1.02 (m, 2H), 1.00-0.98 (m, 2H), 0.93 (d,
J= 6.5 Hz, 3H, Cl-H).
Pentacyclic amine (-)-81: 157.4 (carbamate C=O),
137.5 (C16), 128.9 (C17), 80.6 (C20), 61.7
(OCH 2CH2N), 56.2, 53.8, 47.8, 47.6, 46.3, 45.8,
45.1, 42.1, 40.6, 40.1, 38.1, 33.8, 31.6, 29.4, 27.1,
26.9, 24.0, 23.4.
Pentacyclic amine (+)-82: 157.5 (carbamate C=O),
138.0 (C16), 128.9 (C17), 81.1 (C20), 61.9
(OCH 2CH2N), 48.6, 48.0, 47.3, 46.2, 44.0 (br),
40.9, 40.6, 40.0 (br), 37.6, 33.9, 29.7, 28.2, 27.3,
27.1, 21.1, 20.6.
Pentacyclic amine (-)-81: 3430 (br-s, OH), 2926
(s), 2855 (m), 1748 (s), 1662 (m), 1481 (w), 1447
(w), 1413 (m), 1279 (w), 1101 (m), 735 (m).
Pentacyclic amine (+)-82: 3424 (br-s, OH), 2926
(s), 2856 (m), 1743 (s), 1666 (w), 1482 (w), 1446
(w), 1416 (m), 1280 (w), 1101 (w), 734 (m).
Pentacyclic amine (-)-81: caled for C23H35N20 3
[M+H]*: 387.2642, found: 387.2635.
Pentacyclic amine (+)-82: caled for C23H35N20 3
[M+H]*: 387.2642, found: 387.2636.
(-)-81, 0.63 (KMnO4)(+)-82, 0.26 (KMnO4)
CICO 2Bn, Na2CO3
H20, CH 2C120-+23 *C
65%
HO
H 20 8 H
HH H
H H N4. 15
me H
0(-83O
Carbamate (-)-83:
A solution of sodium carbonate (21 mg, 0.19 mmol, 10 equiv) in water (475 [tL) was
added to a solution of amine (-)-81 (7.5 mg, 0.019 mmol, 1 equiv) in dichloromethane (600 [tL)
at 23 'C. The heterogeneous mixture was stirred vigorously and cooled to 0 'C.
Benzylchloroformate (8.2 [tL, 0.057 mmol, 3.0 equiv) was added dropwise and the resulting
mixture was warmed to room temperature for 15 minutes. Two additional portions of
benzylchloroformate (8.2 [tL, 0.057 mmol, 3.0 equiv each) were added over 30 minutes,
followed by dilution of the reaction mixture with dichloromethane (10 mL) and saturated
aqueous sodium bicarbonate solution (5 mL). The layers were separated and the aqueous layer
was extracted with dichloromethane (2 x 10 mL). The combined organic layers were washed
with brine (5 mL), were dried over anhydrous sodium sulfate, were filtered, and were
concentrated under reduced pressure. Purification of the resulting yellow oil via flash column
chromatography (silica gel: diam. 1 cm, ht. 2.5 cm; eluent: hexanes:acetone [90:10] to
hexanes:acetone [80:20] to hexanes:acetone [75:25] to hexanes:acetone [70:30]) provided the
carbamate (-)-83 ([a]22 D = -62 (c 0.6, CH2Cl2)) as a clear film (6.6 mg, 65%).
The corresponding enantiomer, carbamate (+)-83 (17.0 mg, 63%), was obtained using the
same procedure and starting with amine (+)-81.
'H NMR (500 MHz, C6D6, 200C):
3C NMR (125 MHz, C6D6, 20*C):
7.32 (d, J= 7.2 Hz, 2H, ArH), 7.18 (m, 2H, ArH),
7.07 (t, J= 7.4 Hz, 1H, ArH), 5.86 (br-s, IH, C17-
H), 5.27-5.19 (m, 2H, PhCH 2OC(O)N), 4.66-4.57
(m, lH, C6-H), 4.39 (br-s, 1H, C2-H), 3.55-3.43 (m,
2H, OCH 2CH2N), 3.01 (app-q, J= 8.3 Hz, 1H,
OCH2CH 2N), 2.75 (td, J= 8.6, 5.9 Hz, 1H,
OCH 2CH 2N), 2.66-2.61 (m, 1H, C19-H), 2.45-2.37
(m, 2H, OH, C7-H), 2.09-2.01 (m, 3H, C5-H, C15-
H), 1.78-1.65 (m, 3H, C8-H), 1.64 (m, 2H, C21-H),
1.56-1.43 (m, 3H, C4-H, C4-H, C3-H), 1.37-1.28
(m, 2H, C3-H, C21-H), 1.26 (dt, J= 13.2, 3.2 Hz,
1H), 1.20 (app-t, J= 9.7 Hz, 1H, C9-H), 1.13 (m,
IH), 1.12 (d, J= 6.9 Hz, 3H, Cl-H), 1.04-0.95 (m,
2H, C7-H), 0.83-0.74 (m, 2H, C10-H).
157.3 (carbamate-C=0), 156.0 (PhCH 2OC(O)N),
139.3 (C16), 138.3 (HC-CCH20C(O)N), 129.1
(Ar-C), 128.9 (Ar-C), 128.6 (Ar-C), 127.9 (Ar-C),
123.6 (br, C17), 80.5 (C20), 67.4 (PhCH2OC(O)N),
62.0 (OCH 2CH2N), 52.9 (C9), 48.1 (C5), 48.0
(OCH 2CH2N), 47.9 (C6), 46.8 (C2), 45.0 (C 10),
40.8 (C 15), 39.4 (C 19), 34.7 (C21), 34.4 (C4), 33.5
HO
H
HH
H HNH
Me N
(-)-81 0
(C8), 33.0, 30.2 (C3), 29.6, 27.1, 27.0, 20.7 (C1),
17.8 (C4).
FTIR (thin film) cm-1: 3427 (br-s, OH), 2928
(s), 1415 (s), 1316 (s),
(s), 2855 (w), 1733 (s), 1688
1093 (s).
HRMS (ESI): calcd for C31H4 0NaN205 [M+Na]*: 543.2829,
found: 543.2808.
TLC, Rf
(50% acetone:hexanes)
81, <0.05 (KMnO 4)
83, 0.31 (KMnO4)
NOESY correlations (600 MHz, C6D6 , 20'C): Additional data: H2-H3, H3-H4, H4-H5, H4-H19,
H3-H5, H5-H6, H6-H7a, H6-H21a, H7a-H8, H7b-
H9, H9-H19, H17-H19, H19-H4a,b. Key
correlations are shown in bold.
HO
H
Me ]
s3 0
OH
H, HHH
H HN M
OH H Me
(+)-82
CIC 2Bn, Na2 03
H20, CH2CI20-23 'C
74%
OH
H,8 2p HHH
10 -
(-2 -N
HNCzH H 2Me
(+)-2-ept-83
Carbamate (+)-2-epi-83
A solution of sodium carbonate (62 mg, 0.58 mmol, 10 equiv) in water (1 mL) was added
to a solution of pentacyclic amine (+)-82 (22.5.0 mg, 0.0580 mmol, 1 equiv) in dichloromethane
(1.2 mL) at 23 'C. The heterogeneous mixture was stirred vigorously and cooled to 0 'C.
Benzylchloroformate (25 tL, 0.18 mmol, 3.0 equiv) was added dropwise and the resulting
solution was warmed to room temperature for 15 minutes. The reaction mixture was diluted with
dichloromethane (15 mL) and saturated aqueous sodium bicarbonate solution (10 mL), and water
(3 mL). The layers were separated and the aqueous layer was extracted with dichloromethane (4
x 15 mL). The combined organic layers were washed with brine (20 mL), were dried over
anhydrous sodium sulfate, were filtered, and were concentrated under reduced pressure.
Purification of the resulting yellow oil via flash column chromatography (silica gel: diam. 1 cm,
ht. 7.5 cm; eluent: hexanes:acetone [90:10] to hexanes:acetone [80:20] to hexanes:acetone
[75:25] to hexanes:acetone [70:30]) provided the carbamate (+)-2-epi-83 ([a]2 D = +63 (c 0.7,
CH 2Cl 2)) as a clear film (22.4 mg, 74%).
The corresponding enantiomer, carbamate (-)-2-epi-83 (18.2 mg, 54%), was obtained
using the same procedure and starting with amine (-)-82.
'H NMR (500 MHz, CD 6, 20 C):
3C NMR (125 MHz, C6D6, 20'C):
7.28 (d, J= 7.6 Hz, 2H, ArH), 7.08 (app-t, J= 8.1
Hz, ArH), 5.69 (br-s, 1H, C17-H), 5.21 (d, J= 12.4
Hz, 1H, PhCH 2OC(O)N), 5.11 (d, J= 12.4 Hz, 1H,
PhCH 2OC(O)N), 4.13 (app-q, J= 8.2 Hz, 1H, C6-
H), 4.05 (app-q, J= 6.0 Hz, 1H, C2-H), 3.53-3.43
(m, 2H, OCH 2CH 2N), 2.96 (app-q, J= 8.5 Hz, IH,
OCH2CH 2N), 2.85-2.80 (M, 1H, C19-H), 2.73-2.67
(m, 1H, OCH 2CH 2N), 2.30-2.21 (m, 2H, C 15-H,
C5-H), 2.01-1.97 (m, 3H, C8-H, C10-H), 1.87-1.85
(m, 2H, C9-H, C4-H), 1.79 (br-d, J= 12.6 Hz, 1H,
C7-H), 1.68-1.61 (m, 3H, C3-H), 1.58-1.53 (m, 2H,
C4-H, C21-H), 1.38 (d, J= 11.4 Hz, 1H, C21-H),
1.27-1.24 (m, 2H), 1.16-1.14 (m, 2H), 1.15-1.13 (m,
3H, Cl-H), 1.09 (m, 2H, C3-H), 0.86-0.85 (m, 2H,
C7-H).
157.3 (carbamate-C=O), 156.4 (PhCH2OC(O)N),
139.2 (C16), 138.3 (HC=CCH2OC(O)N), 129.1
(Ar-C), 128.9 (Ar-C), 128.7 (Ar-C), 123.3 (br,
C17), 81.3 (C20), 67.1 (PhCH2OC(O)N), 62.0
(OCH 2CH 2N), 49.2 (C2), 49.1 (C9), 48.8 (C6), 47.6
(OCH2CH 2N), 46.9 (C15), 43.5, 40.9 (C10), 39.1
(C 19), 34.2 (C5), 33.6 (C8), 32.4 (C7), 29.8, 29.7,
28.9 (C3), 27.1, 27.0, 20.1, 18.9 (C4).
FTIR (thin film) cm-:
HRMS (ESI):
TLC, Rf
(50% acetone:hexanes)
NOESY correlations (600
3423 (br-s, OH), 2927 (s), 2855 (w), 1734 (s), 1691
(s), 1407 (m), 1297 (m), 1095 (w), 1039 (w).
caled for C31H40NaN205 [M+Na]*: 543.2829,
found: 543.2817.
82, <0.05 (KMnO 4)
2-epi-83, 0.31 (KMnO4)
MHz, C6D6, 20'C): Additional data: H1-H6, H5-H6, H9-H19, H17-
Hb, H17-H19, H19-H4, H15-H9, H4-H2, H4-H6.
Key correlations are shown in bold.
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IBX, TsOH
benzene-d
DMSO-d, 65 *C
80%
HO
I H20H HH
H 6N 17
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(-)-84
(-)-N-Cbz-Galbulimima alkaloid 13 (84):
p-Toluenesulfonic acid monohydrate (12 mg, 60 [tmol, 4.0 equiv) and IBX (47 mg, 0.16
mmol, 11 equiv) were added to a solution of vinyl oxazolidinone (-)-83 (8.0 mg, 15 [tmol, 1
equiv) in benzene-d (300 [tL) and DMSO-d 1 " (400 L) at 23 'C. The resulting suspension was
sonicated (1.5 h) until it became homogeneous, then heated to 65 'C. 'H NMR spectral analysis
of the reaction mixture was used to monitor conversion to product. After 10 h, the solution was
diluted with ethyl acetate (10 mL), saturated aqueous sodium bicarbonate solution (5 mL) and
water (3 mL). The layers were separated and the aqueous layer was extracted with ethyl acetate
(2 x 10 mL). The combined organic layers were washed with brine (5 mL), were dried over
anhydrous sodium sulfate, were filtered, and were concentrated under reduced pressure.
Purification of the resulting yellow residue via flash column chromatography (silica gel: diam.
0.5 cm, ht. 3.5 cm; eluent: hexanes:acetone [85:15] to hexanes:acetone [70:30]) provided enone
(-)-84 (5.5 mg, 80%, ([aE]22D = -71 (c 0.3, CH2Cl2)).
The corresponding enantiomer, enone (+)-84 (3.5 mg, 67%) was obtained using the same
procedure and starting with vinyl oxazolidinone (+)-83.
'H NMR (500 MHz, C6D6, 20 C):
13C NMR (125 MHz, C6D6, 20'C):
FTIR (thin film) cm-':
HRMS (ESI):
7.32 (d, J= 7.2 Hz, 2H, ArH), 7.20-7.15 (m, 2H,
ArH 7.09 (t, J= 7.2 Hz, 1H, ArH), 5.99 (d, J= 2.1
Hz, 1H, C17-H), 5.23 (m, 2H, PhCH20C(O)N),
4.69 (app-q, J= 8.5 Hz, C6-H), 4.46-4.39 (m, 1H,
C2-H), 2.67-2.52 (m, 2H), 1.97-1.90 (m, 1H), 1.75-
1.64 (m, 4H), 1.55-1.44 (m, 3H), 1.38-1.24 (m, 3H),
1.21-1.13 (m, 2H), 1.12-1.04 (m, 5H, Cl-H), 1.04-
0.85 (m, 311), 0.84 (dd, J= 11.6, 5.2 Hz, 1H), 0.61
(app-dq, J= 12.2, 3.3 Hz, 1H) .
199.0 (C16), 172.5 (C19), 155.8 (PhCH2OC(O)N),
138.1 (HC=CCH20C(O)N), 129.1 (Ar-C), 128.7
(Ar-C), 128.5 (Ar-C), 119.3 (C17), 81.1 (C20), 67.5
(PhCH2OC(O)N), 56.7, 52.6, 47.4, 47.3, 46.2, 45.2,
36.1, 35.7, 31.7, 30.3, 30.2, 26.9, 26.5, 25.9, 20.4,
19.3.
3428 (br-s, OH), 2924 (s), 2852 (m), 1687 (m),
1666 (s), 1412 (w), 1314 (w).
calcd for C28H37NI0 4 [M+H]*: 450.2639,
found: 450.2639.
18 Deuterated solvent was used to facilitate evaluation of reaction progress by direct 'H NMR monitoring.
TLC, Rf
(50% acetone:hexanes) 83, 0.31 (KMnO4)
84, 0.57 (UV, CAM)
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H H
OHH H H H
H NMe
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(+)-2-epi-83
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DMSO-d, 65 *C
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(+)-N-Cbz-2-epi-Galbulimima alkaloid 13 (84):
p-Toluenesulfonic acid monohydrate (8.0 mg, 42 [tmol, 4.6 equiv) and IBX (31 mg, 0.11
mmol, 12 equiv) were added to a solution of vinyl oxazolidinone (+)-2-epi-83 (4.8 mg, 9.2 [tmol,
1 equiv) in benzene-d (300 [tL) and DMSO-d 1 9 (450 [tL) at 23 'C. The suspension was
sonicated (1 h) until it became homogeneous, then heated to 65 'C. 'H NMR analysis of the
reaction mixture was used to monitor conversion to product. After 10 h, the solution was diluted
with ethyl acetate (8 mL), saturated aqueous sodium bicarbonate solution (8 mL) and water (3
mL). The layers were separated and the aqueous layer was extracted with ethyl acetate (3 x 8
mL). The combined organic layers were washed with brine (5 mL), were dried over anhydrous
sodium sulfate, were filtered, and were concentrated under reduced pressure. Purification of the
resulting yellow residue via flash column chromatography (silica gel: diam. 1 cm, ht. 2 cm;
eluent: hexanes:acetone [85:15] to hexanes:acetone [80:20]) provided enone (+)-2-epi-84 (2.3
mg, 56%, ([a]2 2 D =+70 (c 0.3, CH 2Cl 2)).
The corresponding enantiomer, enone (-)-2-epi-84 (4.8 mg, 59%) was obtained using the
same procedure and starting with vinyl oxazolidinone (-)-2-epi-83.
'H NMR (500 MHz, C6D6, 20"C):
13C NMR (125 MHz, C6D6, 200C):
FTIR (thin film) cm-':
7.30-7.27 (m, 2H, ArH), 7.15-7.12 (m, 2H, ArH),
7.09-7.05 (m, 1H, ArH), 5.99-5.96 (m, 1H, C17-H),
5.18 (d, J= 12.4 Hz, PhCH2OC(O)N), 5.14 (d, J=
12.4 Hz, PhCH2OC(O)N), 4.50 (app-q, J= 9.2 Hz,
1H, C6-H), 3.71-3.64 (m, 1H, C2-H), 2.64-2.59 (m,
1H), 2.30 (dt, J= 13.8, 8.0 Hz, 1H), 2.23-2.16 (m,
1H), 1.77-1.65 (m, 3H), 1.64-1.43 (m, 6H), 1.36-
1.27 (m, 2H), 1.22 (d, J= 6.5 Hz, 3H, Cl-H), 1.18-
1.04 (m, 4H), 1.04-0.96 (m, 1H), 0.96-0.86 (m, 2H),
0.74-0,65 (m, 1H).
199.0 (C 16), 173.3 (C 19), 156.6 (PhCH2OC(O)N),
138.1 (HC=CCH2OC(O)N), 129.1 (Ar-C), 128.7
(Ar-C), 128.5 (Ar-C), 119.6 (C17), 82.0 (C20), 67.3
(OCH 2CH2N), 54.4, 52.4, 49.1, 48.5, 47.4, 43.1,
39.3, 35.6, 31.8, 30.6, 29.9, 27.0, 26.5, 26.0, 21.1,
21.0.
3423 (br-s, OH), 2929 (m), 2857 (w), 1687 (m),
1662 (s), 1300 (m), 1154 (w).
19 Deuterated solvent was used to facilitate evaluation of reaction progress by direct 1H NMR monitoring.
HRMS (ESI):
TLC, Rf
(50% acetone:hexanes)
calcd for C28H37N10 4 [M+H]*: 450.2639,
found: 450.2644.
2-epi-83, 0.31 (KMnO 4)
2-epi-84, 0.57 (UV, CAM)
HO HOH H 20 ~H
CH2TMSI 10
N, NH isH meCbz H CH 2 CI 2, 0 C H2, Me HMe OH Me 0
(-)-84 89% (-)-galbulimima alkaloid 13 (2)
(-)-Galbulimima alkaloid 13 (2):20
N-Cbz enone (-)-84 (2.7 mg, 6.0 [tmol, 1 equiv) was azeotropically dried from toluene (3
x 1 mL), was dissolved in dichloromethane (1.0 mL), and was cooled to 0 'C.
Trimethylsilyliodide (TMSI, 1.2 tL, 9.0 [tmol, 1.5 equiv) was added to the cooled solution, and
the resulting yellow solution was stirred at 0 0C. Additional portions of TMSI were added at 20
minute intervals until complete consumption of (-)-84 was observed by TLC analysis (70 min).
The reaction mixture on completion was a cloudy yellow solution, with a brown residue. Excess
silylated products were quenched at 0 0C by the addition of aqueous hydrochloric acid solution
(IN, 1.5 mL) and the mixture was allowed to warm to ambient temperature. The reaction
mixture was diluted with hexanes (10 mL) and aqueous hydrochloric acid solution (IN, 2 mL)
and the layers were separated. The organic layer was extracted with aqueous hydrochloric acid
solution (IN, 4 mL). The combined acidic aqueous layers were washed sequentially with
hexanes (2 x 10 mL), dichloromethane (10 mL), and hexanes (10 mL). The aqueous layer was
then basified to pH 13 with aqueous sodium hydroxide solution (IN, 10 mL). The resulting
solution was stirred at ambient temperature for 1 h. The aqueous solution was extracted with
dichloromethane (3 x 20 mL) and the combined organic layers were washed sequentially with
water (18 mL) and brine (20 mL), were dried over anhydrous sodium sulfate, were filtered, and
were concentrated under reduced pressure to provide (-)-galbulimima alkaloid 13 (2, [a]2 2D _
-34 (c 0.045, CH2Cl2)21 ) as a white film (1.7 mg, 89%).
The corresponding enantiomer, (+)-galbulimima alkaloid 13 (2, 1.4 mg, 58%, [c] 2 2 D
+34 (c 0.090, CH 2Cl2)2 1), was obtained using the same procedure and starting with N-Cbz amine
ent-84.
'H NMR (500 MHz, C6D6, 200 C): 6.07 (d, J= 2.2 Hz, 1H, C17-H), 3.28 (dt, J= 11.4,
2.3 Hz, 1H, C9-H), 2.88 (app-t, J= 5.1 Hz, 1H, C6-
H), 2.72-2.66 (in, 1H), 2.60-2.55 (in, 1H), 2.15
(app-qd, J= 6.1, 2.3 Hz, 1H, C2-H), 1.98 (m, 1H,
OH), 1.91 (app-t, J= 4.4 Hz, 1H, C5-H), 1.84-1.81
(in, 1H, C8-H), 1.78 (dd, J= 11.2, 3.6 Hz, 1H, C15-
H), 1.75-1.69 (m, 1H), 1.67-1.60 (in, 1H), 1.55
20 a) For the prior synthesis of (±)-2, please see: Mander, L. N.; McLachlan, M. M. J. Am. Chem. Soc. 2003, 125,
2400. The Supporting Information of this same report contains copies of the NMR spectra of the natural (-)-2 along
with synthetic (±)-2. b) For isolation and optical rotation data, see: Ritchie, E.; Taylor, W. C. In The Alkaloids;
Manske, R. H. F., Ed.; Academic Press: New York, 1967; Vol. 9, Chapter 14 and references therein.
21 Literature value: [a] = -84 (CHCl 3); see reference 22b. We have also measured the rotation of (-)-2 in
chloroform (2 sources): a) chloroform passed through basic alumina (Grade I) and dried over 4A-MS, [U] 2 2"D = -51
(c 0.06, CHCI3), and b) chloroform passed through basic alumina (Grade I) and distilled from P205, [a]2 2 D = -64 (c
0.06, CHC13). Additionally, we have measured the rotation of (+)-2 in chloroform: a) chloroform passed through
basic alumina (Grade I) and dried over 4A-MS, [a]2 2 D = +51 (c 0.07, CHCl3), and b) chloroform passed through
basic alumina (Grade I) and distilled from P20 5 , [a]2 2D = +66 (c 0.07, CHCl 3).
"C NMR (125 MHz, C6D6, 20'C):
FTIR (thin film) cm~:
HRMS (ESI):
(app-dq, J= 13.9, 2.9 Hz, 1H, C7-Ha), 1.53-1.47
(m, 1H), 1.40 (ddd, J= 10.8, 5.6, 2.1 Hz, 1H, C21-
Ha), 1.26 (dd, J= 5.6, 2.4 Hz, 1H, C21-Hb), 1.23-
0.90 (m, 8H, C10-H, C7-Hb), 0.77 (m, 1H), 0.75 (d,
J= 6.1 Hz, 3H, Cl-H).
199.4 (C16), 178.9 (C19), 119.2 (C17), 79.7 (C20),
55.4 (C6), 53.3 (C 15), 53.2 (C2), 51.2 (C9), 48.2
(C21), 47.6 (C10), 46.6 (C5), 41.0 (C7), 33.1 (C8),
31.9, 30.6, 27.3 (C3 or C4), 26.7, 26.1, 25.0 (C3 or
C4), 23.6 (C 1).
3403 (br-s, OH), 2921 (s), 2851 (m), 1708 (w),
1646 (s), 1447 (m), 1261 (m). (Literature values:
3406, 2929, 2854, 1705, 1646, 1446).20
caled for C20H30N10 2 [M+H]*: 316.2271,
found: 316.2280.
NOESY correlations (600 MHz, C6D6, 20*C): Additional data: H 1-H2, H2-H6, H5-H6, H5-
H21b, H6-H7a, H6-H21b, H7a-H8, H7a-H6, 18-
H21a, H9-H15. Key correlations are shown in
bold.
NH"
Me 0
(-)-galbulimima alkaloid 13 (2)
Comparison of our assignments for (-)-galbulimima alkaloid 13 (2) with prior assignments for (+)-
2:
Assignment Mander's report This report This report This report
(±)-GB 13 (2) (-)-GB 13 (2) (-)-GB 13 (2) (-)-GB 13 (2)
('H, 300 MHz, CDC13) ('H, 500 MHz, CDC13 ) (H, 500 MHz, C6D 6) 13C (125 MHz, CD 6 )Cl 0.89, (d, J= 6.2 Hz) 0.89, (d, J= 6.1 Hz) 0.75, (d, J= 6.1 Hz) 23.6
C2 2.15, (app-qd, J= 6.1, 2.3 53.2
Hz)
C3,C4 2.72-2.66 (m); 2.60-2.55 27.3, 25.0
(M)
C5 1.91 (app-t, J = 4.4 Hz) 46.6
C6 3.34, (t, J= 5.1 Hz) 3.34, (t, J= 5.1 Hz) 2.88, (app-t, J= 5.1 Hz) 55.4
C7 1.55 (app-dq, J= 13.9, 2.9); 41.0
1.02 (m)
C8 1.84-1.81 (m) 33.1
C9 3.47, (dt, J= 11.3, 2.2 3.47, (dt, J= 11.2, 2.1 Hz) 3.28, (dt, J= 11.4, 2.3 Hz) 51.2
Hz)
CO -1.13, m 47.6
CI 1-C14 31.9, 30.6, 26.7, 26.1
C15 1.78, dd, J= 11.2, 3.6 Hz 53.3
C16 199.4
C17 5.92, (d, J 2.0 Hz) 5.93 (d, J= 2.1 Hz) 6.07, (d; J= 2.2 Hz) 119.2
C19 178.9
C20 79.7
C21 1.40 (ddd, J= 10.8, 5.6, 2.1 48.2
Hz); 1.26 (dd, J= 5.6, 2.4
Hz)
OH
H, HHH'
/ H
N
H Cbz' Me
(+)-2-epi-84
OH
CHH CMS *CTMSI O H
CH2CI2,O~ 0 2Me
H0  H
93% (+)-2-epi-1 6-oxohimgaline
(2-ep-21)
(+)-2-epi-16-Oxohimg-aline (2-epi-21):
N-Cbz enone (+)-2-epi-84 (2.1 mg, 4.7 [tmol, 1 equiv) was azeotropically dried from
toluene (3 x 1 mL), was dissolved in dichloromethane (800 tL), and was cooled to 0 'C.
Trimethylsilyliodide (TMSI, 1.5 [tL, 11 tmol, 2.2 equiv) was added to the cooled solution, and
the resulting yellow solution was stirred at 0 'C. Additional portions of TMSI were added at 20
minute intervals until complete consumption of (+)-2-epi-84 was observed by TLC analysis (50
min). The reaction mixture on completion was a cloudy yellow solution, with a brown residue.
Excess silylated products were quenched at 0 'C by the addition of aqueous hydrochloric acid
solution (IN, 1.5 mL) and the reaction mixture was allowed to warm to ambient temperature.
The reaction mixture was diluted with hexanes (10 mL) and aqueous hydrochloric acid solution
(IN, 3 mL) and the layers were separated. The organic layer was extracted with aqueous
hydrochloric acid solution (IN, 4 mL). The combined acidic aqueous layers were washed
sequentially with hexanes (2 x 10 mL), dichloromethane (10 mL), and hexanes (10 mL). The
aqueous layer was then basified to pH 13 with aqueous sodium hydroxide solution (IN, 11 mL).
The resulting solution was stirred at ambient temperature for 1 h. The aqueous solution was
extracted with dichloromethane (3 x 20 mL) and the combined organic layers were washed
sequentially with water (18 mL) and brine (10 mL), were dried over anhydrous sodium sulfate,
were filtered, and were concentrated under reduced pressure to provide (+)-2-epi-oxohimgaline
((+)-2-epi-21, [a]2 D =+24 (c 0.07, CH2Cl 2)) as a white film (1.4 mg, 93%).
The corresponding enantiomer, (-)-2-epi-oxohimgaline ((-)-2-epi-21, 2.8 mg, 82%,
[a]2 2D = -24 (c 0.085, CH 2Cl2)), was obtained using the same procedure and starting with N-Cbz
enone (-)-2-epi-84.
'H NMR (500 MHz, C6D6, 20'C):
13C NMR (125 MHz, C6D6, 200C):
3.08-3.02 (m, 2H, C2-H, C6-H), 3.02 (d, J= 13.5
Hz, 1H, C17-Ha), 2.55 (br-d, J= 12.9 Hz, 1H, C17-
Hb), 1.99-1.91 (m, 2H, C9-H, OH), 1.91-1.88 (m,
1H, C8-H), 1.87-1.81 (m, 1H), 1.80-1.72 (m, 2H,
C15-H, C21-Ha), 1.68-1.48 (m, 7H, C5-H, C21-Hb,
C7-Ha), 1.43-1.30 (m, 3H), 1.26 (br-d, J= 12.7 Hz,
1H, C7-Hb), 1.14 (qd, J= 11.4, 3.4 Hz, 1H, C10-
H), 1.06 (d, J= 7.0 Hz, 3H, Cl-H), 1.02-0.89 (m,
3H), 0.79 (dd, J= 13.6, 6.5 Hz, 1H), 0.73-0.63 (m,
1H).
212.3 (C 16), 87.4 (C20), 75.7 (C 19), 60.5 (C9),
57.3 (C6), 55.0 (C5), 52.8 (C 15), 50.6 (C2), 47.9
(C21), 44.4 (ClO), 40.9 (C17), 37.1 (C7), 36.2 (C8),
32.5, 30.3, 26.4, 25.7, 24.1, 22.4, 20.7 (C1).
FTIR (thin film) cm-': 3302 (br-m, OH), 2929 (s), 2853 (w), 1706 (m,
C=O), 1314 (w), 1300 (w), 1182 (w).
HRMS (ESI): caled for C20H30N10 2 [M+H]*: 316.2271,
found: 316.2270.
NOESY correlations (600 MHz, C6D6, 20'C): H6-H7b, H8-H7a, H8-H7b, H9-H15, H5-H21b,
H5-H7b, H1O-H21a. Key correlations are shown
in bold.
Hb
a OH
H,, 20 H
HH
1 A H9 6 H
O N 2Me
(+)-2-epi-1 6-oxohimgaline
(2-epi-21)
H H Formalin -H H
H NaBH(OAc) 3  HNH NH NH CH3CN H Me HMe 0 H 50% (2 steps) Me 0
(-)-Galbulimima Alkaloid 13 (2) (-)-Himbadine (4)
(-)-Himbadine (4):
A solution of crude (-)-galbulimima alkaloid 13 (1.4 mg, 4.4 mmol, 1 equiv) in
acetonitrile (0.75 mL) was treated sequentially with formaldehyde, 37 wt% in H20 (18 mL, 0.60
mmol, 50 equiv) and sodium triacetoxyborohydride (19 mg, 88 mmol, 20 equiv) at 23 'C, and
the reaction mixture was sealed under an argon atmosphere. After 1 h, a mixture of saturated
aqueous sodium bicarbonate solution and saturated aqueous sodium chloride solution (1:1, 8 mL)
was added, and the layers were separated. The aqueous layer was extracted with ethyl acetate (2
x 5 mL). The combined organic layers were washed with brine (5 mL), were dried over
anhydrous sodium sulfate, were filtered, and were concentrated under reduced pressure.
Purification via flash column chromatography (silica gel: diam. 0.5 cm, ht. 5.5 cm; eluent: 1%
NEt 3 in [1% 'propanol in dichloromethane] to 1% NEt 3 in [1% methanol in dichloromethane] to
1% NEt3 in [2% methanol in dichloromethane] to 1% NEt3 in [4% methanol in dichloromethane]
afforded (-)-himbadine (4, 0.7 mg, 50%, two steps) ([a]2 2 D = -47 (c 0.045, CHCl3)). Complete
assignment was possible with the aid of additional information from gCOSY, HSQC, HMBC,
and ROESY.
1H NMR (500 MHz, C6D6, 20 'C):
13C NMR (125 MHz, C6D6, 20 0C):
FTIR (neat) cm-':
HRMS (ESI):
6.06 (s, 1H, C17H), 3.18-3.15 (m, 1H, C9H), 2.70-
2.67 (m, 1H, C3HH'), 2.49-2.46 (m, 1H, C4HH'),
2.21 (app-t, J= 9.3 Hz, 4.7 Hz, 1H, C6H), 2.03-1.96
(br-s, 3H, C5H, N-CH 3, C7HH'), 1.82-1.77 (in, 2H,
CisH, CsH), 1.74-1.71 (m, 1H, CH 2 ), 1.67-1.64 (in,
2H, Ci H1H', C2H), 1.57-1.49 (m, 2H, CH 2), 1.36-
1.32 (m, 1H, C21HH'), 1.25-1.23 (m, 1H, C21HH'),
1.21-0.96 (in, 7H, C7HH', C3HH', C4HH', CioH,
CH 2), 0.86 (d, J= 6.0 Hz, 3H, CIH), 0.85-0.78 (m,
1H, C1IHH').
199.7 (C16), 179.5 (C19), 119.2 (C17), 80.3 (C20),
63.3 (C), 59.8 (C2), 53.1 (C15), 49.7 (C9), 48.7
(C21), 48.1 (C5), 47.5 (CIO), 40.0 (N-CH3), 34.7
(C7), 33.2 (C8), 32.2 (C 1 ), 30.9 (CH2), 27.2 (C3),
26.6 (CH2), 26.1 (CH 2), 24.8 (C4), 22.9 (C1).
3407 (br-s, OH), 2923 (s), 2853 (m), 2774 (w),
1737 (w), 1648 (s), 1447 (w).
caled for C21H32NO2 [M+Na]+: 330.2428,
found: 330.2425.
TLC (1% NEt3 in [4% MeOH in CH 2Cl2])
Comparison of our assignments for (-)-himbadine (4) with literature:
Assignment Isolation This report This report This report
paper2 2  (-)-himbadine (-)-himbadine (4) (-)-himbadine (4)
(-)-himbadine (4) ('H, 500 MHzC 6D6) ("C, 125 MHz,
(4) ('H, 500 C6D6)('H, 300 MHz, MHz, CDC13)
CDC1
3 )
C17  5.95 (d, 1H) 5.91 (d, 1H) 6.06 (s, 1H) 119.2
C9  - - 3.18-3.15 (m, 1H) 49.7
C3  - - 2.70-2.67 (m, 1H) 27.2
C4  - - 2.49-2.46 (m, 1H) 24.8
C6  - - 2.21 (app-t, J= 9.3 63.3
Hz, 4.7 Hz,_1H, C6-H)
C5 , 2.2 (br-s, 3H, N- 2.17 (br-s, 2.03-1.96 (br-s, 3H) 48.1 (C5), 40.0 (N-
N-CH 3, C7  CH 3) 3H, N-CH 3) CH 3), 34.7 (C7)
C1s, C8 - - 1.82-1.77 (m, 2H) 53.1 (C15),33.2
(C8)
CH 2  - - 1.74-1.71 (m, 1H) 26.6 (CH 2)
C1, C2 - - 1.67-1.64 (m, 2H) 32.3 (C11), 59.8
(C2)
CH2  - 1.57-1.49 (m, 2H) 30.9 (CH 2)
C2 1 - - 1.36-1.32 (m, 1H) 48.7
C2 1 ' - - 1.25-1.23 (m, 1H) 48.7
C7 , C3, C4 , - - 1.21-0.96 (m, 7H) 34.7 (C7), 27.2
Cio, CH2  (C2), 23.8 (C4),
47.5 (C10), 26.1
(CH
2 )
C, 0.93 (d, 3H) 0.92 (d, 3H) 0.86 (d, J= 6.0 Hz, 22.9
1H)
C, - - 0.85-0.78 (m, 1H) 32.2
2 Mander, L. N.; Prager, R. H.; Rasmussen, M.; Ritchie, E.; Taylor, W. C. Aust. J. Chem., 1967, 20, 1473.
Rf 0.25 (UV, CAM).
H HO H
?HH
H I 7
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Me 0
(-)-Galbulimima Alkaloid 13 (2)
NaBH(OAc) 3
CH3CN, AcOH
23 oC, 5 min
73%
ROESY
(-)-Himgaline (3)
(--Himp-aline (3):
A solution of (-)-galbulimima alkaloid 13 (1.4 mg, 4.4 mmol, 1 equiv) in acetonitrile
(0.75 mL) was treated sequentially with acetic acid (14 mL, 0.24 mmol, 50 equiv) and sodium
triacetoxyborohydride (19 mg, 88 mmol, 20 equiv) at 23 'C, and the reaction mixture was sealed
under an argon atmosphere. After 30 min, aqueous potassium carbonate solution (IM, 2 mL) was
added, and the layers were separated. The aqueous layer was extracted with dichloromethane (3
x 5 mL). The combined organic layers were dried over anhydrous sodium sulfate, were filtered,
and were concentrated under reduced pressure. Purification via flash column chromatography
(silica gel: diam. 0.5 cm, ht. 1 cm; eluent: 10% methanol in dichloromethane to 3% NH3 in [10%
methanol in dichloromethane] afforded (-)-himgaline (3, 1.1 mg, 73%) ([a]2 2 D= -82 (c 0.11,
CHCl 3)). Complete assignment was possible with the aid of additional information from gCOSY,
HSQC, HMBC, and ROESY.
'H NMR (500 MHz, CDCl 3, 20 C):
3 C NMR (125 MHz, CDCl 3, 20 C):
FTIR (neat) cm-1:
HRMS (ESI):
3.20-3.24 (m, 1H, C16H), 3.07 (br-s, 1H1, C6H), 2.96
(br-s, 1 H,C 2H), 2.40 (dd, J= 12.2, 2.9 Hz, 1H,
C17H), 2.16 (br-d, 1H, C21HH'), 2.12-2.08 (m, 2H,
C14HH', C8H), 2.03-1.99 (m, 2H, C5H, C4HH'),
1.95-1.85 (m, 2H, C7H, C17H), 1.81 (br-d, 1 H,
C21HH'), 1.77-1.68 (m, 4H, C IHH', C12HH',
C13HH', C9H), 1.61-1.54 (m, 3H, C3HH', C4HH',
C7H), 1.50-1.44 (m, 1H, C3HH'9), 1.2 8 (d, J = 6.5
Hz, 3H, CIH), 1.20-1.12 (m, 2H, C 3HH', C12HH'),
1.03-1.01 (m, 1H, Ci 5H), 0.91-0.82 (m, 3H, CjoH,
CHH', C14HH').
86.8 (40), 74.2 (40), 72.4 (C16), 68.5 (C6 ), 61.5 (C2 ),
60.0. 55.0 (Cs), 48.0 (C21), 47.6 (Cis), 42.7 (C10 ),
37.3 (C17), 36.8 (C7), 35.9 (Cs), 32.3 (C,1), 29.9
(C,), 28.8 (C14), 27.1 (C3), 26.5 (C12), 25.9 (C3),
25.4 (C4).
3340 (br-s, OH), 2919 (s), 2850 (m), 1738 (w),
1448 (w), 1261 (w).
calcd for C20H32NO2 [M+Na]*: 318.2428,
found: 318.2438.
TLC (3% NH3 in [10% MeOH in CH 2Cl 2]) Rf 0. 1 (CAM).
Comparison of our assignments for (-)-himgaline (3) with literature:
Assignment Chackalamannil's This report This report
report 23  (-)-himgaline (3) (-)-himgaline (3)
(-)-himgaline (3) ('H, 500 MHz, CDCl 3) (13C, 125 MHz,(H, 500 MHz, CDC13) CDC13)
C16 3.34 (m, 1H) 3.23-3.27 (m, 1H) -
C6 3.05 (t, J= 2.8 Hz, 1H) 3.10 (br-s, 1H) 68.5
C2 2.98-2.89 (m, 1H) 2.99 (br-s, 1H) 61.5
C17 2.46 (dd, J= 12.3, 3.5 2.43 (dd, J = 12.2, 2.9 Hz, 37.3
Hz, 1H) 1H)
C21, C14, 2.19 (br-d, 1H, C21-H') 48.0 (C21), 28.8
C8 2.25-2.12 (m, 3H) 2.15-2.11 (m, 2H, C14-H, (C14), 35.9 (C8)
C8-H)
C5,
C4 2.09-2.03 (m, 2H) 2.06-2.02 (m, 2H) 55.0 (C5), 25.4 (C4)
C7, C17ax, 1.98-1.88 (m, 2H) 36.8 (C7), 37.3 (C 17)
C21' 1.84 (br-d, 1H) 48.0
Ci1, C12, 1.96-1.48 (m, 11H) 1.80-1.71 (m, 4H) 32.3 (Cl1), 26.5
C13, C9 (C12), 25.9 (C13)
C3' 1.53-1.47 (m, 3H) 27.1 (C3), 25.4 (C4),
36.8 (C7)
C1 1.34 (d, J= 7.3 Hz, 3H) 1.31 (d, J= 6.5 Hz, 3H) 29.9
C13', C12' 1.32-1.15 (m, 2H) 1.23-1.15 (m, 2H) 25.9 (C13), 26.5 (C12)
C15 1.11-1.03 (m, 1H) 1.06-1.04 (m, 1H) 47.6 (C15)
CIO, CIl', 0.99-0.88 (m, 3H) 0.94-0.85 (m, 3H) 42.7 (C1O), 32.3
C14ax (Cl 1), 28.8 (C14)
23 Chackalamannil, S. et. Al. J. Am. Chem. Soc., 2006, 128, 12654-12655.
Chapter II.
Total Synthesis of (-)-Himandrine
Introduction and Background
The galbulimima alkaloid (-)-himandrine (3) is a topologically fascinating compound
isolated from the bark of Galbulimima belgraveana, a tree indigenous to Papua New Guinea and
northern Australia.' The promise that natural and synthetic derivatives of galbulimima alkaloids
have shown for treatment of human ailments2 has resulted in substantial attention in both
academia and industry. In chapter 1, we reported the first enantioselective total synthesis of (-)-
galbulimima alkaloid 13 (2, class III)3 and revised the absolute stereochemical assignment of the
class II and III derivatives.4 As continuation of this program, we describe the total synthesis of
class II alkaloid 3 guided by our previously disclosed hypothesis for its biogenesis, featuring a
final stage oxidative spirocyclization to secure the BCF ring juncture.
Me.-N Me HHO HHOH A H HbHH
HH - H E - D C HMe H N H A
0 HNH NH H H O .H OMe
H HMe Me OMeOBz
Himbacine (1) Galbulimima Alkaloid 13 (2) (-)-himandrine (3)
Figure 1. Representative galbulimima alkaloids.
Hypothesis for the Biosynthesis of (-)-Himandrine:
Based on our biomimetic hypothesis for the biogenesis of class II and III galbulimima
alkaloids, 3 we identified aminoketoester 4 (Scheme 1) as a plausible point of divergence en route
to more complex alkaloids. We envisioned that aminoketoester 4 would tautomerize to form the
conjugated enol 5. At this point, enol 5 could undergo a C 17-oxidation (or a synthetic
HO HO HO
H R HO
H H H c1*c1 H Hc6 H ,HH
x t H (epo redation rPtaUtornerization hydroxylation)
H N'H 
- o H NH- 1- D H NHOH
H O H H 0 17 H H 0  HMe OMeO R MeOMeOH Me OMeO 6
4 N C9
R1O HO HO bond formation
H H H ~H H HH C13-,C14- H C6
oxidation; reduction
H' N- aa kylation, H- N- 16 H- N
H 0 ~H R3  ~clto H 0 ~HH 0 HMe OMe bR2  R4  Me 6 OeH Me. ne_ 7
9 (R1, R3, R4 = H, R2 = Bz) 8
Class II GB alkaloids
Scheme 1. Our biosynthetic hypothesis of (-)-himandrine.
equivalent) to give the hydroxy ketoester 6, followed by an intramolecular allylic displacement
by the amine to give the N-C9 bond present in the Class II galbulimima alkaloids (himandrine
and himandridine).
Previous Synthetic Study of class II Galbulimima alkaloids:
While there have been several outstanding syntheses of himbacine 1, class I (Figure 1)6
and class III7 galbulimima alkaloids, no total synthesis of the class II galbulimima alkaloids
possessing the unique N-C9 spirofused polycyclic framework has been reported. In 2004,
Mander and co-workers disclosed an intriguing synthesis of the himandrine skeleton (Scheme
2).8 The key steps in the synthesis included a Diels Alder reaction, Curtius rearrangement, Birch
reduction, an intramolecular nucleophilic amination, and a palladium mediated alkene amination.
The synthesis began with cycloaddition between dienophile 10 and diene 11 to give the
corresponding endo product, which was subjected to hydrolysis of the resulting enol ether
followed by thiolate-mediated cleavage of the corresponding ester to afford carboxylic acid 12.
Generation of methyl carbamate moiety of 13 was achieved by refluxing the corresponding acyl
OMOM 0 OMOM MOM H OMOM
Me02-- a-b I 4. H c-f .HMe2  ~ H H
OO S MsaOM Me OH
10 eOO HO2 C' 12 MeOOCH 13
g-h
OMOM OMOM MOMQ H OMOM
MOMO k MOMO.- N 1 eH NOMS H H 
0 q INH ( NH MO M-Cl OH
"C,~70. () MeOO(COe K2O3 MeH,4h C 9% (k)L/N MeOH, 204, ~5% (1C3SOCl
MeCC 1 8 16 Me(C 15%. 14 HO OH
~6%-n
OMOM OMOM OH
MO O-- 0 MOMO I'.. p-q - HO---
N N N
17 H 18 H 3C (±t)-19
Scheme 2. Mander's synthesis of himandrine skeleton. Conditions: (a) 10, 48 h, 100 0C; AcOH, THF, H20, 87% (2
steps). (b) HMPA, NaH, EtSH, 97%. (C) (COCI)2, DMF, py, D; NaN3, RT, THF, 5h, 77%. (d) A, toluene, 20 min,
-100%. (e) MeOH, NaOMe, -100%. (f) Li, NH3 , MeOH; AcOH, THF, H20; MOM-Cl, 'Pr 2NEt, DMAP; HCl,
CHCl3, 32% (4 steps). (g) 9-BBN, THF, MeOH, H20 2, 87%. (h) 0S0 4, py, THF, --75%. (i) Pb(OAc)4, MeOH, 2h, 0
0C, '-70%. (j) (MeO)2POC(N2)COMe, K2C0 3, MeOH, 4h, 0 C, 91%. (k) Li/NH3, MeOH, 20 s, --95%. (1) CH3SO2Cl,
Et3N, DCM, 0 C, 2h, 93%. (in) NaH, DMF, 97%. (n) NaH, HMPA, EtSH, 90%. (o) PdCl2, CUCI, 02, "BU4NCl,
K2C0 3, CI- 3CN, A, 16h, 85%. (p) Rh/A1203, H2, (CF3)2CHOH, 95%. (r) Dowex® 50W, MeOH/H 20, 5: 1, A, 8h,
--60%.
azide in toluene followed by methanolysis. At this point, Birch reduction9 reduced the aromatic
ring and the decalone functionality, followed by hydrolysis of the methyl enol ether and
isomerization to provide unsaturated ketone 13 in moderate yield. Oxidative cleavage of the E
ring was accomplished in a 3-step sequence. First, selective 1,2-reduction of enone 13 followed
by OsO 4 oxidation of the resulting allylic alcohol gave triol 14. Ring cleavage of triol 14
afforded the corresponding ketoaldehyde, that was converted to alkyne 15, which contained all
the requisite carbon atoms to construct the remaining pyrrolidine and piperidine rings. Ring
closure to form the pyrrolidine 17 was accomplished in excellent yield by treatment of mesylate
16 with NaH in DMF followed by thiolate-mediated carbamate cleavage. Final ring closure was
achieved via oxidative amination to afford hexacycle 18, followed by hydrogenation and
deprotection to provide the himandrine skeleton 19 in racemic form.
Results and Discussion
Guided by our biosynthetic hypothesis, 3 we envisioned formation of the N-C9 bond by a
late stage oxidative spirocyclization of the pentacyclic aminoketoester 21 (Scheme 3). We
envisioned that oxidation of 21, potentially facilitated by dienol formation, would afford allylic
alcohol 20, which is poised for the critical condensative spirocyclization. We expected that
application of our annulation methodology0 to enone 22 and iminium chloride 23 would
convergently assemble a pentacycle primed for our proposed biomimetic oxidative
spirocyclization.
H HO N-9 H HO oxid IationH bond formation HH
D ' H H
c, ~ H spirocyclization H
H N = H' NHOH
MeH 0 H OMe
me OmeoBZ Me OMeO(-)-himandrine (3) 20
formal [3+3] ' 2'
cycloaddition
Me O - condenstion H HO H
H HH
HCI+ H' H H 7 H
GTMe Hh_ NH\17
rom Diels-Alder H OMe H 0 H OMe
23 L-alanino HO 22 carboxylation Me OMe0  21
Scheme 3. Retrosynthetic analysis of (-)-himandrine (3).
Our enantioselective synthesis of a tricyclic enone 22 mimic is illustrated in Scheme 4.
14 '4
OH a OTBS bc OH(-)-24 OH (+)-25 OH I (+)-26 OMe
d,e
g-j f Me
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16 OMe Me OMe \
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Scheme 4. Enantioselective synthesis of tricyclic enone (-)-31. Conditions: (a) TBSC, imidazole, DMAP, DMF, 0
"C, 94%. (b) 4A-MS, Proton Sponge*, Me 30-BF4, CH 2Cl2, 23 "C, 93%. (c) HC1, MeOH, 23 "C, 98%. (d) DMSO,
'Pr 2NEt, S03-pyr, CH2Cl2, 23 "C. (e) CBr4, PPh 3, CH2Cl2, 0 "C, 65% (2-steps). (f) Pd(PPh3)4, T12CO3, THF, H20, 23
'C, 97%. (g) 2-azetidinone, CuI, K2CO 3, (MeNHCH 2)2, PhMe, 120 'C, 85%. (h) TBAF, THF, 0--23 "C. (i) DMSO,
'Pr 2NEt, S03-pyr, CH2Cl2, 23 "C, 80% (2-steps). (j) TBSOTf, Et3N, CH2Cl2, -78 'C, 82%. (k) acrolein, 4,5-
dihydrolMesCl 2Ru=CH(2-'PrO)Ph (10 mol%), CH2Cl2, 23 'C, 85%. (1) BHT, NN-diethylaniline, MeCN, 95 'C,
75%, 5:1 dr. (m) TiC14, CH2C12, -78 *C. (n) Martin sulfurane, PhH, 23 "C, 57% (2-steps).
The C14-stereochemistry, introduced through the use of MacMillan's D-proline-catalyzed a-
oxidation"' of hept-6-enal, afforded the enantiomerically enriched diol (-)-24 (>98.5% ee).12 The
Cl4-methyl ether was then secured by etherification 3 of alcohol (+)-25 to provide the
methoxyalcohol (+)-26, setting the stage for the substrate-directed synthesis of the trans-decalin
AB-ring system. Oxidation 14 of alcohol (+)-26 followed by conversion of the corresponding
aldehyde to dibromoolefin provided (-)-27. A highly efficient Suzuki cross-coupling reaction3" 5
involving boronic acid 28 and dibromide (-)-27 afforded the cis-vinyl bromide 29 in 97% yield.
A copper-promoted coupling' 6 of vinyl bromide 29 with 2-azetidinone followed by conversion of
the C20-silyl ether to the corresponding C20-silyl enol ether gave the desired tetraene (-)-30.
The 2-azetidinone group at C16 was strategically introduced to serve a dual role in facilitating
the planned Diels-Alder reaction by providing a 2-N-acylaminodiene with greater preference for
s-cis C16-C17 conformation, and masking the C16-carbonyl for subsequent transformations. A
Ru-catalyzed olefin cross-metathesis reaction 17 with acrolein enabled selective functionalization
of the acid sensitive tetraene (-)-30 to the corresponding unsaturated aldehyde (-)-31 in 85%
yield. Heating a solution of tetraenal (-)-31 in acetonitrile at 95 'C afforded the desired trans-
decalin aldehyde (-)-32 as the major endo Diels-Alder product (75%, dr = 5:1) as supported by
nOe studies. Treatment of aldehyde (-)-32 with titanium tetrachloride provided the
corresponding Mukaiyama aldol' 8 product, which upon exposure to Martin sulfurane19 afforded
the oxygen and acid sensitive enone (-)-33 in 57% yield over two steps (Scheme 4).
Lithiation of the readily available iminium chloride (-)-233 followed by copper-promoted
conjugate addition'4 to the enantiomerically enriched enone (-)-33 afforded the highly air
sensitive pentacyclic iminoalcohol 34 (Scheme 5). Importantly, blocking of the si-face of the
enone by the trans-decalin AB-ring system imposed exquisite stereochemical control during the
C7-C8 bond formation. Rapid tautomerization of the transiently formed iminoketone 34 enabled
nucleophilic addition of C5 to the C20-ketone of 35, consistent with our biosynthetic hypothesis
for the D-ring formation. 3 Addition of sodium borohydride to crude imino alcohol 36 resulted in
completely diastereoselective C6-imine reduction, at which point benzyloxycarbonylation of the
resulting aminoalcohol 37 provided the desired product (-)-38 (Scheme 5, Z =
HO H HHO H
MeH()-33e 
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Scheme 5. Enantioselective total synthesis of (-)-himandrine (3). Conditions: (a) "BuLi, THF, (-)-23, -78-~ 0 *C;
CuBr-SMe 2; (-)-33, -78--1O0*C. (b) NaBH 4, EtOH, 0 "C. (c) ClCO2Bn, 'Pr2NEt, K2CO3, THF, H20, 50% (3-
steps). (d) TsOH-H 20, PhH, 23 *C, 81%. (e) POCl3 , DMF, CH2Cl 2, 0-23 0C, 71%. (f) DDQ, SiO 2, MeCN, H20, 23
0C. (g) NaClO2, NaH 2PO 4-H20, 2-methyl-2-butene, 'BuOH, H20, 23 "C. (h) CH2N2, THF, 0 "C, 61% (3-steps). (i)
TMS-I, 2,6-di-'Bu-4-Me-Pyr, CH2 Cl2 , 0 "C, 66%. (j) Et3N-(HF) 3 , THF, 23 "C, 90%. (k) NCS, MeCN, 23 "C, 45 min,
89%. (1) NaBH4, EtOH, 0 "C, 90%. (in) BzCl, pyridine, 23 "C, 7 d, 87%.
benzyloxycarbonyl) in 50% yield over three steps. Importantly, the formal cycloaddition
between iminium chloride (-)-23 and enone (-)-33 and subsequent C6-reduction of imine 36
secured four stereogenic centers and expediently assembled the pentacyclic substructure of (-)-
himandrine (3) as a single diastereomer.
Mild hydrolysis of N-vinyl-carbamate (-)-38 with p-toluene sulfonic acid monohydrate in
benzene afforded the key intermediate ketone (-)-39 in 75% yield. The mild reaction conditions
used in hydrolysis of the C16 N-vinyl lactam circumvent the competing acid catalyzed p-
elimination of the C14-methyl ether in ketone (-)-39.20 At this juncture, we required a mild
method for introduction of the Cl 7-methoxycarbonyl group in order to access the aminoketoester
21. After exploring a variety of strategies, we found that treatment of ketone (-)-39 with
Vilsmeier's reagent provided the vinyl ether (+)-41 in 71% yield, likely occurring through
nucleophilic addition of enol 40 (Scheme 5) followed by trapping with the C20-alcohol.
Exposure of vinyl ether (+)-41 to 2,3-dichloro-5,6-dicyano-1,4-benzoquinone (DDQ)22 furnished
the corresponding unsaturated p-ketoaldehyde 42. Immediate oxidation of the acid sensitive
C18-aldehyde 42 to the corresponding carboxylic acid 43 followed by treatment with
diazomethane provided the desired p-ketoester (-)-44 in 61% yield over three steps (Scheme 5).
Sequential treatment of carbamate (-)-44 with trimethylsilyliodide (TMS-I) 3'23 and triethylamine
trihydrofluoride provided pentacyclic aminoketoester (-)-21, our proposed common biosynthetic
intermediate to the class II and class III galbulimima alkaloids.
With the key intermediate in hand, we were able to evaluate the feasibility of our
postulated biomimetic late stage N-C9 bond formation. We expected that p-ketoester 21 might
undergo rapid tautomerization to the electron rich dienol 45, enabling facile C17 oxidation as a
prelude to intramolecular allylic displacement by the amine to give the N-C9 spirocycle.
Deuterium labeling studies were employed in monitoring H/D exchange at C9 (Scheme 6).
Compellingly, simple dilution of aminoketoester (-)-21 in methanol-d 4 resulted in immediate and
quantitative deuterium incorporation at C9 in the form of aminoketoester 21-d 3 (Scheme 6).24
Dissolution of aminoketoester 21-d 3 in methanol returned aminoketoester (-)-21, indicating the
exchange of C9-methine occurs with retention of C9-stereochemistry. Cumulatively, our results
are consistent with the amino group being intimately involved in facilitating C9-
deprotonation. 2 6,27 The preservation of the C9-stereochemistry is consistent with intramolecular
protium/deuterium delivery by the corresponding ammonium ion from the more sterically
hindered face of the Cl 9-C9 tetrasubstituted alkene of 45.
H HO H H DO H
HH H CD30D DH H
H' >98% C9-D HNH CH30H H NDH O H OMe - H 0 H OMe
Me OMe0 (-)-21 >98% C9-H Me OMeO 21-d 3
NCS
MeCN, 23 *C
H HO H HO
~H HHO
HH HH H
?- H (-)-21H
')N \2 H -NH - (+)-46
H 0 Cl H OMe H Of H OMe
Me OMe0  48 Me bMeO 49
Scheme 6. Key observations relevant to N-C9 bond formation.
Guided by our biosynthetic hypothesis and with evidence for rapid dienol formation from
aminoketoester (-)-21, we wished to capitalize on the inherent chemistry of this plausible
biosynthetic intermediate. In the event, treatment of aminoketoester (-)-21 with N-
chlorosuccinimide (NCS) in acetonitrile at 23 'C over 45 min afforded the desired spirofused
hexacyclic enone (+)-46 in 89% yield. The structure of (+)-46 was supported through detailed
2D NMR analysis. 28 Treatment of ketone (+)-46 with sodium borohydride in ethanol effected
completely diastereoselective C16-reduction to the desired diol (+)-47 in 90% yield.
Benzoylation of the C16-hydroxyl group of diol (+)-47 proceeded to give the first synthetic
sample of (-)-himandrine (3) in 87% yield ([a]22 D = -21 (c, 0.12 CHCl3); Lit.la ([a] = -38 (c
1.22, CHCl3).29 All spectroscopic data for synthetic (-)-3 matched those reported for the natural
compound.' The structure of our synthetic (-)-3 was unequivocally confirmed by X-ray
crystallographic analysis.
Intrigued by the high efficiency in the conversion of aminoketoester (-)-21 to hexacyclic
enone (+)-46, we sought to gain further mechanistic insight into this transformation. Close
monitoring of the reaction mixture indicated that exposure of aminoketoester (-)-21 to NCS in
acetonitrile resulted in concomitant formation of hexacycle (+)-46 and the light-sensitive N-
chloro pentacycle 48 (Scheme 6) that would disappear by the end of the reaction. Use of
benzene as solvent for this transformation reduced the overall rate of hexacycle (+)-46 formation
and allowed for the isolation of N-chloro pentacycle 48.30 Importantly, dissolution of N-chloro
pentacycle 48 in acetonitrile for 12 h did not result in formation of any hexacycle (+)-46 and
completely returned 48.313 Additionally, when the deuterium incorporation studies described
above were conducted with 48, there was no evidence for formation of the corresponding dienol,
suggesting the nitrogen of 48 is not basic enough to enable deprotonation at C9. Interestingly,
exposure of aminoketoester (-)-21 to samples of N-chloro pentacycle 48 in acetonitrile resulted
in formation of hexacycle (+)-46 and (-)-21.33 This result is consistent with an intermolecular N
to C halogen transfer from N-chloro pentacycle 48 to aminoketoester (-)-21 (likely via 45). A
plausible mechanism for conversion of aminoketoester (-)-21 to spirofused hexacycle (+)-46 is
halogenation of the dienol 45 to give a-chloroester 49, followed by intramolecular allylic
displacement by the amine. Significantly, this mechanism is consistent with our proposed
biomimetic hypothesis for the advanced stage oxidative spirocyclization of aminoketoester (-)-
Conclusion
We have described the first total synthesis of all class II galbulimima alkaloid (-)-
himandrine (3), a member of the class II galbulimima alkaloids. Noteworthy features of this
chemistry include the diastereoselective Diels-Alder reaction for rapid synthesis of the trans-
decalin containing tricycle (-)-33 in enantiomerically enriched form, the formal [3+3] annulation
strategy to secure the CDE-ring system with complete diastereoselection, and successful
implementation of our biogenetically inspired oxidative spirocyclization in converting 48 to (+)-
46. The successful and direct conversion of (-)-21 to (+)-46 drew on the power of biogenetic
considerations and fully utilized the inherent chemistry of this plausible biosynthetic
intermediate.
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Experimental Section
General procedure. All reactions were performed in oven-dried or flame-dried round-bottomed
flasks, modified Schlenk (Kjeldahl shape) flasks, or glass pressure vessels. The flasks were
fitted with rubber septa and reactions were conducted under a positive pressure of argon.
Stainless steel syringes or cannulae were used to transfer air- and moisture-sensitive liquids.
Flash column chromatography was performed as described by Still et al. using silica gel (60 A
pore size, 40-63 rim, 4-6% H20 content, Zeochem).' Where necessary (so noted), silica gel was
neutralized by treatment of the silica gel prior to chromatography with the eluent containing 1%
triethylamine or 1% ammonium hydroxide. Analytical thin-layer chromatography was
performed using glass plates pre-coated with 0.25 mm 230-400 mesh silica gel impregnated with
a fluorescent indicator (254 nm). Where necessary (so noted), silica gel plates were neutralized
by treatment with a solution of 1% triethylamine or 1% ammonium hydroxide in
dichloromethane followed by heating on a hot plate (~250 C). Thin layer chromatography
plates were visualized by exposure to ultraviolet light and/or by exposure to an ethanolic
phosphomolybdic acid (PMA), an acidic solution of p-anisaldehyde (anis), an aqueous solution
of ceric ammonium molybdate (CAM), an aqueous solution of potassium permanganate
(KMnO4) or an ethanolic solution of ninhydrin followed by heating (<1 min) on a hot plate
(-250 C). Organic solutions were concentrated on Bichi R-200 rotary evaporators at ~20 Torr
at 25-35 'C unless otherwise indicated.
Materials. Commercial reagents and solvents were used as received with the following
exceptions: dichloromethane, diethyl ether, tetrahydrofuran, acetonitrile, and toluene were
purchased from J.T. Baker (CycletainerT ) and were purified by the method of Grubbs et al.
2
under positive argon pressure. Triethylamine, diisopropylethylamine, and benzene were
distilled over calcium hydride immediately before use. Acrolein was distilled over calcium
sulfate immediately before use. Methyl vinyl ketone was distilled over potassium carbonate and
calcium chloride immediately prior to use. Martin sulfurane was purchased from Aldrich and
stored in a glove box under nitrogen atmosphere. N-Chlorosuccinimide (NCS) was
recrystallized from benzene prior to use. Phosphorus oxychloride was distilled under reduced
pressure before use. The molarity of n-butyllithium solutions was determined by titration using
diphenylacetic acid as an indicator (average of three determinations).3 Ammonia saturated
dichloromethane was obtained by agitation of dichloromethane in the presence of ammonium
hydroxide followed by drying over anhydrous sodium sulfate. Where necessary (so noted)
solutions were deoxygenated by alternate freeze (liquid nitrogen)/evacuation/argon-flush/thaw
cycles (FPT, three iterations) or degassed by purging with argon for several minutes.
Instrumentation. Proton nuclear magnetic resonance (IH NMR) spectra were recorded with a
Varian 300 Mercury or a Varian inverse probe 500 INOVA spectrometer or a Bruker 400
spectrometer or a Bruker inverse probe 600 Avance spectrometer. Chemical shifts are recorded
in parts per million on the 8 scale and are referenced from the residual protium in the NMR
solvent (CHCl 3: 6 7.27, C6 D5H: 67.16). Data is reported as follows: chemical shift [multiplicity
(s = singlet, d - doublet, t = triplet, q = quartet, m = multiplet, app = apparent, br = broad),
'Still, W. C.; Kahn, M.; Mitra, A. J. Org. Chem. 1978, 43, 2923.
2 Pangborn, A. B.; Giardello, M. A.; Grubbs, R. H.; Rosen, R. K.; Timmers, F. J. Organometallics 1996, 15, 1518.
3 Kofron, W. G.; Baclawski, L. M. J. Org. Chem. 1976, 41, 1879.
coupling constant(s) in Hertz, integration, assignment]. Carbon-13 nuclear magnetic resonance
( C NMR) spectra were recorded with a Bruker 600 Avance spectrometer, a Varian 500 INOVA
spectrometer or a Bruker 400 spectrometer with a Magnex Scientific superconducting magnet
and are recorded in parts per million on the 8 scale and are referenced from the carbon
resonances of the solvent (CDCl3: 8 77.2, benzene-d: 6 128.4). Infrared data were obtained with
a Perkin-Elmer 2000 FT-IR and are reported as follows: [frequency of absorption (cm-1),
intensity of absorption (s = strong, m = medium, w = weak, br = broad), assignment]. Optical
rotations were measured on a Jasco- 1010 polarimeter. We are grateful to Dr. Li Li for obtaining
the mass spectroscopic data at the Department of Chemistry's Instrumentation Facility,
Massachusetts Institute of Technology. High-resolution mass spectra (HRMS) were recorded on
a Bruker APEX 4.7 Tesler FTMS spectrometer using electronspray ion source (ESI) or
electronspray (ES). The structure of (-)-himandrine was obtained with the assistance of Dr. Peter
Muller at the X-ray diffraction facility of Department of Chemistry, Massachusetts Institute of
Technology, and Justin Kim of the Movassaghi group.
Additional Notes. Positional numbering system: For ease of direct comparison, particularly
from trans-decalin (-)-32 to himandrine (-)-3, the numbering scheme used by Taylor and
coworkers in the isolation paper4 is used in this supporting document. In key instances the
products are accompanied by the numbering system as shown below for this document.
1Me OM
(-)-himandrine (3)
4 Ritchie, E.; Taylor, W. C. In the Alkaloids; Manske,
Chapter 14.
R. H. F., Ed.; Academic Press; New York, 1967; Vol. 9,
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S1
D-proline (4 mol%)
PhNO, CH2CI2, 0 *C; OH
NaBH 4, MeOH, 0 *C
(-)-S2 ONHPh
90%, >98.5% ee
(-)-(S)-2-(N-Phenyl-aminooxy)-hept-6-en-1-ol (S2):
Nitrosobenzene (9.7 g, 0.090 mmol, 1 equiv) was added as a solid to a suspension of D-
proline (0.46 g, 4.0 mmol, 4.0 mol%) in chloroform (50 mL) at 0 'C, and the resulting mixture
was sealed under an argon atmosphere. After 15 min, hept-6-enal5 (11.2 g, 10.0 mmol, 1.10
equiv) was added drop-wise via additional funnel to the bright green solution. After 3 h, the
resulting brown reaction mixture was added dropwise via additional funnel to a suspension of
sodium borohydride (14.2 g, 0.375 mol, 4.17 equiv) in methanol (50 mL) at 0 'C. After 30 min,
saturated aqueous sodium bicarbonate solution (100 mL) was added, and the layers were
separated. The aqueous layer was extracted with dichloromethane (3 x 150 mL). The combined
organic layers were washed with brine (200 mL), were dried over anhydrous sodium sulfate,
were filtered, and were concentrated under reduced pressure. The resulting oil was purified by
flash column chromatography (silica gel: diam. 7 cm, ht. 7 cm; eluent: 33% EtOAc in hexanes)
to afford alcohol (-)-S2 (18.1 g, 91%) as a yellow oil ([a]22 D -- 26.4 (c 1.0, CH 2Cl 2)). This
compound was determined to be of >98.5% ee by chiral HPLC analysis (Chirapak AD-H, 95%
hexanes / 5% iso-propanol, 3 mL/min, 215 nm tR (major) = 18.03 min; tR (minor) = 22.15 min).
The corresponding enantiomer, (+)-(R)-2-(N-Phenyl-aminooxy)-hept-6-en-1-ol (3.22 g,
80%, [a]22 D = +26 (c 0.90, CH 2Cl 2)), was prepared according to the same procedure using L-
proline as the catalyst. This compound was determined to be of >98.5% ee by chiral HPLC
analysis (Chirapak AD-H, 95% hexanes / 5% iso-propanol, 3 mL/min, 215 nm tR (minor) =
18.12 min; tR (major) = 22.02 min). Structural assignment utilized additional information from
gCOSY and HSQC.
'H NMR (400 MHz, CDCl 3, 20 C):
13 C NMR (100 MHz, CDCl 3, 20 C):
FTIR (thin film) cm-':
7.29-7.23 (m, 2H, ArH), 7.03 (br-s, 1H, NHPh),
7.00-6.94 (m, 3H, ArH), 5.90-5.72 (m, 1H,
CH=CH2), 5.07-4.90 (m, 2H, CH=CH 2), 4.00-3.91
(m, 1H, CHONHPh), 3.88-3.71 (in, 2H, CH 2OH),
2.60 (br-s, 1H, CH 2OH), 2.13-2.02 (m, 2H,
CH 2=CHCH2), 1.72-1.43 (m, 4H, CH 2CH 2).
148.5 (ArC), 138.5 (CH 2=CH), 129.3 (ArCH),
122.8 (ArCH), 115.1 (CH2=CH), 115.0 (ArCH),
84.0 (CHNHPh), 65.7 (CH2OH), 34.0
(CH2CH=CH2), 29.6 (CH 2CHNHPh), 25.2
(CH2CH2CH=CH2).
3385 (br, s), 3273 (s), 3076 (w), 2939 (s), 1641 (in),
1602 (s), 1494 (s), 1460 (w), 1241 (in), 1028 (s),
997 (in), 911 (s), 767 (in), 693 (m).
5 6-Heptenal was prepared from 7-octene-1,2-diol (commercially available), sodium metaperiodate, diethyl ether,
water, lh, 93%. Spectroscopic data matched those in the literature; see: Taylor, R. E.; Galvin, G. M.; Hilfiker, K. A.;
Chen, Y. J. Org. Chem. 1998, 63, 9580.
calc'd for C13H19NNaO2 [M+Na]*: 244.1308,
found: 244.1308.
TLC (17% EtOAc in hexanes), Rf 0.20 (UV, CAM).
HRMS (ESI):
OH
(-)-S2 ONHPh
Zn, AcOH
EtOH, 23 O
80%
OH
(-)-24 OH
(-)-(S)-Hept-6-ene-1,2-diol (24):
Zinc powder (8.89 g, 136 mmol, 2.00 equiv) was added as a solid to a solution of alcohol
(-)-S2 (15.1 g, 68.0 mmol, 1 equiv) in a mixture of ethanol and acetic acid (3:1, 340 mL) at 23
'C. After 2 h, the resulting mixture was filtered through a plug of celite (diam. 8.5 cm, ht. 2 cm),
and the residue was washed with ethanol (3 x 150 mL). The filtrate was concentrated under
reduced pressure at 30 'C. The residue was dissolved in ethyl acetate (400 mL), was washed with
saturated aqueous sodium bicarbonate solution (100 mL), was dried over anhydrous sodium
sulfate, was filtered, and was concentrated under reduced pressure. The resulting light yellow oil
was purified via flash column chromatography (silica gel: diam. 5 cm, ht. 25 cm; eluent: 5%
EtOAc in hexanes to 75% EtOAc in hexanes) to afford diol (-)-24 (7.1 g, 80%) as a yellow oil
([a]22D = -21 (c 0.44, EtOH)). The spectroscopic data was consistent with the literature.6
Structural assignment utilized additional information from gCOSY and HSQC.
'H NMR (500 MHz, CDCl 3, 20 C):
3 C NMR (100 MHz, CDCl 3, 20 C):
FTIR (thin film) cm-':
HRMS (ESI):
TLC (75% EtOAc in hexanes), RfJ
5.83-5.71 (m, 1H, CH 2=CH), 5.04-4.87 (m, 2H,
CH 2=CH), 3.65 (br-s, 1H, CHOH), 3.59 (app-d, J=
11.0Hz, 1H, CHH'OH), 3.43-3.34 (m, IH,
CHH'OH), 3.33-3.12 (br-s, 2H, OH, OH), 2.08-1.99
(m, 2H, CH 2CH=CH2), 1.57-1.34 (m. 4H,
CH2CH 2).
138.6 (CH 2=CH), 115.0 (CH2=CH), 72.4 (CHOH),
66.9 (CH 2OH), 33.8 (CH 2=CHCH 2), 32.6
(CH 2=CHCH2-CH 2CH 2), 25.0
(CH 2=CHCH2CH2CH 2).
3364 (br, s), 1641 (m), 1064 (m), 908 (m), 666 (w).
calc'd for C7Hj 4NaO2 [M+Na]*: 153.0886,
found: 153.0892.
0.40 (KMnO 4, CAM).
6 Takahata, H.; Takahashi, S.; Kouno, S.; Momose, T. J. Org. Chem. 1998, 63, 2224.
OH
(-)-24 OH
TBSCI
imidazole, DMAP
DMF, 0O*C
94%
OTBS
(+)-25 OH
(+)-(S)-1-(tert-Butyl-dimethyl-silanyloxy)-hept-6-en-2-ol (25):
tert-Butylchlorodimethylsilane (6.4 g, 42 mmol, 1 equiv) was added as a solid to a
solution of diol (-)-24 (6.10 g, 47.0 mmol. 1.05 equiv), 4-dimethylaminopyridine (229 mg, 1.90
mmol, 4.00 mol%), and imidazole (4.1 g, 60 mmol, 1.5 equiv) in NN-dimethylformamide (230
mL) at 0 "C, and the reaction mixture was sealed under an argon atmosphere. After 3 h, the
reaction mixture was diluted with diethyl ether (300 mL) and brine (150 mL), and the layers
were separated. The aqueous layer was extracted with diethyl ether (3 x 150 mL). The combined
organic layers were washed with brine (250 mL), were dried over anhydrous sodium sulfate,
were filtered, and were concentrated under reduced pressure. The resulting oil was purified via
flash column chromatography (silica gel: diam. 5 cm, ht. 17 cm; eluent: 10% EtOAc in hexanes)
to provide silyl ether (+)-25 (9.6 g, 94%) as a pale yellow oil ([a]2 2D = ±3.5 (c 1.4, CH 2Cl 2)).
'H NMR (600 MHz, CDCl 3, 20 C):
3 C NMR (100 MHz, CDCl 3, 20 C):
FTIR (thin film) cm-:
HRMS (ESI):
TLC (10% EtOAc in hexanes), Rf.
5.82-5.72 (m, iH, CH 2=CH), 4.99-4.91 (m, 2H,
CH 2=CH), 3.61-3.57 (m, 2H, CHOH, CHH'OTBS),
3.37-3.34 (m, 1H, CHH'OTBS), 2.45 (br-s, 1H,
CHOH), 2.08-2.03 (m, 2H, CH 2=CHCH 2), 1.58-
1.49 (m, 1H, CHH'CH2), 1.44-1.33 (m, 3H,
CHH'CH2), 0.87 (s, 9H, SiC(CH 3)3), 0.04 (s, 6H,
Si(CH 3)2).
138.9 (CH 2=CH), 114.8 (CH=CH), 71.8, 67.4, 34.1,
32.3, 26.1 (SiC(CH 3)3), 25.1, 18.6, -5.2 (Si(CH 3)2).
3446 (br, s), 3078 (m), 2859 (s), 1642 (m), 1463
(m), 1472 (m), 1362 (w), 1257 (m).
calc'd for C13H28NaO2Si [M+Na]*: 267.1751,
found: 267.1750.
0.55 (KMnO4).
OTBS
(+)-25 OH
Me3O-BF 4Proton Sponge*
4A-MS, CH2CI2, 23 *C
OTBS
(-)-S3 OMe
93%
(-)-(S)-tert-Butvl-(2-methoxy-hept-6-envloxy)-dimethyl-silane (S3):
Oven-dried 4A molecular sieves (19.6 g, 2:1, wt/wt), Proton Sponge* (25.5 g, 118 mmol,
3.00 equiv), and trimethoxyl oxonium tetrafluoroborate (14.5 g, 98.0 mmol, 2.51 equiv) were
added sequentially to a solution of alcohol (+)-25 (9.6 g, 39 mmol, 1 equiv) in dichloromethane
(392 mL) at 23 'C, and the reaction mixture was sealed under an argon atmosphere. After 3 h,
the reaction mixture was filtered through a plug of celite (diam. 8.5 cm, ht. 3 cm), and the
residue was washed with dichloromethane (3 x 100 mL). The filtrate was concentrated under
reduced pressure. The residue was dissolved in a mixture of hexanes and ethyl acetate (1 : 1, 400
mL), and the residual insoluble light brown solid was removed by filtration, and was washed
with a mixture of hexanes and ethyl acetate (1 : 1, 2 x 100 mL). The filtrate was washed with
saturated aqueous copper sulfate solution (150 mL) and brine (150 mL), was dried over
anhydrous sodium sulfate, was filtered, and was concentrated under reduced pressure. The
resulting oil was purified via flash column chromatography (silica gel: diam. 5 cm, ht. 17 cm;
eluent: 3% EtOAc in hexanes) to afford methyl ether (-)-S3 (9.3 g, 93%) as a colorless oil
([a]22D = -11 (c 1.4, CH 2Cl 2)). Structural assignment utilized additional information from
gCOSY and HSQC.
H NMR (600 MHz, CDCl 3, 20 'C):
13C NMR (100 MHz, CDCl 3, 20 *C):
FTIR (thin film) cm-1:
HRMS (ESI):
TLC (3% EtOAc in hexanes), Rf-
5.83-5.73 (m, 1H, CH 2=CH), 5.01-4.88 (m, 2H,
CH 2=CH), 3.60 (dd, J= 6.0, 10.2 Hz, 1H,
CHH'OTBS), 3.52 (dd, J= 4.8, 10.2 Hz, 1H,
CHH'OTBS), 3.38 (s, 3H, OCH3), 3.19-3.16 (m,
1H, CHOCH 3), 2.04-2.03 (m, 2H, CH 2=CHCH2),
1.53-1.46 (m, 2H, CH 2 CH2), 1.45-1.36 (m, 2H,
CH2 CH 2), 0.87 (s, 9H, SiC(CH 3)3), 0.03 (s, 6H,
Si(CH 3)2).
139.0 (CH2=CH), 114.8 (CH=CH), 82.1 (OCH3),
65.4, 58.2, 34.1, 31.0, 26.2 (SiC(CH 3)3), 24.9, 18.4,
-5.1 (Si(CH 3)2).
2929 (s), 2859 (s), 1642 (w), 1472 (m), 1463 (m),
1256 (s), 1107 (s), 837 (s), 776 (s).
calc'd for C14H30NaO2Si [M+Na]*: 281.1907,
found: 281.1918.
0.63 (KMnO 4).
OTBS
(-)-S3 OMe
HCI
MeOH, 23 0
98%
OH
(+)-26 OMe
(+)-(S)-2-Methoxy-hept-6-en-1-ol (26):
Thionyl chloride (0.495 mL, 13.6 mmol, 0.400 equiv) was added dropwise to methanol
(340 mL) at 23 'C. After 5 min, the resulting methanolic hydrochloric acid solution (0.04 M)
was added to a solution of silyl ether (-)-S3 (8.6 g, 34 mmol, 1 equiv) in methanol (340 mL) at
23 'C. After 15 min, the reaction solvent was removed under reduced pressure, and the residue
was purified by flash column chromatography (silica gel: diam. 3 cm, ht. 10 cm; eluent: 33%
EtOAc in hexanes) to afford alcohol (+)-26 (4.9 g, 98%) as a pale yellow oil ([a]2 2D = + 22 (c
0.70, CH 2Cl2)).
'H NMR (400 MHz, CDCl3 , 20 C):
13C NMR (125 MHz, CDCl 3, 20 C):
FTIR (thin film) cm-1:
HRMS (ESI):
TLC (33% EtOAc in hexanes), Rf-
5.80-5.67 (m, 1H, CH 2=CH), 5.00-4.87 (m, 2H,
CH 2=CH), 3.64-3.57 (m, 1H, CH 2OH), 3.45-3.39
(m, 1H, CH 2OH), 3.34 (s, 3H, OCH3), 3.23-3.16
(m, 1H, CHOCH3 ), 2.56-2.53 (m, 1H, CH 2OH),
2.05-1.98 (m, 2H, CH 2=CHCH2), 1.55-1.44 (m, 1H,
CHH'CH2), 1.44-1.32 (m, 3H, CHH'CH2).
138.5 (CH 2=CH), 114.9 (CH=CH), 81.7 (OCH3),
63.9, 57.2, 33.9 (CH 2=CHCH2), 29.8, 24.7.
3421 (br, s), 2935 (s), 1641 (w), 1458 (w), 1093 (s),
910 (m).
calc'd for C8Hi 6NaO2 [M+Na]*: 167.1043,
found: 167.1040.
0.60 (KMnO4).
OH SO3-pyridine O Br BrPr2NEt CBr 4, PPh3
OMe DMSO OMe CH2CI2, 0 *C
CH2C2, 23 C 65% (2-steps)
(-)-1,1-Dibromo-3-methoxy-octa-1,7-diene (27):
Dimethyl sulfoxide (24.2 mL, 340 mmol, 10.0 equiv), diisopropylethylamine (30.5 mL,
170 mmol, 5.00 equiv) and sulfur trioxide pyridine complex (16.2 g, 102 mmol, 3.00 equiv) were
added sequentially to a solution of alcohol (+)-26 (4.9 g, 34 mmol, 1 equiv) in dichloromethane
(170 mL) at 23 'C, and the reaction mixture was sealed under an argon atmosphere. After 15
min, the reaction mixture was diluted with diethyl ether (250 mL) and water (100 mL), and the
layers were separated. The aqueous layer was extracted with diethyl ether (3 x 150 mL). The
combined organic layers were washed sequentially with aqueous hydrochloric acid solution (1 M,
100 mL), saturated aqueous sodium bicarbonate solution (100 mL), and brine (100 mL), were
dried over anhydrous sodium sulfate, were filtered, and were concentrated under reduced
pressure. The resulting oil was purified via flash column chromatography (silica gel: diam. 3 cm,
ht. 10 cm; eluent: 33% diethyl ether in hexanes) to afford aldehyde S4 as a colorless oil. 7
Triphenylphosphine (21.4 g, 81.6 mmol, 2.40 equiv) was added as a solid to a solution of
carbon tetrabromide (13.5 g, 40.8 mmol, 1.20 equiv) in dichloromethane at 0 "C, and the reaction
mixture was sealed under an argon atmosphere. After 15 min, the solution of aldehyde S4 in
dichloromethane (10 mL) was added dropwise via cannula to the resulting orange reaction
mixture. After 15 min, excess dibromophosphorane was quenched by sequential addition of
triethylamine (11.5 mL, 81.6 mmol, 2.40 equiv) and methanol (3.5 mL, 81.6 mmol, 2.40 equiv).
The reaction mixture was added dropwise to a mixture of hexanes and ethyl acetate (5:1, 400
mL). The resulting light brown solid was removed by filtration, and was washed with a mixture
of hexanes and ethyl acetate (5:1, 100 mL). The filtrate was concentrated, and the residue was
purified by flash column chromatography (silica gel: diam. 5 cm, ht. 17 cm; eluent: 10% diethyl
ether in hexanes) to provide dibromide (-)-27 (6.1 g, 65% 2-steps) as a colorless oil ([a]2 2 D
-19 (c 2.8, CH 2Cl 2)). Structural assignment utilized additional information from gCOSY.
'H NMR (500 MHz, CDCl 3, 20 C): 6.30 (d, J= 8.5 Hz, 1H, CBr2=CH), 5.83-5.72 (in,
1H, CH 2=CH), 5.03-4.91 (in, 2H, CH 2=CH), 3.89-
3.84 (m, 1H, CHCH=CBr 2), 3.28 (s, 3H, OCH 3),
2.08-2.03 (m, 2H, CH2=CHCH2), 1.65-1.57 (m, 1H,
CHH'CH2), 1.53-1.37 (m, 3H, CHH'CH2).
13C NMR (125 MHz, CDCl 3, 20 C): 140.1 (CH 2=CH), 138.7, 115.1 (CH2=CH), 91.4,
81.5 (OCH 3), 57.2, 33.9, 33.8, 24.3.
FTIR (thin film) cm-: 2931 (s), 2822 (w), 1641 (in), 1617 (in), 1458 (m),
1105 (s), 912 (s), 782 (s).
7 Reduction of a sample of aldehyde S4 (NaBH 4) returned the alcohol (+)-26 with the same optical activity as
compared to the starting alcohol (+)-26.
Elemental Analysis:
TLC (10% Et 20 in hexanes), Rf:
calc'd for C9H14Br 2O: C, 36.27; H, 4.74,
found: C, 35.98; H, 4.70.
0.78 (UV, CAM).
Br Br OTBS
Pd(PPh3)4, T12CO3
+ Me I TBSO
OMe (HO)2B THF, H20,23 C Me Me
(-)-27 28 97% 29 Br
(4-Bromo-6-methoxy-1-methyl-undeca-2,4,10-trienyloxy)-tert-butyl-dimethyl-silane (29):
Tetrakis(triphenylphosphine)palladium (1.54 g, 1.30 mmol, 8.00 mol%) and thallium
carbonate (15.7 g, 33.0 mmol, 2.00 equiv) were added sequentially to a degassed solution of
dibromide (-)-27 (4.99 g, 17.0 mmol, 1 equiv) and boronic acid 288 (4.04 g, 17.6 mmol, 1.10
equiv) in a mixture of tetrahydrofuran and water (2:1, 68 mL) at 23 'C in the dark, and the
reaction mixture was sealed under an argon atmosphere. After 10 h, the pale yellow
heterogeneous reaction mixture was diluted with ethyl acetate, was filtered through a plug of
silica gel (diam. 5 cm, ht. 3 cm), and the residue was washed with ethyl acetate (3 x 100 mL).
The filtrate was washed with saturated aqueous sodium bicarbonate solution (100 mL) and brine
(100 mL), was dried over anhydrous sodium sulfate, was filtered and was concentrated under
reduced pressure. The resulting oil was purified by flash column chromatography (silica gel:
diam. 5 cm, ht. 10 cm; eluent: 33% EtOAc in hexanes) to afford vinyl bromide 29 (6.7 g, 97%)
as a 1:1 mixture of two diastereomers. Structural assignment utilized additional information from
gCOSY.
'H NMR (500 MHz, CDC13, 20 C, one diastereomer noted by *): 6.23-6.19 (m, 1H,
CH=CH-CBr; 1H, CH=CH-CBr*), 6.12-6.08 (m,
1H, CH=CH-CBr; 1H, CH=CH-CBr*), 5.83-5.73
(m, 2H, CBr=CH, CH 2=CH; 2H, CBr-CH*,
CH2=CH*), 5.03-4.90 (m, 2H, CH 2=CH; 2H,
CH 2=CH*), 4.47-4.40 (m, 1H, CHOTBS; 1H,
CHOTBS*), 4.22-4.15 (m, 1H, CHOCH3; 1H,
CHOCH3*), 3.29 (s, 3H, OCH 3), 3.28 (s, 3H,
OCH 3*), 2.06 (app-q, J= 7.0 Hz, 2H,
CH2CH=CH2; 2H, CH 2CH=CH2*), 1.67-1.40 (m,
4H, CH 2CH 2; 4H, CH 2CH 2*), 1.24 (d, J- 6.0 Hz,
3H, CH 3CHOTBS; 3H, CH 3CHOTBS*), 0.89 (s,
9H, SiC(CH 3)3; 9H, SiC(CH 3)3*), 0.05 (s, 6H,
Si(CH 3)2), 0.05 (s, 6H, Si(CH 3)2*).
13C NMR (100 MHz, CDCl 3, 20 C): 140.5, 140.4, 138.8, 138.8, 134.2, 134.1, 127.0,
126.9, 126.9, 126.8, 114.9, 80.5, 77.4, 68.3, 56.9,
34.4, 33.9, 26.1, 24.6, 18.5, -4.5.
FTIR (thin film) cm-1: 2929 (s), 1470 (m), 1368 (w), 1253 (s), 1147 (s),
1093 (s), 835 (m), 776 (m).
HRMS (ESI): calc'd for C19H35BrNaO2Si [M+Na]*: 425.1482,
found: 425.1491.
8 The boronic acid was prepared as described previously; see Movassaghi, M.; Hunt, D. K.; Tjandra, M. J. Am.
Chem. Soc. 2006, 128, 8126.
TLC (10% EtOAc in hexanes), Rf 0.65(UV, CAM).
Cul, K2CO3
TBSO + NO MeNH(CH 2)2NHMe TBSO
Me O / bMe + Toluene, 120*C Me / Me
29 Br 85% S5N
0;
1-{1-[3-(tert-Butyl-dimethyl-silanyloxy)-but-1-enyll-3-methoxy-octa-1,7-dienyl}-azetidin-2-
one (S5):
2-Azetidinone (1.16 g, 16.3 mmol, 2.50 equiv), copper iodide (1.58 g, 8.30 mmol, 50.0
mol%), potassium carbonate (5.74 g, 41.5 mmol, 2.50 equiv) and NN-dimethyl ethylene diamine
(4.50 mL, 41.5 mmol, 2.50 equiv) were added sequentially to a solution of vinyl bromide 29
(6.72 g, 16.6 mmol, 1 equiv) in anhydrous toluene (16 mL) at 23 'C in a 50-mL schlenk flask.
The reaction vessel was sealed under an argon atmosphere, and it was heated to 120 C. After 16
h, the reaction mixture was cooled to 23 'C and filtered through a plug of silica gel (diam. 3 cm,
ht. 3 cm), and the residue was washed with ethyl acetate (3 x 200 mL). The filtrate was
concentrated under reduced pressure, and the residue was purified by flash column
chromatography (silica gel: diam. 3 cm, ht. 15 cm; eluent: 33% EtOAc in hexanes) to afford
triene S5 (5.4 g, 85%) as a 1:1 mixture of two diastereomers. Structural assignment utilized
additional information from gCOSY.
H NMR (400 MHz, CDC13, 20 C, one diastereomer noted by *): 6.02 (app-dt, J= 4.0, 15.6 Hz,
1H, CH=CH-CN; 1H, CH=CH-CN*), 5.83-5.65
(m, 2H, CH 2=CH, CH=CHCN; 2H, CH 2=CH*,
CH=CHCN*), 5.30 (app-dd, J= 2.0, 8.8 Hz, 1H,
NC=CH; 1H, NC=CH*), 5.00-4.89 (m, 2H,
CH 2=CH; 2H, CH 2=CH*), 4.40-4.31 (m, 1H,
CHOTBS; 1H, CHOTBS*), 3.95-3.85 (m, 1H,
CHOCH3; 1H, CHOCH 3*), 3.50-3.39 (m, 2H,
CH 2C=O; 2H, CH 2C=O*), 3.25 (s, 3H, OCH 3),
3.24 (s, 3H, OCH 3*), 3.11-3.05 (app-t, J= 4.4 Hz,
2H, CH 2N; 2H, CH2N*), 2.06 (app-q, J= 6.8 Hz,
2H, CH 2CH=CH2; 2H, CH 2CH=CH2*), 1.65-1.33
(m, 4H, CH 2CH 2; 4H, CH 2CH 2*), 1.23 (d, J= 6.5
Hz, 3H, CH 3CHOTBS; 3H, CH 3CHOTBS*), 0.87
(s, 9H, SiC(CH 3)3; 9H, SiC(CH 3)3 *), 0.04 (s, 6H,
Si(CH 3)2), 0.03 (s, 6H, Si(CH 3)2 *).
3 C NMR (100 MHz, CDC13, 20 'C): 166.1, 166.0, 138.9, 138.8, 136.9, 136.9, 135.1,
135.0, 130.1, 130.1, 124.1, 124.1, 114.8, 114.7,
77.1, 77.1, 68.6, 68.5, 56.7, 56.7, 41.7, 41.7, 36.7,
34.8, 34.7, 33.9, 26.1, 24.8, 24.6, 18.4, -4.5.
FTIR (thin film) cm 1: 2929 (s), 1761 (s), 1640 (w), 1472 (w), 1396 (m),
1252 (w), 1093 (s), 966 (m), 909 (m), 834 (m), 777
(m).
calc'd for C22H39NNaO3Si [M+Na]+: 416.2591,
found: 416.2599.
TLC (33% EtOAc in hexanes), Rf 0.50 (UV, CAM).
HRMS (ESI):
TBSO
Me OMe
S5]
0
TBAF, THF HO
0 -23 *C Me OMe
S6 N
OT
DMSO, 'Pr2NEt
S0 3 pyridine
CH2CI2, 23 *C
80% (2-steps)
(-)-(S)-1-[3-Methoxv-1-(3-oxo-but-1-enyl)-octa-1,7-dienvll-azetidin-2-one (S7):
Tetrabutylammonium fluoride solution in tetrahydrofuran (1.0 M, 21 mL, 21 mmol, 1.5
equiv) was added via syringe to a solution of triene S5 (6.9g, 17.6 mmol) in tetrahydrofuran (176
mL) at 0 C under an argon atmosphere, and the reaction mixture was allowed to warm to 23 'C.
After 2 h, the reaction mixture was diluted with diethyl ether (400 mL) and brine (150 mL), and
the layers were separated. The aqueous layer was extracted with diethyl ether (3 x 150 mL). The
combined organic layers were washed with brine (100 mL), were dried over anhydrous sodium
sulfate, were filtered, and were concentrated under reduced pressure. The residue was purified by
flash column chromatography (silica gel: diam. 3 cm, ht. 8 cm; eluent: 75% EtOAc in hexanes)
to afford alcohol S6 (4.6 g, 95%) as a pale yellow oil, which was used directly in the following
oxidation step.
Dimethyl sulfoxide (12.5 mL, 175 mmol, 10.0 equiv), diisopropylethylamine (15.7 mL,
87.5 mmol, 5.00 equiv), and sulfur trioxide pyridine complex (8.40 g, 52.5 mmol, 3.00 equiv)
were added sequentially to a solution of alcohol S6 (4.62 g, 16.6 mmol, 1 equiv) in
dichloromethane (176 mL) at 23 'C, and the reaction mixture was sealed under an argon
atmosphere. After 15 min, the reaction mixture was diluted with diethyl ether (250 mL) and
brine (100 mL), and the layers were separated. The aqueous layer was extracted with diethyl
ether (3 x 100 mL). The combined organic layers were washed with brine (200 mL), were dried
over anhydrous sodium sulfate, were filtered, and were concentrated under reduced pressure. The
resulting oil was purified by flash column chromatagraphy (silica gel: diam. 3 cm, ht. 10 cm;
eluent: 75% EtOAc in hexanes) to afford ketone (-)-S7 (3.9 g, 83%) as a pale yellow oil ([a] D
= -29 (c 0.27, CH 2Cl 2)). Structural assignment utilized additional information from gCOSY and
HSQC.
'H NMR (600 MHz, CDCl 3, 20 C):
13C NMR (100 MHz, CDCl 3, 20 C):
6.94 (d, J= 15.6 Hz, 1H, CH=CHCN), 6.08 (d, J=
16.2 Hz, 1H, CH=CHCN), 5.80 (d, J= 9.0 Hz, IH,
CN=CH), 5.78-5.71 (m, 1H, CH 2=CH), 4.97-4.90
(m, 2H, CH 2=CH), 3.95-3.90 (m, 1H, CHOCH3),
3.51-3.44 (m, 2H, CH2C=ON), 3.24 (s, 3H, OCH 3),
3.09 (t, J= 10.2 Hz, 2H, CH 2N), 2.26 (s, 3H,
CH 3C=O), 2.01 (app-q, J= 7.2 Hz, 2H,
CH 2CH=CH2), 1.64-1.36 (m, 4H, CH 2CH 2).
197.7 (C=O), 166.0 (C=ON), 140.1 (CN=CH),
139.5 (CH=CHCN), 138.5 (CH 2=CH), 134.1
(CN=CH), 128.5 (CH=CHCN), 115.0 (CH 2=CH),
77.1 (CHOCH3), 57.1 (OCH 3), 42.1 (CH 2C=O),
37.2 (CH2NC=O), 34.3 (CH2CHOTBS), 33.7
(CH 2CH=CH 2), 27.8 (CH3C=O), 24.6
(CH2CH 2CH=CH2).
0
Me 'OMe
(-)-S7
O
FTIR (thin film) cm~1:
HRMS (ESI):
TLC (75% EtOAc-hexanes), Rf:
2932 (s), 1756 (s), 1692 (w), 1673 (m), 1603 (m),
1401 (m), 1361 (w), 1256 (m), 1101 (m), 977 (w),
911 (w), 779 (w).
calc'd for C16H32NNaO3 [M + Na]*: 300.1570,
found: 300.1579.
0.65 (UV, CAM).
0Me OMe
(-)-S7
0
TBSOTf, NEt3
CH2CI2, -78 0C
82%
TBSO
OMe
(-)-30
O
(-)-(S)1-{1-[3-(tert-Butyl-dimethyl-silanyloxy)-buta-1,3-dienyll-3-methoxy-octa-1,7-dienvl}-
azetidin-2-one (30):
Triethylamine (2.1 mL, 15 mmol, 1.5 equiv) and tert-butyldimethylsilyl
trifluoromethanesulfonate (2.9 mL, 12 mmol, 1.2 equiv) were added sequentially to a solution of
ketone (-)-S7 (2.77g, 10.0 mmol, 1 equiv) in dichloromethane (100 mL) at -78 'C under an
argon atmosphere. After 2 h, saturated aqueous sodium bicarbonate solution (40 mL) was added,
and the reaction mixture was allowed to warm to 23 'C. The layers were separated, and the
aqueous layer was extracted with dichloromethane (3 x 100 mL). The combined organic layers
were washed with brine, were dried over anhydrous sodium sulfate, were filtered, and were
concentrated under reduced pressure. The resulting oil was then purified by flash column
chromatography (silica gel, treated with 1% NEt3 in [49% EtOAc in hexanes], diam. 3 cm, ht. 10
cm; eluent: 1% of NEt3 in [49% EtOAc in hexanes]) to afford silyl enol ether (-)-30 (3.4 g, 86%)
as a pale yellow oil ([a] 22 D= -28 (c 0.27, CH2Cl 2)). Structural assignment utilized additional
information from gCOSY and HSQC.
'H NMR (600 MHz, C6D6, 20 'C):
"C NMR (100 MHz, C6D6, 20 C):
FTIR (thin film) cm-:
HRMS (ESI):
6.67 (d, J= 15 Hz, 1H, CH=CHCN), 6.19 (d, J
15.6 Hz, 1H, CH=CHCN), 5.81-5.72 (in, 1H,
CH2=CH), 5.48 (d, J= 9.0 Hz, 1H, NC=CH), 5.04-
4.95 (m, 2H, CH 2=CH), 4.42 (s, 1H,
CHH'=COTBS), 4.38 (s, 1H, CHH'=COTBS),
4.09-4.04 (m, 1H, CHOCH3), 3.21 (s, 3H, OCH 3),
2.87 (app-q, J= 4.8 Hz, 1H, CH 2C(=O)N), 2.80
(app-q, J= 4.8 Hz, 1H, CH 2C(=O)N), 2.45 (t, J=
4.2 Hz, 2H, CH 2NC=O), 2.00 (app-t, J= 6.6 Hz,
2H, CHH'CH=CH2), 1.74-1.49 (m, 4H, CH 2 CH 2),
0.98 (s, 9H, SiC(CH 3)3), 0.14 (s, 6H, Si(CH 3)2).
165.3, 155.4, 139.4, 135.9, 131.5, 129.2, 126.6,
115.1, 98.0, 77.6, 56.8, 41.8, 37.1, 35.5, 34.4, 26.3,
25.6, 18.8, -4.2, -4.2.
2930 (in), 1760 (s), 1622 (w), 1583 (w), 1396 (m),
1318 (in), 1254 (m), 1102 (in), 1028 (in), 840 (m),
782 (m).
calc'd for C22H37NNaO3 Si [M+Na]*: 414.2435,
found: 414.2436.
TLC (1% NEt3 in [32% EtOAc in hexanes]), Rf 0.55 (UV, CAM).
/bMeTBSO N
(-)-30 
001
acrolein
4,5-DihydrolMES-
Cl2Ru=CH(o-O'Pr)Ph(10 mol%)
CH2CI2 23 *C, 1 h
85%
OHC
TBSO 'OMe
(-)-31 Oi
0
(-)-(S,2E,8Z,10E)-12-(tert-Butyl-dimethyl-silanyloxy)-7-methoxy-9-(2-oxo-azetidin-1-yl)-
trideca-2,8,10,12-tetraenal (31):
Acrolein (0.80 mL, 12 mmol, 5.0 equiv) and the Grubbs-Hoveyda catalyst (150 mg,
0.240 mmol, 10.0 mol%) were added sequentially to a solution of silyl enol ether (-)-30 (0.95 g,
2.4 mmol, 1 equiv) in dichloromethane (8 mL) at 23 'C, and the reaction vessel was sealed under
an argon atmosphere. After 1 h, the reaction mixture was directly loaded onto and purified by
flash column chromatography (silica gel, treated with 1% NEt3 in [32% EtOAc in hexanes],
diam. 5 cm, ht. 15 cm; eluent: 1% NEt3 in [32% EtOAc in hexanes]) to afford tetraenal (-)-31
(855 mg, 85%) as a pale yellow oil ([a]22 D = -70 (c 0.20, benzene)). The starting material (-)-30
(140 mg, 15%) was also recovered.
'H NMR (500 MHz, C6D6, 20 C):
13C NMR (125 MHz, C6D6, 20 0C):
FTIR (thin film) cm-':
HRMS (ESI):
9.32 (d, J= 7.5 Hz, 1H, HC=O), 6.68 (d, J= 15.0
Hz, 1H, CH=CHCN), 6.19 (d, J= 15.5 Hz, 1H,
CH=CHCN), 6.14-6.06 (m, 1H, CHOCH=CH),
5.99-5.92 (m, 1H, CHOCH=CH), 5.47 (d, J= 9.5
Hz, 1H, N-C=CH), 4.44 (s, 1H, CHH'=COTBS),
4.37 (s, 1H, CHH'=COTBS), 4.08-4.02 (m, 1H,
CHOCH3), 3.18 (s, 3H, OCH 3), 2.92-2.89 (m, 1H,
CHH'C=ON), 2.76-2.73 (m, 1H, CHH'C=ON), 2.43
(t, J= 4.8 Hz, 2H, CH 2NC=O), 1.87-1.80 (m, 2H,
CH2=CHCH 2), 1.61-1.57 (m, 2H, CH 2), 1.53-1.38(m, 2H), 0.99 (s, 9H SiC(CH 3)3), 0.15 (s, 6H,
Si(CH 3)2).
193.1, 165.3, 157.6, 155.3, 135.9, 133.8, 130.7,
129.5, 128.9, 128.7, 126.3, 98.2, 77.5, 56.8, 41.5,
37.0, 35.3, 32.8, 26.3, 24.3, 18.6, -4.2, -4.2.
2931 (s), 1756 (s), 1694 (s), 1628 (m), 1466 (m),
1398 (m), 1097 (m), 840 (m), 782 (m).
calc'd for C23H37NNaO4Si [M+Na]*: 442.2384,
found: 442.2381.
TLC (1% NEt3 in [32% EtOAc in hexanes]), Rf 0.33 (UV, CAM).
OMe
N,N-Diethylaniline
BHT, MeCN
95 *C, 7 h
75%
(-)-32 5 1 (+)-S8 0.64%
trans-Decalin aldehyde (-)-32:
2,6-Di-tert-butyl-4-methylphenol (10 mg, 45 [tmol, 0.56 mol%) and NN-diethyl aniline
(0.13 mL, 0.81 mmol, 10 mol%) were added sequentially to a solution of tetraenal (-)-31 (3.4 g,
8.1 mmol, 1 equiv) in acetonitrile (800 mL). The resulting solution was degassed thoroughly by
passage of a stream of argon. The resulting pale yellow solution was partitioned into two 500-mL
pressure vessels. The vessels were sealed under an argon atmosphere and heated to 95 C. After
7 h, the reaction vessels were allowed to cool to 23 'C, and the combined mixture was
concentrated under reduced pressure. The residue was purified by flash column chromatography
(silica gel, treated with 1% NEt3 in [32% EtOAc in hexanes], diam. 5 cm, ht. 10 cm; 1% NEt3 in
[32% EtOAc in hexanes]) to afford the desired trans-decalin aldehyde (-)-32 (2.1 g, 63%) as a
pale yellow oil ([a] 22D -39 (c 1.5, CH 2Cl2)). The minor diastereomer (+)-S8 (420 mg, 13%)
was also isolated ([a] 2 2 D =+66 (c 0.45, CH2Cl 2)). Structural assignment utilized additional
information from gCOSY, HSQC, and HMBC.
Data for the major and desired diastereomer
'H NMR (400 MHz, C6D6, 20 *C):
13C NMR (125 MHz, C6D6, 20 C):
FTIR (thin film) cm-1:
(-)-32:
9.62 (d, J= 5.2 Hz, 1H, C8H), 5.70 (dd, J= 2.0, 5.2
Hz, 1H, C17H), 4.63 (d, J= 1.6 Hz, 1H, C21HH'),
4.39 (d, J= 1.2 Hz, 1H, C21HH'), 3.36-3.31 (m, 1H,
CHH'C=ON), 3.05 (s, 3H, OCH 3), 2.92 (dt, J= 2.0,
6.0 Hz, 1H, C14H), 2.71-2.65 (m, 1H, CHH'C=ON),
2.58-2.43 (m, 2H, CH 2NC=O), 2.17-2.08 (m, 1H,
C9H), 2.05-1.94 (m, CioH), 1.90-1.83 (m, 1H,
C13HH'), 1.73 (app-tt, J = 2.4, 12.4 Hz, IH CXisH,
1.50-1.36 (m, 2H, CIIHH', C12HH'), 1.05-0.90 (m,
2H, C12HH', C13HH'), 0.97 (s, 9H, SiC(CH 3)3), 0.64
(app-dq, J= 6.6, 18.0 Hz, 1H, C1 1HH'), 0.15 (s, 3H,
SiCH3), 0.10 (s, 3H, SiCH 3).
202.8 (Cs), 165.8, 157.1, 137.6, 124.8 (C17), 96.2
(C21), 82.3 (C14), 56.3 (CHOCH3), 53.4 (C9), 47.4
(C1 5), 44.4 (C19), 42.1 (CH2C=ON), 37.3(CH 2CH2C=ON), 35.2 (Cro), 32.1 (C13), 29.8 (C,1),
26.2 (SiC(CH 3)3), 24.0 (C12), 18.6 (SiC(CH 3)3), 4.0
(SiCH 3), 4.6 (SiCH 3).
2929 (s), 2863 (m), 1750 (s), 1723 (m), 1628 (w),
1383 (m), 1093 (m), 832 (m).
calc'd for C23H37NNaO 4Si [M+Na]*: 442.2384,
found: 442.2361.
TLC (1% NEt3 in [32% EtOAc in hexanes]), Rf 0.25 (UV, CAM).
Data for the minor diastereomer (+)-S8:
1H NMR (600 MHz, C6D6, 20 C):
'
3C NMR (125 MHz, C6D6, 20 C):
FTIR (thin film) cm-1:
HRMS (ESI):
9.69 (d, J= 5.4 Hz, 1H, C8H), 4.74 (dd, J= 1.8, 5.4
Hz, 1H, C17H), 4.54 (s, 1H, C21HH'), 4.41 (s, 1H,
C21HH'), 4.23 (br-s, 1H, C14H), 3.10 (s, 3H, OCH3),
3.04-3.01 (m, 1H, CI9H), 2.75 (app-dq, J= 2.4, 12.0
Hz, CioH), 2.67-2.65 (m, 1H, CHH'C=ON), 2.49-
2.43 (m, 2H, CHH'C=ON, C15H), 2.37-2.32 (m, 1H,
CHH'NC=O), 2.23-2.19 (m, 1H, C9H), 2.16-2.13
(m, 1H, CHH'NC=0), 1.89-1.87 (m, 1H, C13HH'),
1.65-1.53 (m, 2H, C11HH', C12HH'), 1.32-1.27 (m,
2H, C13HH', C12HH'), 0.98 (s, 9H, SiC(CH 3)3), 0.84(app-dq, J= 3.0, 12.6 Hz, 1H, C1 HH'), 0.14 (s, 6H,
Si(CH 3)2).
203.6 (C8), 164.1, 158.3, 139.8, 109.4 (C17), 95.4
(C21), 76.6 (C1 4), 56.8 (OCH3), 53.9 (C9 ), 47.0
(C15), 44.1 (C19), 37.6 (CH2C=ON), 35.1(CH 2CH 2C=ON), 30.4 (C1 ), 29.7 (Clo), 28.4 (C13),
26.1 (SiC(CH 3)3), 21.2 (C12), 18.6 (SiC(CH3)3),
-4.1 (SiCH 3), -4.6 (SiCH 3).
2931 (s), 2858 (m), 1750 (s), 1723 (m), 1629 (w),
1363 (m), 1254 (m), 1224 (s), 1094 (m), 1002 (w),
837 (m), 781 (m).
calc'd for C23H37NNaO4Si [M+Na]+: 442.2384,
found: 442.2383.
TLC (1% NEt 3 in [32% EtOAc in hexanes]), Rf 0.40 (UV, CAM).
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HRMS (ESI):
C R
TBSO
z
N OMe
(-)-32
TiC 4, 4A MS
CH2Cl2, -78 'C;
Martin Sulfurane
benzene, 23 *C
57% (2-steps)
H
N OMe
(-)-33
Tricyclic Enone (-)-33:
A freshly prepared solution of titanium tetrachloride in dichloromethane (1.0 M, 0.36
mL, 0.36 mmol, 2.0 equiv) was added in one portion via syringe to a suspension of trans-decalin
aldehyde (-)-32 (75 mg, 0.18 mmol, 1 equiv) and oven-dried 4A-molecular sieves (100 mg) in
dichloromethane (8.9 mL) at -78 'C under an argon atmosphere. After 2 min, saturated aqueous
sodium chloride solution (10 mL) was added in one portion via syringe. The resulting mixture
was allowed to warm to 23 'C, and the layers were separated. The aqueous layer was extracted
with dichloromethane (3 x 50 mL). The combined organic layers were washed with brine (25
mL), were dried over anhydrous sodium sulfate, were filtered and were concentrated under
reduced pressure to afford the desired crude intramolecular aldol addition product as an oil. The
residue was dried by concentration from anhydrous benzene (2 x 5 mL) and was directly used in
the following dehydration step.
A solution of the Martin sulfurane reagent (133 mg, 0.198 mmol, 1.10 equiv) in
anhydrous benzene (3.6 mL) was added via cannula to the crude solution of aldol product in
anhydrous benzene (3.6 mL) at 23 'C. After 30 min, the reaction mixture was directly loaded
onto and purified via flash column chromatography (silica gel: diam. 1.5 cm, ht. 4 cm; eluent:
75% EtOAc in hexanes) to afford enone (-)-33 (30 mg, 57%) as an oil ([a] 22D = -18 (c 0.65,
CH 2Cl 2)). Structural assignment utilized additional information from gCOSY, and HSQC.
'H NMR (600 MHz, C6D6, 20 'C):
3 C NMR (150 MHz, C6D6, 20 C):
FTIR (thin film) cm-l:
6.89 (dd, J= 3.0, 6.0 Hz, 1H, C8H), 6.13, (app-t, J=
3.0 Hz, 1H, C17H), 5.84 (dd, J= 1.8, 6.0 Hz, 1H,
C21H), 3.47-3.42 (in, 1H, C14H), 3.14 (s, 3H,
OCH 3), 3.11-3.08 (in, 1H, CHH'C=ON), 2.76-2.74
(m, 1H, CHH'C=ON), 2.52-2.41 (in, 3H, Ci9H,
CHH'NC=O, CHH'NC=O), 2.07-2.01 (in, 1H,
C13HH'), 1.99-1.93 (m, 1H, C9H), 1.79-1.73 (in,
1H, Ci5H), 1.43-1.35 (in, 2H, C12HH', C IHH'),
0.89-0.76 (in, 3H, C 3HH', CoH, C12HH'), 0.48 (m,
1H, CIIHH').
205.7 (C20), 166.1, 164.5 (C8), 139.9, 132.7 (C21),
125.2 (C, 7), 78.6 (C14), 55.4 (OCH3), 48.1 (C, 5),
47.4 (C9), 46.7 (C19), 43.8 (Cio), 42.9 (CH2C=ON),
36.7 (CH2NC=0), 30.8 (C1,), 30.7 (C13), 23.0
(C12).
2931 (s), 1741 (s), 1710 (s), 1384 (in), 1083 (in).
101
calc'd for C17H21NaNO 3 [M+Na]*: 310.1414,
found: 310.1421.
TLC (75% EtOAc in hexanes), Rf 0.35 (UV, CAM).
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HRMS (ESI):
0 1. (-)-5, "BuLi, THF; H HO H HO
HH CuBr-Me2S, -78--40 *C; HH Cbz-Cl HH
N- HCI H (-)-15, -78--10 *C; PhSH H H K2CO3 'Pr2NEt H H 3H + H *-Do H MU-i . a H N.'' 7- 5
Mew h H~ H 'H H OMe H'b ~MeN OMe 2. NaBH 4, EtOH, 0 *C Me THF, H20 H H OMe
O O-Q 000-23 *C O
(-)-23 (-)-33 (-)-37 50% (3-steps) (-)-38
Hydroxycarbamate (-)-38:
A solution of n-butyl lithium in hexanes (2.5 M, 0.80 mL, 2.0 mmol, 4.0 equiv) was
added dropwise via syringe to a degassed suspension of the iminium chloride (-)-239 (145 mg,
0.980 mmol, 2.00 equiv) in tetrahydrofuran (1.4 mL) at -78 'C under an argon atmosphere. After
15 min, the reaction mixture was allowed to warm to 0 'C. Complete dissolution of the iminium
chloride was detected after 15 min at which time the reaction mixture was cooled to -78 'C. The
brown solution of the lithioenamine was transferred via cannula under positive argon pressure to
a degassed suspension of copper bromide dimethyl sulfide (101 mg, 0.490 mmol, 1 equiv) in
tetrahydrofuran (0.7 mL) at -78 'C. The reaction mixture was allowed to gradually warm to -40
'C over 1 h. The resulting brown reaction mixture was cooled to -78 'C, and a degassed solution
of enone (-)-33 (150 mg, 0.520 mmol, 1.05 equiv) in tetrahydrofuran (0.5 mL) was added via
cannula. The resulting reaction mixture was allowed to warm to -10 'C over 1.5 h. A solution of
degassed thiophenol (0.11 mL, 1.0 mmol, 2.2 equiv) in absolute ethanol (200 proof, 1 mL) was
added to the reaction mixture. The resulting mixture was diluted with a degassed aqueous
ammonium hydroxide in a saturated aqueous ammonium chloride solution (1:5, 2.4 mL), and the
reaction was allowed to warm to 23 'C. After 1.5 h of vigorous stirring, the reaction mixture was
diluted with degassed dichloromethane (8 mL), and the layers were separated under an argon
atmosphere. The organic layer and the aqueous layer were partitioned, and the aqueous layer was
extracted with degassed dichloromethane (3 x 8 mL) under an argon atmosphere. The combined
organic layers were concentrated under reduced pressure, and the residue was dried by
concentration from degassed anhydrous benzene (2 x 5 mL) and was directly used in the
following reduction step.
Sodium borohydride (59 mg, 1.6 mmol 3.2 equiv) was added as a solid to a degassed
solution of the crude pentacylic imine in ethanol (8 mL) at 0 'C under an argon atmosphere.
After 30 min, aqueous sodium carbonate solution (1.0 M, 10 mL) was added, and the layers were
separated. The aqueous layer was extracted with dichloromethane (3 x 50 mL). The combined
organic layers were washed with aqueous sodium carbonate solution (1.0 M, 15 mL), and were
dried over anhydrous sodium sulfate, were filtered, and were concentrated under reduced
pressure. The residue was filtered through a plug of silica gel (silica gel, treated with 1% NH3 in
[3% MeOH in CH 2Cl 2], diam. 1.5 cm, ht. 3 cm; eluent: 1% NH3 in [3% methanol in
dichloromethane]) to afford crude pentacyclic compound (-)-37 and was directly used in the
following step.
Benzyl chloroformate (0.32 mL, 2.2 mmol, 4.5 equiv) was added via syringe to a
heterogeneous mixture of crude pentacyclic amine (-)-37, a solution of potassium carbonate (1.3
g, 9.4 mmol, 19 equiv) in water (9.2 mL), and diisopropylethyl amine (1.3 mL, 7.4 mmol, 15
equiv) in tetrahydrofuran (9.2 mL) at 0 'C. The reaction vessel was sealed under an argon
atmosphere, and the reaction mixture was allowed to warm to 23 'C. Additional portions of
benzyl chloroformate (2 x 0.32 mL) were added at 0 'C at 30 min intervals. Morpholine (0.58
9 Movassaghi, M.; Hunt, D. K.; Tjandra, M. J. Am. Chem. Soc. 2006, 128, 8126
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mL, 6.7 mmol, 14 equiv) was added to quench excess benzyl chloroformate. The reaction
mixture was diluted with dichloromethane (50 mL), and the layers were separated. The aqueous
layer was extracted with dichloromethane (2 x 35 mL). The combined organic layers were
washed with aqueous sodium carbonate solution (1.0 M, 20 mL), were dried over anhydrous
sodium sulfate, were filtered, and were concentrated under reduced pressure. The residue was
purified by flash column chromatography (silica gel, treated with 1% NEt3 in [5% acetone in
hexanes], diam. 1.5 cm, ht. 4 cm; eluent: 1% NEt 3 in [5% acetone in hexanes] to 1% NEt3 in[35% acetone in hexanes]) to afford hydroxy carbamate (-)-38 (132 mg, 50%) as a white solid
([a]2 2D = -22 (c 1.0, CH 2Cl2)). Structural assignment utilized additional information from
gCOSY, HSQC, HMBC, and NOESY.
IH NMR (600 MHz, C6D6, 20 'C):
13C NMR (125 MHz, C6D6, 20 C):
FTIR (thin film) cm~':
HRMS (ESI):
TLC (40% acetone in hexanes), Rf
7.33-7.28 (m, 2H, ArH), 7.16-7.12 (m, 2H, ArH),
7.08-7.04 (m, 1H, ArH), 6.18 (app-t, J= 2.4 Hz,
1H, C17H), 5.24 (d, J= 12 Hz, 1H,
PhCHH'OC=ON), 5.21 (d, J= 12 Hz, 1H,
PhCHH'OC=ON), 4.57-4.50 (m, 1H, C6H), 4.44-
4.37 (m, 1H, C2H), 3.50-3.41 (m, 1H, C 14H), 3.29-
3.22 (m, 1H, CHH'C=ON), 3.14 (s, 3H, OCH 3),
2.84-2.77 (CHH'C=ON), 2.55-2.34 (m, 4H,
CH 2NC=O, C1gH, C7HH'), 2.16-2.05 (m, 1H,
C13HH'), 2.03-1.98 (m, 1H, C5H), 1.78-1.72 (m,
1H, C15H), 1.66-1.23 (m, 9H, C8H, C4HH', C12HH',C11HH', C3HH', C3HH', C2 1HH', C4HH', C21HH'),
1.17 (t, J= 9.8 Hz, 1H, C9H), 1.06 (d, J= 6.6 Hz,
3H, CIH), 1.02-0.81 (m, 4H, C7HH', CIoH, C12HH',
C13HH'), 0.68 (app-q, J= 11.6 Hz, 1H, CIIHH').
166.7 (Camide), 155.9 (Ccarbamate), 139.4 (CI6), 138.3
(ArC), 129.5 (C17), 129.0 (ArCH), 128.9 (ArCH),
128.6 (ArCH), 80.2 (C20), 79.5 (C14), 67.4(PhCH2), 55.4 (OCH3), 54.8 (C9), 48.3 (C5), 47.8
(C), 47.0 (Ci5), 46.4 (C2), 44.6 (CIO), 43.5(CH 2C=ON), 39.7 (C19), 36.7 (CH2NC=O), 34.7
(C4), 34.4 (C7), 34.6 (C13), 32.5 (Cs), 31.2 (CI1),
30.3 (C21), 23.6 (C12), 20.5 (C1), 17.8 (C3).
3414 (br, s), 2932 (s), 1742 (s), 1722 (s), 1689 (s),
1454 (m), 1391 (s), 1315 (s), 1084 (s), 978 (w), 666
(m).
calc'd for C32H43N20 5 [M+H]*: 535.3166,
found: 535.3175.
0.50 (UV, KMnO 4, CAM).
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HHO
HH H
H-
HH 'Cbz H OMe
me N
(-)-38
TsOH-H 20
bezene, 23 0C
81%
HO
H H
H H
H2N Cbz H 11OMe
me 0
(-)-39
Ketoalcohol (-)-39:
p-Toluenesulfonic acid monohydrate (8.3 mg, 0.043 mmol, 30 mol%) was added as a
solid to a solution of hydroxy carbamate (-)-38 (77 mg, 0.14 mmol, 1 equiv) in benzene (15 mL)
at 23 'C, and the reaction mixture was sealed under an argon atmosphere. Because of the
sensitivity of the product to acid, aqueous work-up was avoided. After 1.5 h, the reaction mixture
was directly loaded onto and purified via flash column chromatography (silica gel, treated with
1% NEt3 in [35% acetone in hexanes]: diam. 1.5 cm, ht. 4 cm; eluent: 1% NEt3 in [35% acetone
in hexanes]) to afford ketone (-)-39 (54.8 mg, 81%) as a white solid ([a] 22D= -62 (c 1.1,
CH2Cl2)). Structural assignment utilized additional information from gCOSY, HSQC, HMBC,
and NOESY.
'H NMR (600 MHz, C6D6, 20 'C):
13 C NMR (125 MHz, C6D6, 20 C):
FTIR (thin film) cm-:
7.32-7.29 (m, 2H, ArH), 7.16-7.13 (m, 2H, ArH),
7.07-7.04 (m, 1H, ArH), 5.23 (br-s, 2H,
PhCH 20C=ON), 4.54 (br-s, 1H, C6H), 4.43 (br-s,
1H, C2H), 3.53 (s, 3H, OCH 3), 3.25-3.18 (m, 1H,
C14H), 2.45-2.36 (m, 2H, C17HH', C7HH'), 2.13-
1.98 (m, 4H, C17HH', C8H, C 3HH', C, 9H), 1.82
(dd, J= 9.1, 12.5 Hz, 1H, Ci5H), 1.61-1.56 (m, 1H,
CH), 1.47-1.36 (m, 3H, CnHH', C21HH', C21HH'),
1.35-1.20 (m, 3H, C12HH', C3HH', C3HH'), 1.16-
1.09 (m, 2H, C13HH', C4HH'), 1.07 (d, J= 7.2 Hz,
3H, CiH), 1.02 (app-t, J= 10.8 Hz, 1H, C9H), 1.00-
0.94 (m, 2H, C4HH', C7HH'), 0.80-0.71 (m, 1H,
C12HH'), 0.67 (app-dq, J= 3.6, 12.0 Hz, 1H, CioH),
0.52-0.45 (m, 1H, C,,HH').
210.8 (C, 6 ), 156.0 (Ccarbamate), 138.1 (ArC), 133.3
(ArCH), 130.4 (ArCH), 129.9 (ArCH), 80.6 (C20),
78.0 (C14), 67.5 (PhCH2), 57.2 (OCH3 ), 56.7 (C, 5 ),
56.0 (C 9), 48.9 (C5), 47.8 (C6 ), 46.4 (C2 ), 41.1
(CIo), 39.3 (C17), 39.2 (C8), 37.1 (C19), 34.9 (C7 ,
C2 1), 32.5 (C,1), 31.7 (C, 3 ), 30.4 (C3), 23.3 (C12),
20.4 (C), 18.4 (C4 ).
3429
1347
1088
(br, s), 2933 (s), 1739 (s), 1690 (s), 1440 (m),
(m), 1317 (s), 1245 (w), 1188 (w), 1114 (m),
(s), 741 (w), 697 (m).
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calc'd for C29H39NNaO5 [M+Na]*: 504.2720,
found: 504.2721.
TLC (50% acetone in hexanes), Rf 0.63 (UV, CAM).
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HRMS (ESI):
H HO H
HH
H HNhH M'Cbz H OMe
(-)-39
POCl3 , DMF
H2C120 -23 'C
71%
H 20 H
HH H
H'sO
H 14 h
MeCb OH OMe
(+)-41
Vinyl ether (+)-41:
Freshly distilled phosphorus oxychloride (13 [tL, 0.14 mmol, 2.0 equiv) was added
dropwise via syringe to NN-dimethylformamide (450 L, 5.61 mmol, 81.0 equiv) at 0 'C under
an argon atmosphere. After 30 min, a solution of ketone (-)-39 (33.3 mg, 69.0 tmol, 1 equiv) in
dichloromethane (1.4 mL) was added dropwise via cannula to the reaction mixture at 0 'C, and
the resulting yellow solution was allowed to warm to 23 'C. After 30 min, saturated aqueous
sodium bicarbonate solution (4 mL) was added to quench excess acid, and the layers were
separated. The aqueous layer was extracted with dichloromethane (3 x 10 mL). The combined
organic layers were washed with brine (10 mL), were dried over anhydrous sodium sulfate, were
filtered, and were concentrated under reduced pressure. Purification of the resulting yellow oil
via flash column chromatography (silica gel: diam. 1.5 cm, ht. 3 cm; eluent: 40% EtOAc in
hexanes then 50% acetone in hexanes afforded the vinyl ether (+)-41 (24 mg, 71%) as a white
film ([a]22 D = +19 (c 0.50, CH 2Cl 2)). Structural assignment utilized additional information from
gCOSY, HSQC, HMBC, and NOESY.
'H NMR (600 MHz, C6D6, 20 "C):
13C NMR (125 MHz, C6D6, 20 *C):
7.29 (app-d, J= 7.2 Hz, 2H, ArH), 7.16-7.13 (m,
2H, ArH), 7.07 (app-t, J= 7.2 Hz, 1H, ArH), 6.89
(app-d, J= 1.8 Hz, 1H, C18H), 5.20 (br-s, 2H,
PhCH20C=ON), 4.52 (br-s, 1H, C6H), 4.26 (br-s,
1H, C2H), 3.64 (s, 3H, OCH 3), 3.55-3.49 (m, 1H,
C14H), 3.00 (d, J= 9.0 Hz, 1H, CI9H), 2.33 (br-s,
1H, C5H), 2.27 (br-s, 1H, C7HH'), 2.11 (app-d, J=
15.0 Hz, 1H, C13HH'), 1.89 (app-dd, I H, J= 9.0,
12.0 Hz, Ci5H), 1.49-1.44 (m, 4H, C8H, C21HH',
C,,HH', CI 2HH'), 1.30 (app-dd, J= 3.6, 11.4 Hz,
1H, C21HH'), 1.27-1.07 (m, 6H, C3HH', C3HH',
C4HH', C4HH', C13HH', C9H), 1.05 (d, J= 6.6 Hz,
3H, CIH), 0.82-0.70 (m, 3H, C7HH', C, 2HH',
CoH), 0.59 (app-q, J= 13.8 Hz, 1H, C, HH').
194.7 (C16), 155.7 (Ccarbamate), 151.0 (C18), 138.0
(ArC), 129.1 (ArCH), 128.9 (ArCH), 128.7
(ArCH), 119.4 (C17), 102.7 (C20), 77.1 (C14), 67.5
(PhCH20C=ON), 57.4 (OCH 3), 56.9 (C, 5 ), 55.6
(C9), 47.6 (C6), 46.9 (C2), 42.0 (C19), 41.1 (Cio),
40.1 (C5), 35.4 (C7), 34.5 (Cs), 32.4 (CI1), 32.0
(C2 1), 31.3 (C13), 29.1 (C4), 23.1 (C12), 20.8 (CIH),
18.0 (C3).
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FTIR (thin film) cm-1:
HRMS (ESI):
TLC (50% EtOAc in hexanes), Rf-
2932 (s), 1693 (s, C=O), 1596 (s), 1312 (w), 1120
(in).
calc'd for C30H 38NO5 [M+H]*: 492.2744,
found: 492.2745.
0.49 (UV, CAM).
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H AH H HO HH HO
HH H H H 1. NaCIO 2, NaH2PO4  H H
'H H HH "HHH DDQ, SiO 2  H 2-methyl-2-butene S H
H-0H- \-
H OMe MeCN,H 20 N H20, 'BuOH, 23'CMe'b Q 'R~ H 0 H OMe H0,BOH2~ HC O 23 HC OR O 2. CH2N2, THF, OC O R H OMeMeMe OMe
(+)-41 42 R = Cbz 61% (3-steps) (-).44 R = Cbz
Ketoester (-)-44:
A solution of vinyl ether (+)-41 (7.5 mg, 15 [tmol, 1 equiv) in mixture of acetonitrile and
water (5:1, 150 [iL) was treated sequentially with silica gel (1.7 mg) and 2,3-dichloro-5,6-
dicyano-p-benzoquinone (DDQ, 3.5 mg, 16 [tmol, 1.1 equiv) at 23 'C, and the reaction vessel
was sealed under an argon atmosphere. After 6 h, the reaction mixture was filtered through a
plug of cotton to remove the silica gel and the filtrate was partitioned between water (1 mL) and
dichloromethane (8 mL). The aqueous layer was extracted with dichloromethane (3 x 5 mL). The
combined organic layers were dried over anhydrous sodium sulfate, were filtered, and were
concentrated under reduced pressure to afford the crude ketoaldehyde 42. The ketoaldehyde was
directly used in the following oxidation step.
To a solution of the crude ketoaldehyde 42 in tert-butanol (380 [tL) at 23 'C was added
2-methyl-2-butene (16 [tL, 0.15 mmol 10 equiv) and a solution of sodium phosphate
monohydrate monobasic (21 mg, 0.15 mmol, 10 equiv) in water (150 [tL) followed by a solution
of sodium chlorite (14 mg, 0.15 mmol, 10 equiv) in water (150 [tL) via syringe. After 1 h,
saturated aqueous sodium thiosulfate solution (1 mL) was added to quench excess oxidant, and
the layers were separated. The aqueous layer was extracted with dichloromethane (3 x 5 mL).
The combined organic layers were dried over anhydrous sodium sulfate, were filtered, and were
concentrated under reduced pressure to afford the crude ketoacid that was directly used in the
following methylation step.
Freshly prepared diazomethane solution in ether (1.50 mL, 1.60 mmol, 100 equiv) was
added to a solution of the crude sample and acetic acid (31 [tL, 61 tmol, 4.0 equiv) in THF (100
[tL) at 0 'C. After 30 min, a tetrahydrofuran solution of acetic acid (2 M, 0.5 mL) was added to
quench excess diazomethane and the volatiles were removed under reduced pressure.
Purification of the resulting yellow oil via flash column chromatography (silica gel: diam. 1.5
cm, ht. 2 cm; eluent: 50% EtOAc in hexanes to 75% EtOAc in hexanes then 50% acetone in
hexanes afforded the ketoester (-)-44 (5 mg, 61%) as a clear film ([a]2 2 D -64 (e 0.42,
CH 2 Cl 2)). Structural assignment utilized additional information from gCOSY, HSQC, and
HMBC.
'H NMR (500 MHz, C6D6, 20 *C): 7.29 (app-d, J= 7.2 Hz, 2H, ArH), 7.16-7.14 (in,
2H, ArH), 7.10-7.05 (m, 1H, ArH), 5.22 (d, J=
12.5 Hz, 1H, PhCHH'OC=ON), 5.18 (d, J= 12.5
Hz, 1H, PhCHH'OC=ON), 4.66 (br-s, 1H, C6H),
4.38 (br-s, lH, C2H), 3.57 (s, 3H, OCH 3), 3.55 (s,
3H, COOCH 3), 3.15 (dt, J = 5.5, 10.5 Hz, 1H,
C14H), 2.58-2.40 (m, 2H, C7HH', OH), 2.10-1.94
(m, 3H, C5H, C13HH', Ci5H), 1.94-1.86 (m, 1H,
C4HH'), 1.78 (app-d, J= 12.0 Hz, 1H, C9H), 1.72
(br-s, 1H, C21HH'), 1.57 (br-s, 1H, C8H), 1.39-1.20
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13C NMR (125 MHz, C6D6, 20 C):
FTIR (thin film) cm-:
HRMS (ESI):
TLC (50% acetone in hexanes), Rf
(m, 4H, C3HH', C12HH', C 1iHH', C3HH'), 1.13-0.87
(m, 5H, Ci 3HH', C4HH', C7HH', C21HH', CioH),
1.02 (d, J= 7.0 Hz, 3H, C1H3), 0.75-0.64 (m, 1H,
C12HH'), 0.48-0.38 (m, 1H, CiiHH').
195.1 (C16), 168.4 (C,8), 167.9 (C19), 155.8
(Ccarbamate), 138.1 (ArC), 129.1 (ArCH), 128.9
(ArCH), 128.7 (ArCH), 128.3 (C 17), 82.5 (C2 0),
77.1 (C 14), 67.6 (PhCH2OC=ON), 58.3 (C9 ), 58.1
(C15), 57.6 (OCH3), 52.4 (COOCH 3), 47.0 (C6 ),
46.4 (C5), 46.2 (C2), 46.1 (CIO), 35.8 (C7 , C21), 31.8
(C13), 30.2 (C8), 30.1 (C3, C11), 22.6 (C1 2), 20.3
(C1), 19.1 (C4 ).
3440 (br, s, OH), 2928 (s), 2856 (m), 1733
(COOMe), 1675 (C=O), 1316 (w), 1111 (w).
calc'd for C31H40N0 7 [M+H]*: 538.2799,
found: 538.2803.
0.75 (UV, CAM).
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TMS-1
2,6-di-tu-4-Me-pyr
CH2CI2, 0 *C
66%
TMSOH H
HH
H
H- I N,
H OH H OMe
Me OMe0
(-)-S9
Amino Ketoester (-)-S9:
lodotrimethylsilane (26 [tL, 0.18 mmol, 14 equiv) was added via syringe to a solution of
keto ester (-)-44 (7.1 mg, 13 mmol, 1 equiv) and 2,6-di-tert-butyl-4-methyl-pyridine (670 mg,
3.25 mmol, 250 equiv) in dichloromethane (500 [L) at 0 'C under an argon atmosphere.
Additional portions of iodotrimethylsilane (8 x26 L )were added at 1 h intervals until
complete consumption of (-)-44 was observed by TLC analysis (~8 h). Isopropanol (300 L) and
aqueous sodium carbonate solution (1 M, 6 mL) were added, and the biphasic reaction mixture
was stirred vigorously at 23'C. After 2 h, the organic layer and the aqueous layer were separated.
The aqueous layer was extracted with dichloromethane (4 x 5 mL). The combined organic layers
were dried over anhydrous sodium sulfate, were filtered, and were concentrated under reduced
pressure. Purification of the resulting yellow oil via flash column chromatography (silica gel,
treated with 1% NEt 3 in [35% EtOAc in hexanes], diam. 1.5 cm, ht. 4 cm; eluent: 1% NEt3 in
[5% EtOAc in hexanes] to 1% NEt3 in [35% EtOAc in hexanes] then 5% methanol in CH 2Cl 2)
afforded the pentacyclic amino ketoester (-)-S9 (4.1 mg, 66%) as a clear film ([a] 2 2D = -4.7 (c
0.15, CH2 Cl 2)). Structural assignment utilized additional information from gCOSY, HSQC, and
HMBC.
'H NMR (500 MHz, C6D6, 20 'C):
13C NMR (125 MHz, C6D6, 20 'C):
FTIR (thin film) cm-1 :
3.75 (app-d, J= 11.0 Hz, IH, C9H), 3.64 (s, 3H,
COOCH3), 3.57 (s, 3H, OCH 3), 3.19-3.11 (m, 1H,
C14H), 2.93 (app-t, J= 5.0 Hz, 1H, C6H), 2.50 (app-
d, J= 14.0 Hz, 1H, C4H'), 2.22-2.13 (m, 2H, Ci 5H,
C2H), 2.00-1.91 (m, 2H, C21HH', C13HH'), 1.88-
1.81 (m, 2H, C8H, C5H), 1.75-1.63 (i, 1H, C3HH'),
1.57-1.49 (m, 1H, C7H), 1.46-0.97 (m, 8H, C, 2HH',
CjjHH', C21HH', C3HH', CoH, C4HH', C 3HH',
C7HH'), 0.72 (d, J= 6.5 Hz, 3H, CH), 0.77-0.62(m, 2H, C12HH', C,,HH'), 0.21 (br-s, 9H, Si(CH 3)3).
195.6 (C16), 171.7 (C19), 167.1 (C8), 127.9 (C17),
82.8 (C20), 77.5 (C14), 58.7 (C2), 57.7 (OCH3), 55.4
(C6), 53.3 (C5), 51.4 (COOCH 3), 50.6 (C9), 48.2
(Cs), 47.2 (C21), 46.2 (C o), 41.0 (C7), 33.6 (C8),
32.2 (C3), 31.0 (C3), 30.4 (C,1), 24.8 (C4), 23.7
(C1), 22.7 (C12), 2.6 (Si(CH3) 3).
2927 (s), 2855 (m), 1741 (s, COOMe), 1673 (s,
C=O), 1251 (w), 1113 (w), 842 (m).
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R = Cbz
(-)-44
HRMS (ESI): calc'd for C26H42NO5Si [M+H]*: 476.2827,
found: 476.2820.
TLC (5% Methanol in CH 2Cl 2), Rf 0.33 (UV, CAM).
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TMSO H H HO HH".. IH." HH
H Et3N-(HF) 3  H
HN THF, 23 * H NH O H H OMe H O H H OMe
Me OMe 0  90% Me OMe 0
(-)-S9 (-)-21
Pentacyclic amino alcohol (-)-21:
Triethylamine trihydrogen fluoride (0.114 mL, 0.700 mmol, 82.0 equiv) was added via
syringe to a solution of pentacyclic amine (-)-S9 (4.0 mg, 8.4 [mol, 1 equiv) in tetrahydrofuran
(100 [tL) at 23'C under an argon atmosphere. After 4 h, aqueous sodium carbonate solution (1
M, 5 mL) was added to quench excess acid. The reaction mixture was diluted with
dichloromethane (5 mL), and the layers were separated. The aqueous layer was extracted with
dichloromethane (4 x 5 mL). The combined organic layers were dried over anhydrous sodium
sulfate, were filtered, and were concentrated under reduced pressure. Purification of the resulting
residue via flash column chromatography (silica gel: diam. 1.5 cm, ht. 3 cm; eluent: 2% to 5% to
10% methanol in CH2Cl2) afforded the pentacyclic amino alcohol (-)-21 (3 mg, 90%) as a clear
film ([a]22D = -24 (c 0.080, CH 2Cl2). Structural assignment utilized additional information from
gCOSY, HSQC, and HMBC.
'H NMR (600 MHz, C6D6, 20 'C): 3.69 (dd, J= 1.8, 11.4 Hz, 1H, C9H), 3.55 (s, 6H,
COOCH 3, OCH 3), 3.28-3.19 (m, 1H, C14H), 2.93-
2.83 (m, 2H, C6H, OH), 2.57 (app-d, J= 12.6 Hz,
1H, C4HH'), 2.21-2.13 (m, 2H, Ci5H, C2H), 1.97
(app-dd, J= 4.2, 13.2 Hz, 1H, CI3HH'), 1.89 (app-t,
J= 5.4 Hz, 1H, C5H), 1.76 (br-s, 1H, C8H), 1.73-
1.68 (m, 1H, C21HH'), 1.57 (app-dd, J= 3.8, 11.2
Hz, 1H, C3HH'), 1.50 (ddd, J= 3.2, 6.1, 14.3 Hz,
1H, C7HH'), 1.45-1.17 (m, 6H, C, HH', C12HH',
C3HH', C21HH', C4HH', CoH), 1.17-1.08 (m, 1H,
CiOHH'), 0.97 (app-d, J= 16.2 Hz, 1H, C7HH'),
0.85-0.74 (m, 1H, C12HH'), 0.71 (d, J= 6.0 Hz, 3H,
CiH 3), 0.62 (app-dq, J= 3.4, 11.9 Hz, 1H, C IHH').
3C NMR (125 MHz, C6D6, 20 'C):
FTIR (thin film) cm-:
HRMS (ESI):
195.7 (C, 6), 174.9 (C19), 169.1 (Ci8), 127.3 (C17),
80.4 (C20), 77.6 (C14), 58.8 (C2), 57.6 (OCH3), 55.2
(C6), 53.2 (C, 5), 52.3 (C9), 52.1 (COOCH3), 48.1
(C21), 47.8 (Cs), 46.3 (C Io), 40.9 (C7), 32.7 (C8),
32.1 (C, 3), 30.9 (C3), 30.3 (C,1), 24.9 (C4), 23.6(C1), 22.9 (C12).
2921 (s), 2850 (m), 1734 (m, COOMe), 1671 (m,
C=O), 1460 (m), 1261 (w), 1111 (w).
calc'd for C23H34NO5 [M+H]*: 404.2431,
found: 404.2432.
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TLC (8% MeOH in CH 2Cl 2), Rf
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0.38 (UV, CAM).
NCS, CH3CN
45 min, 23 0C
89%
(-)-21 (+)-46
(+)-Hexacyclic ketoester (46):
Freshly recrystallized N-chlorosuccinimide (1.6 mg, 12 [tmol, 2.0 equiv) was added as a
solid to a solution of amino alcohol (-)-21 (2.5 mg, 6.2 [mol, 1 equiv) in acetonitrile (0.3 mL) at
23 0C, and the reaction mixture sealed under an argon atmosphere. After 45 min, the reaction
solvent was removed under reduced pressure. The residue was immediately purified by flash
column chromatography (silica gel: diam. 1.25 cm, ht. 2 cm; eluent: 3% methanol in
dichloromethane) to afford hexacyclic ketoester (+)-46 (2.2 mg, 89%) as a white solid ([] 22 D -
+20 (c 0.11, CH 2CL2 )). Structural assignment utilized additional information from gCOSY,
HSQC, HMBC, ROESY, and NOESY.
'H NMR (600 MHz, C6D6, 20 'C):
"C NMR (125 MHz, C6D6, 20 C):
FTIR (thin film) cm-:
HRMS (ESI):
TLC (15% MeOH in CH2Cl2), Rf
3.56 (s, 3H, OCH3), 3.48 (s, 3H, COOCH 3), 3.37
(br-s, 1H, OH), 3.24-3.18 (m, 1H, C14H), 3.13-3.04
(m, 2H, C2H, Ci5H), 2.88 (br-s, 1H, C6H), 2.39-
2.33 (m, 1H, C4HH'), 2.07-1.96 (m, 2H, C3HH',
C, 3HH'), 1.80 (br-s, 1H, C5H), 1.77-1.73 (m, 1H,
C21HH'), 1.65-1.58 (m, 2H, C8H, C7HH'), 1.55-1.46
(m, 2H, C IHH', C12HH'), 1.40-1.24 (m, 4H, CoH,
C,,HH', C4HH', C21HH'), 1.23-1.14 (m, 1H,
C13HH'), 1.11 (d,J= 7.2 Hz, 3H, CIH), 1.07 (app-
d, J= 9.6 Hz, 1H, C7HH'), 0.97-0.78 (m, 2H,
C3HH', CI2HH').
195.8 (C16), 171.9 (C19), 169.5 (Ci8), 123.0 (C17),
81.0 (C20), 78.2 (C14), 69.9 (C6), 66.0 (C9), 57.6
(OCH3), 56.3 (C2), 52.7 (COOCH 3), 52.6 (C s),
49.9 (C5), 49.9 (C8), 46.2 (CO), 45.0 (C21), 37.5
(C7), 32.1 (C,3), 27.9 (C3), 27.3 (C,1), 26.4 (C4 ),
25.0 (C,), 23.8 (C2).
3373 (br, s), 2923 (s), 1771 (m), 1712 (s), 1664 (s),
1461 (m), 1348 (m), 1269 (m), 1180 (m), 1091 (w),
802 (w).
calc'd for C23H32NO5 [M+H]*: 402.2275,
found: 402.2290.
0.56 (CAM).
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NaBH 4
EtOH
0 *C
90%
(+)-46
125%
nOe
1.85%
(+)-47
(+)-16-Debenzoyl-himandrine (47):
Sodium borohyride (4.0 mg, 0.11 mmol, 10 equiv) was added as a solid to a solution of
hexacyclic ketoester (+)-46 (4.0 mg, 9.9 mmol, 1 equiv) in ethanol (150 [tL) at 0 'C, and the
reaction mixture was sealed under an argon atmosphere. After 30 min, aqueous sodium
carbonate solution (1 M, 0.5 mL) was added, and the layers were separated. The aqueous layer
was extracted with dichloromethane (4 x 5 mL). The combined organic layers were dried over
anhydrous sodium sulfate, were filtered, and were concentrated under reduced pressure.
Purification of the resulting residue via flash column chromatography (silica gel: diam. 1.25 cm,
ht. 1.5 cm; eluent: 5% methanol in CH 2Cl 2) afforded the hexacyclic diol (+)-47 (3.6 mg, 90%) as
a single diastereomer ([c] 2 2D = +28 (c 0.035, CHCl3). Structural assignment utilized additional
information from gCOSY, HSQC, and HMBC.
'H NMR (600 MHz, CDCl 3, 20 C):
3 C NMR (125 MHz, CDCl 3, 20 C):
FTIR (thin film) cm-:
HRMS (ESI):
TLC (10% Methanol in CH 2Cl 2), Rf
4.53 (app-d, J= 7.2 Hz, 1H, C,6H), 4.22 (br-s, 1H,
C200H), 3.84 (s, 3H, COOCH 3), 3.86-3.80 (br-s,
1H, C 60H), 3.43-3.37 (m, 1H, C2H), 3.40 (s, 3H,
OCH 3), 3.31 (br-s, 1H, C6H), 3.08 (dt, J= 4.2, 10.2
Hz, lH, C14H), 2.27-2.12 (m, 5H, C4HH', C 3HH',
Ci5 H, C3HH', C8H), 1.94 (br-s, 1H, C5H), 1.90-1.68(m, 4H, C12HH', C7HH', C21HH', C4HH'), 1.65-1.56
(m, 2H, CIIHH', C21HH'), 1.52 (app-d, J= 10.2 Hz,
1H, C7HH'), 1.46 (app-dq, J= 3.6, 12.6 Hz, 1H,
CIIHH'), 1.34 (d, J- 7.2 Hz, 3H, CIH), 1.38-1.30
(in, 1H, CoH), 1.29-1.08 (M, C3HH', C12HH',
C13HH').
170.7 (Ci8 ), 158.8 (C19), 118.2 (C17), 87.5 (Ci 4),
80.7 (C20), 72.3 (C16), 69.5 (C6 ), 67.6 (C9), 56.4(OCH 3), 55.9 (C2), 52.5 (COOCH 3), 49.6 (Cs), 49.3
(C8 ), 48.4 (CI5), 44.9 (C21), 42.9 (Clo), 37.6 (C7),
30.4 (C13), 27.3 (C3), 27.0 (C,,), 25.7 (C4), 24.3
(C12), 24.0 (C).
3496 (br, s), 2930 (s), 2858 (m), 1733 (m), 1689
(in), 1459 (m), 1281 (m), 1262 (m), 1080 (m).
calc'd for C23H34NO5 [M+H]*: 404.2431,
found: 404.2428.
0.19 (UV, CAM).
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Comparison of our assignments for (+)-16-debenzoyl-himandrine (47) with literature data:
Assignment Original report0  This report This report
(+)- 1 6-Debenzoyl- (+)-1 6-Debenzoyl- (+)-1 6-Debenzoyl-himandrine
himandrine (47) himandrine (47) (47)
('H, 60 MHz, CDCl3) ('H, 600 MHz, CDC 3) ( 3C, 125 MHz, CDC 3)
Cl 1.33 (d, J= 7 Hz) 1.34 (d, J= 7.2 Hz) 24.0
C2 3.30 (br) 3.43-3.37 (m)" 55.9
C3, C4, C8, - 2.27-2.12 (m) 27.3 (C3), 25.7 (C4), 49.3
C13, C15 (C8), 30.4 (C13), 48.4 (C15)
C5 - 1.94 (br-s) 49.6
C6 3.30 (br) 3.31 (br-s) 69.5
C4, C7, - 1.90-1.68 (m) 25.7 (C4), 44.9 (C21), 24.3
C12, C21 (C12)
C7 - 1.52 (app-d, J= 10.2 Hz) 37.6
C9 - 67.6
C1O - 1.38-1.30 (m) 42.9
C11, C21 1.65-1.56 (m) 27.0 (C11), 44.9 (C21)
Cli - 1.46 (app-dq, J= 3.6, 12.6 Hz) 27.0
C3, C12, - 1.29-1.08 (m) 27.3 (C3), 24.3 (C 12), 30.4
C13 (C13)
C14 3.10 (br) 3.08 (dt, J= 4.2, 10.2 Hz) 87.5
C1 4.60 (d, J= 8.0 Hz) 4.53 (app-d, J= 7.2 Hz) 72.3
C17 - 118.2
C18 - - 170.7
C19 - - 158.8
C20 - 80.7
C20-OH 4.20 (s) 4.22 (br-s) -
C16-OH 3.80 (s) 3.86-3.80 (br-s) -
COOCH3  3.88 (s) 3.84 (s) 52.5
OCH3 3.43 (s) 3.40 (s) 56.4
'0 Chemical degradation of himandrine (3) gave (+)-16-debenzoyl-himandrine (47); see Mander, L. N.; Prager, R.
H.; Rasmussen, M.; Ritchie, E.; Taylor, W. C. Aust. J. Chem., 1967, 20, 1473.
" Our assignment of the C2 methine is supported by our gCOSY, HSQC and HMBC data. The original paper (ref.
10) listed both C2 and C6 methines at 3.30 ppm (br). Our 2D data reveals the C2 methine is actually obscured by
the methyl ether signal (3.40 ppm), while C6 methine alone corresponds to the signal at 3.31 ppm (br).
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(-)-himandrine (3) 1
(-)-Himandrine (3):
Freshly distilled benzoyl chloride (0.1 mL) was added to a solution of alcohol (+)-47 (2.0
mg, 4.9 [tmol, 1 equiv) in pyridine (0.12 mL) at 23 0C under an argon atmosphere. After 7 d, the
reaction mixture was diluted with dichloromethane (5 mL) and aqueous sodium carbonate
solution (1.0 M, 2 mL). After 30 min, the layers were separated, and the aqueous layer was
extracted with dichloromethane (3 x 10 mL). The combined organic layers were dried over
anhydrous sodium sulfate, were filtered, and were concentrated under reduced pressure. The
crude product was purified by flash column chromatography (silica gel: diam. 0.5 cm, ht. 5 cm;
eluent: 3% methanol in CH 2 Cl2) to afford (-)-himandrine (3, 2.0 mg, 87%) ([a] 2 2 D -21 (c 0.12,
CHCl3)).12 Structural assignment utilized additional information from gCOSY, HSQC, HMBC,
and ROESY. Crystals suitable for X-ray diffraction were obtained from
dichloromethane-hexanes (5:1). For a thermal ellipsoid representation of (-)-himandrine (3) see
page 119
'H NMR (600 MHz, CDCl 3, 20 'C): 7.94 (app-d, J= 7.8 Hz, 2H, ArH), 7.49 (app-t, J=
3 C NMR (125 MHz, CDCl3 , 20 C):
7.2 Hz, 1H, ArH), 7.39 (app-t, J= 7.2 Hz, 2H,
ArH), 6.18 (d, J= 7.8 Hz, 1H, C16H), 4.54 (br-s,
1H, C2oOH), 3.58 (s, 3H, COOCH3), 3.53-3.44 (m,
1H, C2H), 3.35 (br-s, 1H, C6H), 3.12 (s, 3H,
OCH 3), 3.05 (dt, J= 4.2, 10.8 Hz, 1H, C14H), 2.44-
2.37 (m, 1H, C1sH), 2.34-2.27 (m, IH, C4HH'),
2.23-2.08 (m, 3H, C8H, C 3HH', C3HH'), 2.03 (br-s,
1H, CH), 1.91-1.75 (m, 4H, C7HH', C12HH',
C4HH', C21HH'), 1.68-1.62 (m, 2H, CiHH',
C2 1HH'), 1.57 (app-d, J = 11.4 Hz, 1H, C7HH'),
1.45 (d, J= 6.6 Hz, 3H, CIH), 1.45-1.42 (m, 2H,
CjoH, Cn HH'), 1.41-1.33 (m, IH, C3HH'), 1.33-
1.27 (m, lH, C12HH'), 1.13-1.04 (m, 1H, C 13HH').
169.6 (C, 8 ), 165.7 (ArC=O), 163.2 (C19), 132.7
(ArCH), 131.4 (ArCH), 129.6 (ArCH), 128.6
(ArCH), 116.6 (C17), 85.5 (C14), 81.1 (C20), 72.9
(C16), 69.5 (C6), 67.7 (C9), 56.7 (OCH3), 55.8 (C2),
52.3 (COOCH3), 50.2 (C5), 49.4 (Cs), 45.9 (C15),
44.8 (C2 1), 43.4 (Cio), 37.4 (C7), 30.8 (C13), 27.7
(C3 ), 27.3 (C), 25.7 (C4 ), 24.6 (C), 23.8 (C 2).
12 The magnitude of the optical rotation of (-)-himandrine (3) is sensitive to concentration: [a]2 2 D= -12 (c 0.000,
CHC13).
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FTIR (thin film) cm-':
HRMS (ESI)
TLC (15% MeOH in CH 2Cl2 ), Rf
3429 (br, s), 2919 (s), 2852 (s), 1727 (s), 1687 (m),
1450 (w), 1276 (m), 1268 (s), 1097 (m), 1066 (w),
709 (w).
calc'd for C30H38NO 6 [M+H]*: 508.2694,
found: 508.2694.
0.60 (UV, CAM)
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Comparison of our assignments for (-)-himandrine (3) with literature:
Assignment Isolation paper 3  This report This report4
(-)-Himandrine (3) (-)-Himandrine (3) (-)-Himandrine (3)
S (H, 60 MHz, CDC13) ('H, 600 MHz, CDCl3) ("C, 125 MHz, CDCl3)C1 1.48 (d, J= 7 Hz) 1.45 (d, J= 6.6 Hz) 24.6
C2 3.38(br) 3.53-3.44 (M)5  55.8
C3 1.41-1.33 (in) 27.7 (C3), 23.8 (C12), 30.8
(C 13)
C3, C8, C13 2.23-2.08 (in) 27.7 (C3), 49.4 (C8), 30.8
(C 13)
C4 2.34-2.27 (in) 25.7
C5 - 2.03 (br-s) 50.2
C6 3.38 (br) 3.35 (br-s) 69.5
C4, C7, C12, 1.91-1.75 (in) 25.7 (C4), 44.8 (C21), 23.8
C21 (C 12)
C7 - 1.57 (app-d, J= 11.4 Hz) 37.4
C9 - 67.7
C1O, ClI 1.45-1.42 (in) 43.4 (CIO), 27.3 (C 11)
Cl1, C21 1.68-1.62 (m) 27.3 (Cl 1), 44.8. (C21)
C12 1.33-1.27 (in) 23.8 (C12)
C 13 1.13-1.04 (m) 30.8 (C13)
C14 3.10 (br) 3.05 (dt, J= 4.2, 10.8 Hz) 85.5
C15 2.44-2.37 (in) 45.9
C16 6.20 (d, J= 8 Hz) 6.18 (d, J= 7.8 Hz) 72.9
C17 - 116.6
C18 169.6
C19 - - 163.2
C20 - - 81.1
C20-OH 4.50 4.54 (br-s) -
13 The original structure of himandrine was based on X-ray crystallographic analysis of the corresponding
hydrobromide salt of 3; see (a) Guise, G. B.; Mander, L. N.; Prager, R. H.; Rasmussen, M.; Ritchie, E.; Taylor, W.
C. Aust. J. Chem., 1967, 20, 1029, and (b) Willis, A. C.; O'Connor, P. D.; Taylor, W. C.; Mander, L. N. Aust. J.
Chem., 2006, 59, 629.
1 We confirmed the structure of our synthetic (-)-himandrine (3) by both X-ray crystallographic analysis and
extensive 2D NMR data,
1 Our assignment of the C2 methine is supported by our gCOSY, HSQC, HMBC, and ROESY data. Based on the
isolation paper, the C2 and C6 methines correspond to the signal at 3.38 ppm (br). Our 2D data reveals the C2
methine is actually at 3.53-3.44 ppm (in), while C6 methine alone corresponds to the signal at 3.35 ppm (br-s).
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COOCH3  3.58 (s) 52.3
OCH3  3.15 (s) 3.12(s) 56.7
Bz 7.5 (m), 8.0 (m) 7.94 (app-d, J= 7.8 Hz), 165.7 (ArC=O), 163.2, 132.7,
7.49 (app-t, J= 7.2 Hz), 131.4, 129.6, 128.6 (ArCH)
7.39 (app-t, J= 7.2 Hz)
Crystal Structure of (-)-Himandrine (3).
View 1:
71I
View 2:
122
Table S1. Crystal data and structure refinement for (-)-himandrine (3).
Identification code d8_09005
Empirical formula C30 H37 N 06
Formula weight 507.61
Temperature 100(2) K
Wavelength 1.54178
Crystal system Triclinic
Space group P1
Unit cell dimensions a = 8.3136(2) A a
Volume
Z
Density (calculated)
Absorption coefficient
F(000)
Crystal size
Theta range for data collection
Index ranges
Reflections collected
Independent reflections
Completeness to theta = 68.74'
Absorption correction
Max. and min. transmission
Refinement method
Data / restraints / parameters
Goodness-of-fit on F2
Final R indices [I>2sigma(I)]
R indices (all data)
Absolute structure parameter
Largest diff. peak and hole
b = 8.7575(2) A
c = 10.6508(3) A
632.72(3) k3
b
g
= 78.8230(10)0.
= 67.4340(10) .
62.0950(10).
1
1.332 Mg/m 3
0.746 mm'
272
0.30 x 0.25 x 0.03 mm3
4.50 to 68.74*.
-10<=h<=10, -8<=k<=10, -12<=1<=12
11853
3819 [R(int) = 0.0157]
95.4 %
Semi-empirical from equivalents
0.9780 and 0.8072
Full-matrix least-squares on F2
3819 / 374 / 340
1.050
RI = 0.0268, wR2 = 0.0704
RI = 0.0273, wR2 = 0.0707
0.12(12)
0.160 and -0.149 e.A-3
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Table S2. Atomic coordinates ( x 104) and equivalent isotropic displacement parameters (A2x
103) for (-)-himandrine (3). U(eq) is defined as one third of the trace of the orthogonalized Ui
tensor.
x y z U(eq)
0(1)
0(2)
0(3)
0(4)
0(5)
0(6)
N(1)
C(1)
C(2)
C(3)
C(4)
C(5)
C(6)
C(7)
C(8)
C(9)
C(10)
C(11)
C( 12)
C(13)
C(14)
C(15)
C( 16)
C(17)
C(18)
C(19)
C(20)
C(21)
C(22)
C(23)
9286(2)
6909(2)
10744(1)
10437(2)
10469(2)
11133(2)
5882(2)
9013(2)
7830(2)
9083(2)
7936(2)
5954(2)
4864(2)
2890(2)
3544(2)
5574(2)
5535(2)
4371(2)
4213(2)
6223(2)
7374(2)
7549(2)
8698(2)
8412(2)
9843(2)
6985(2)
6117(2)
4089(2)
11947(2)
9405(3)
-3433(2)
3613(2)
-1800(1)
1690(2)
1605(2)
-1066(2)
-875(2)
-3652(2)
-2051(2)
-1168(2)
497(2)
1601(2)
465(2)
1421(2)
1824(2)
207(2)
-649(2)
-1710(2)
-2404(2)
-3455(2)
-2392(2)
-1665(2)
-584(2)
634(2)
1376(2)
1007(2)
2420(2)
3327(2)
2234(2)
-3736(3)
-3435(1)
906(1)
-2501(1)
-759(1)
-2855(1)
-4733(1)
1922(1)
1181(2)
2058(2)
1986(2)
2808(2)
2634(2)
2972(2)
2799(2)
1278(2)
662(2)
-444(2)
141(2)
-996(2)
-1982(2)
-2581(2)
-1466(2)
-2059(2)
-1068(2)
-1511(2)
139(2)
1172(2)
1048(2)
-3369(2)
-4732(2)
24(1)
25(1)
19(1)
25(1)
24(1)
25(1)
20(1)
23(1)
21(1)
22(1)
25(1)
23(1)
23(1)
25(1)
23(1)
20(1)
20(1)
24(1)
26(1)
25(1)
21(1)
19(1)
18(1)
19(1)
20(1)
19(1)
21(1)
24(1)
28(1)
34(1)
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C(24)
C(25)
C(26)
C(27)
C(28)
C(29)
C(30)
11671(2)
13481(2)
14848(2)
16546(2)
16881(2)
15491(2)
13799(2)
-2049(2)
-3698(2)
-4000(2)
-5528(2)
-6760(2)
-6478(2)
-4961(2)
-3856(2)
-4122(2)
-5428(2)
-5694(2)
-4668(2)
-3377(2)
-3103(2)
Table S3. Bond lengths [A] and angles [0] for (-)-himandrine (3).
0(1)-C(23)
O(1)-C(14)
O(2)-C(20)
O(3)-C(24) 0.0
O(3)-C(16)
0(4)-C(18)
O(5)-C(18)
0(5)-C(22)
O(6)-C(24)
N(1)-C(6)
N(1)-C(2)
N(1)-C(9)
C(1)-C(2)
C(2)-C(3)
C(3)-C(4)
C(4)-C(5)
C(5)-C(6)
C(5)-C(20)
C(6)-C(7)
C(7)-C(8)
C(8)-C(21)
C(8)-C(9)
C(9)-C( 19)
C(9)-C(10)
C(l0)-C(11)
1.4142(19)
1.4284(19)
1.412(2)
1.3541(17)
1.4605(16)
1.2153(19)
1.3318(19)
1.453(2)
1.2094(19)
1.482(2)
1.5048(19)
1.5195(19)
1.523(2)
1.535(2)
1.534(2)
1.536(2)
1.547(2)
1.566(2)
1.521(2)
1.525(2)
1.532(2)
1.599(2)
1.515(2)
1.533(2)
1.530(2)
C(10)-C(15)
C(11)-C(12)
C(12)-C(13)
C(13)-C(14)
C(14)-C(15)
C(15)-C(16)
C(16)-C(17)
C(17)-C(19)
C(17)-C(18)
C(19)-C(20)
C(20)-C(2 1)
C(24)-C(25)
C(25)-C(26)
C(25)-C(30)
C(26)-C(27)
C(27)-C(28)
C(28)-C(29)
C(29)-C(30)
C(23)-O(1)-C(14)
C(24)-0(3)-C(16)
C(1 8)-O(5)-C(22)
C(6)-N(1)-C(2)
C(6)-N(1)-C(9)
C(2)-N(1)-C(9)
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20(1)
20(1)
24(1)
26(1)
25(1)
25(1)
22(1)
1.537(2)
1.528(2)
1.526(2)
1.525(2)
1.533(2)
1.535(2)
1.522(2)
1.340(2)
1.495(2)
1.531(2)
1.539(2)
1.493(2)
1.395(2)
1.397(2)
1.391(2)
1.390(2)
1.390(2)
1.383(2)
114.26(13)
117.11(11)
115.22(12)
107.31(12)
101.81(12)
124.53(11)
N(1)-C(2)-C(1)
N(1)-C(2)-C(3)
C(1)-C(2)-C(3)
C(4)-C(3)-C(2)
C(3)-C(4)-C(5)
C(4)-C(5)-C(6)
C(4)-C(5)-C(20)
C(6)-C(5)-C(20)
N(1)-C(6)-C(7)
N(1)-C(6)-C(5)
C(7)-C(6)-C(5)
C(6)-C(7)-C(8)
C(7)-C(8)-C(21)
C(7)-C(8)-C(9)
C(21)-C(8)-C(9)
C(19)-C(9)-N(1)
C(19)-C(9)-C(10)
N(1)-C(9)-C( 10)
C(19)-C(9)-C(8)
N(1)-C(9)-C(8)
C(10)-C(9)-C(8)
C(1 1)-C(10)-C(9)
C(11)-C(10)-C(15)
C(9)-C(10)-C(15)
C(12)-C(11)-C(10)
C(13)-C(12)-C(1 1)
C(14)-C(13)-C(12)
O(1)-C(14)-C(13)
O(1)-C(14)-C(15)
C(13)-C(14)-C(15)
C(14)-C(15)-C(16)
C(14)-C(15)-C( 10)
C(16)-C(15)-C( 10)
O(3)-C(16)-C(17)
O(3)-C(16)-C(15)
C(17)-C(16)-C(15)
C(19)-C(17)-C(18)
115.50(13)
115.94(13)
111.01(13)
113.00(13)
112.15(14)
108.71(13)
112.62(13)
110.63(13)
100.94(13)
108.84(12)
113.24(14)
98.68(12)
108.84(14)
104.54(12)
103.48(12)
108.05(12)
113.70(12)
117.25(13)
102.83(13)
102.66(11)
110.85(12)
112.54(13)
112.64(13)
113.45(12)
110.84(13)
110.31(13)
111.64(14)
110.51(13)
107.72(12)
111.57(13)
111.97(12)
110.17(12)
112.27(13)
107.10(12)
106.85(12)
115.20(12)
121.64(15)
C(19)-C(17)-C(16)
C(1 8)-C(1 7)-C(16)
O(4)-C(1 8)-O(5)
O(4)-C(18)-C(17)
O(5)-C(1 8)-C( 17)
C(17)-C(19)-C(9)
C(17)-C(19)-C(20)
C(9)-C(19)-C(20)
O(2)-C(20)-C(19)
O(2)-C(20)-C(21)
C(19)-C(20)-C(21)
O(2)-C(20)-C(5)
C(19)-C(20)-C(5)
C(21)-C(20)-C(5)
C(8)-C(21)-C(20)
O(6)-C(24)-O(3)
O(6)-C(24)-C(25)
O(3)-C(24)-C(25)
C(26)-C(25)-C(30)
C(26)-C(25)-C(24)
C(30)-C(25)-C(24)
C(27)-C(26)-C(25)
C(28)-C(27)-C(26)
C(29)-C(28)-C(27)
C(30)-C(29)-C(28)
C(29)-C(30)-C(25)
122.44(14)
115.91(13)
122.83(15)
125.03(14)
112.10(13)
123.37(15)
132.98(15)
102.82(12)
118.91(13)
110.00(13)
96.65(12)
111.34(13)
109.96(12)
108.76(12)
102.03(12)
125.12(14)
124.37(14)
110.49(12)
119.63(15)
118.99(14)
121.35(14)
119.79(15)
120.36(15)
119.70(15)
120.32(15)
120.15(15)
Symmetry transformations used to generate
equivalent atoms:
126
Table S4. Anisotropic displacement parameters (A2x 103) for (-)-himandrine (3). The
anisotropic
displacement factor exponent takes the form: -2p 2[ h2 a* 2UI" + ... + 2 h k a* b* U12]
U11 U22 U33 U23 U 13 U12
0(1)
0(2)
0(3)
0(4)
0(5)
0(6)
N(1)
C(1)
C(2)
C(3)
C(4)
C(5)
C(6)
C(7)
C(8)
C(9)
C(10)
C(11)
C(12)
C(13)
C(14)
C(15)
C(16)
C(17)
C(18)
C(19)
C(20)
C(21)
C(22)
C(23)
27(1)
26(1)
18(1)
24(1)
28(1)
28(1)
21(1)
23(1)
21(1)
22(1)
28(1)
25(1)
23(1)
22(1)
20(1)
18(1)
20(1)
20(1)
25(1)
27(1)
25(1)
20(1)
19(1)
19(1)
19(1)
22(1)
21(1)
22(1)
26(1)
43(1)
25(1)
19(1)
17(1)
27(1)
24(1)
21(1)
20(1)
20(1)
20(1)
22(1)
23(1)
21(1)
22(1)
23(1)
20(1)
17(1)
18(1)
23(1)
22(1)
22(1)
17(1)
16(1)
16(1)
16(1)
13(1)
14(1)
16(1)
18(1)
28(1)
38(1)
22(1)
30(1)
21(1)
27(1)
22(1)
22(1)
20(1)
26(1)
20(1)
23(1)
26(1)
22(1)
18(1)
26(1)
26(1)
22(1)
23(1)
30(1)
37(1)
32(1)
24(1)
22(1)
20(1)
22(1)
25(1)
22(1)
24(1)
26(1)
30(1)
24(1)
-4(1)
-4(1)
-2(1)
-3(1)
-1(1)
1(1)
-1(1)
1(1)
1(1)
1(1)
-1(1)
-6(1)
-2(1)
-4(1)
-1(1)
0(1)
0(1)
0(1)
-1(1)
-3(1)
-1(1)
0(1)
0(1)
0(1)
-3(1)
1(1)
-4(1)
-3(1)
1(1)
-5(1)
-8(1)
-7(1)
-6(1)
-9(1)
-5(l)
-6(1)
-6(1)
-11(1)
-7(1)
-9(1)
-11(1)
-6(1)
-3(1)
-4(1)
-7(1)
-6(1)
-8(1)
-8(1)
-13(1)
-12(1)
-12(1)
-10(1)
-7(1)
-9(1)
-7(1)
-12(1)
-5(1)
-7(1)
-3(1)
-13(1)
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-12(1)
-10(1)
-7(1)
-13(1)
-16(1)
-9(1)
-9(1)
-7(1)
-8(1)
-10(1)
-11(1)
-8(1)
-9(1)
-8(1)
-6(1)
-7(1)
-8(1)
-10(1)
-12(1)
-12(1)
-8(1)
-8(1)
-6(1)
-6(1)
-4(1)
-6(1)
-8(1)
-5(1)
-16(1)
-17(1)
C(24)
C(25)
C(26)
C(27)
C(28)
C(29)
C(30)
23(1)
22(1)
28(1)
25(1)
24(1)
29(1)
23(1)
20(1)
20(1)
22(1)
26(1)
19(1)
21(1)
23(1)
20(1)
24(1)
24(1)
25(1)
33(1)
28(1)
23(1)
-1(1)
-3(1)
0(1)
-6(1)
-8(1)
1(1)
-4(1)
-7(1)
-8(1)
-7(1)
-2(1)
-9(1)
-14(1)
-6(1)
-13(1)
-12(1)
-14(1)
-13(1)
-7(1)
-12(1)
-12(1)
Table S5. Hydrogen coordinates ( x 104) and isotropic displacement parameters (A2x 10 3)
for (-)-himandrine (3).
x y z U(eq)
H(20)
H(1A)
H(1B)
H(C)
H(2)
H(3A)
H(3B)
H(4A)
H(4B)
H(5)
H(6)
H(7A)
H(7B)
H(8)
H(10)
H(l l A)
H(11B)
H(12A)
H(12B)
H(13A)
H(13B)
8110(20)
8143
9910
9746
7524
10141
9677
8691
7748
5198
4761
2059
2211
2579
4816
5010
3059
3524
3459
6933
6095
3030(30)
-4058
-4563
-3367
-2517
-1984
-892
1182
194
2559
-69
2484
677
2029
319
-2688
-977
-3143
-1428
-4483
-3862
640(20)
1096
1606
277
3011
2333
1024
2511
3783
3302
3902
3344
3027
848
-979
693
743
-599
-1491
-1499
-2728
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H(14)
H(15)
H(16)
H(21A)
H(21B)
H(22A)
H(22B)
H(22C)
H(23A)
H(23B)
H(23C)
H(26)
H(27)
H(28)
H(29)
H(30)
6709
8282
8361
3174
4127
11418
12362
13058
8788
10767
8744
14619
17482
18055
15703
12852
-1411
-2670
97
4219
3867
3381
2309
1435
-4491
-4294
-2634
-3166
-5729
-7790
-7331
-4778
-3134
-962
-2865
1749
136
-3004
-4364
-3086
-4635
-5306
-5154
-6134
-6582
-4847
-2680
-2220
Table S6. Hydrogen bonds for (-)-himandrine (3) [A and '].
D-H...A d(D-H) d(H...A) d(D...A) <(DHA)
O(2)-H(20)...O(4) 0.834(15) 1.922(17) 2.6693(16) 148.7(19)
Symmetry transformations used to generate equivalent atoms:
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Appendix A.
Spectra for Chapter I
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1 ppm
6 5 4 3 2 1 PPM1110 9 8 7
DEC. & VT
ACQUISITION
sfrq 125.796
tn C13
at 1.736
np 104808
sw 30188.7
fb not used
bs 8
ss 1
tpwr 54
pw 3.5
dl 0.763
tof 629.8
nt 100000
ct 2600
alock n
gain not used
FLAGS
i1 n
in n
dp y
hs nn
DISPLAY
sp -2514.8
wp 30188.2
vs 909
sc 0
wc 250
hzmm 120.75
is 500.00
rfl 12230.3
rip 9715.0
th 18
ins 1.000
ai ph
dfrq 500
dn
dpwr
dof -5
dm
dm
dmf
dseq
dres
homo
PROCESSING
lb
wtfile
proc
in 13
math
werr
wexp
wbs
wnt
.233
Hl
44
00.0
y
w
8000
1.0
n
0.30
ft
1072
f
Me
TBSO
(*)-68 Br
20 180 I-ITII-I - 1 6 14 I2 40 20 0 -ppm .iI.IIiI II. F III
100 80
SAMPLE
200 180 140 120 40 20 0 PPM160
Me
TBSO
(*)-68 Br
2361.88
3077.23
94.7
90
85
80
75
70
65
60
55
50
45
1641.57
1471.92
2856.88
3000 2000 1500 1000
cm-1
2954.95
2928.61
39.8
4000.0 400.0
SAMPLE
solvent Benzene
ACQUISITION
sfrq 499.757
tn H1
at 3.278
np 40960
sw 6248.0
fb not used
bs 16
tpwr 56
pw 8.2
dl 0
tof 358.1
nt 8
ct 8
alock n
gain not used
FLAGS
il n
in n
dp y
hs nn
DISPLAY
sp -250.7
wp 6247.9
vs 151
wc
hzmmO is
rfl
rfp
th
ins
nm cdc
DEC. & VT
dfrq 125
dn
dpwr
dof 14!
dm
dmm
dmf I
dseq
dres
homo
PROCESSING
wtfile
proc
fn 6
math
werr
wexp
wbs
wnt
.677
C13
34
98.1
nnn
w
0400
Me
TBSO
N,
(±)-71 O\ 0
5536
IF
0
250
24.99
33.57
250.9
0
14
1.000
__ _ _ __ _  __ _ _  _ _ __ _ _ __AI~ b~ EM A
4 3 2II II I IIII I I 1 ppm
4 3 2 1 PPM11 10 9 8 7 6 5
L
SAMPLE
solvent Benzene
ACQUISITION
sfrq 125.796
tn C13
at 1.736
np 104808
sw 30188.7
fb not used
bs 8
ss 1
tpwr 53
pw 6.9
dl 0.763
tof 568.4
nt 100000
ut 20096
alock n
gain not used
FLAGS
il n
in n
dp y
hs nn
DISPLAY
sp -2511.4
wp 30188.2
vs 23033
sc 0
wc 250
hzmm 120.75
is 500.00
rfl 18663.2
rfp 16151.4
th 5
ins 1.000
ai ph
DEC. & VT
dfrq 500
dn
d pwr
dof -5
dm
dmm
dmf 1
dseq
dres
homo
PROCESSING
lb
wtfile
proc
fn 13
math
.233
Hl
37
00.0
y
w
0000
1.0
n
0.30
ft
1072
f
werr
wexp
wbs
wnt
2I 1 8 1 6 1 4 I2 1 0 I0 6 0 4 0 Z n I I I I I I I I I I I I I I I I I I I I I , I I T , , . . I I Ip p m F , , j , F I ,
Me
TBSO
N-
(±)-71 O \
140 120200 180 160 100 80 40 20 0 PPM60
103.2
102
100
98
96
94
92
90
%T
88
86
84
82
80
78
Me
TBSO
N-
2360.40
2 56.40
2928.26
1758.04
3000 2000 1500 1000
cm-1
I472.5 667.96
'P08.95
9 7.80
1149.44
1250.51 1 04.68
1088.61
1041.45 P76.12
1414.84
834.61
75.8
4000.0 400.0
SAMPLE
solvent benzene
ACQUISITION
sfrq 499.757
tn H1
at 3.278
np 40960
sw 6248.0
fb not used
bs 4
tpwr 56
pw 8.2
dl 4.000
tof 358.1
nt 128
ct 16
alock n
gain not used
FLAGS
11 n
in n
dp y
hs nn
DISPLAY
sp -250.7
wp .6247.9
vs 161
sc 0
wc 250
hzmm 24.99
is 33.57
rfl 250.9
rfp 0
th 7
ins 1.000
nm cdc ph
DEC. & VT
dfrq 125
dn
dpwr
dof 14
dm
dmm
dmf 1
dseq
dres
homo
PROCESSING
wtfile
proc
fn 61
math
werr
wexp
wbs
wnt
.677
C13
34
98.1
nnn
w
C000
1.0
n
ft
5536
f
11 98 75 54 32 1PPM
Me
HO
N,
(*t)-S3 0_\0
I I I
11 8
SAMPLE
solvent BenZene
ACQUISITION
sfrq 125.796
tn C13
at 1.736
np 131010
sw 37735.8
fb not used
bs 8
ss 1
tpwr 53
.pw 6.9
dl 4.000
tof 631.4
nt 100000
ct 7288
alock n
gain not used
FLAGS
il n
in n
dp y
hs nn
DISPLAY
sp -2517.1
wp 30191.1
vs 2705
sc 0
wc 250
hzmm 120.76
is 500.00
rfl 22374.3
rfp 16151.4
th 20
ins 1.000
ai ph
DEC. & VT
dfrq 500
dn
dpwr
dof -5
dm
dmm
dmf I
dseq
dres
homo
PROCESSING
lb
wtfile
proc
in 13
math
werr
wexp
wbs
wnt
.233
H1
37
00.0
y
w
0000
1.0
n
0.30
ft
1072
f
Li
Me
HO
(±)-S3 O 0
200II 1 0 16 14 1 10 20 0 ppm II-IIII IIII II#I II 80 60
I I
140 120 100200 20- 0 PPM180 160
106.4 Me
104 HO
N
102 ()-S O O
100 .-
98r
3853.70
96-
94 234 .98
2360.56
92 3421.05 2973.45
2906.91
-1 2926.65
%T
86
84
82-
80
78
76-
74
72
70.4
4000.0 3000 2000 1500
cm-1
1000 400.0
475A
467.2
P09.23
1146.34 760.62
967.66 668.04
1246.98
1036.65 455.1
412.1:
SAMPLE
dfrq
DEC. & VT
125.677
solvent Benzene dn
file /data/movassa dpwr
g/Mdh/DKH-IV-55cr-.- dof 149
fid dm
ACQUISITION dim
sfrq 499.757 dmf 1
tn H1 dseq
at 3.278 dres
np 40960 homo
sw 6248.0 PROCESSING
fb not used wtfile
bs 16 proc
tpwr 56 fn 6
pw 8.2 math
dl 2.000
tof 357.8 werr
nt 64 wexp
ct 32 wbs
alock n wnt
gain not used
FLAGS
1ln
in n
dp y
hs nn
DISPLAY
sp -250.7
wp 6247.9
vs 58
sc 0
wc 250
hzmm 24.99
0 is 33.57
rfl 250.9
rfp 0
th 7
ins 1.000
nm cdc ph
Me
N-
(±)-S4O
C13
34
98.1
nnn
w
3000
5536
f
_________________________A 11 *I 11.hi1 
I1 10 7 6 5- 4 3 2 , I I I I I 1 - 1 pr =pm I I I I I I I I
11 10 7 65 43 2 1 PPM
A
i I ,
SAMPLE
solvent Benzene
fil /data/export/-
home/movassag/Mdh/-
rocky/DKH-IV-55.ca-
rbon.fid
ACQUISITION
sfrq 125.796
tn C13
at 1.736
np 104808
sw 30188.7
fb not used
bs 8
ss 1
tpwr 53
pw 6.9
dl 2.000
tof 565.2
nt 1e+08
ct 12456
alock n
gain not used
FLAGS
i1 n
in n
dp y
hs nn
DISPLAY
sp -2514.6
wp 30188.2
vs 25767
sc 0
wc 250
hzmm 120.75
is 500.00
rfl 18666.4
rfp 16151.4
th 20
ins 1.000
ai ph
DEC. & VT
dfrq 500
dn
dpwr
dof -5
dm
dmm
dmf 1
dseq
dres
homo
PROCESSING
lb
wtfile
proc
fn 13
math
werr
wexp
wbs
wnt
.233
hi
37
00.0
y
W
0000
1.0
n
0.30
ft
1072
f
Me
0
N(
(*t)-S4 O-- -
X1f.~,.. ~ '~~..7i.t.2Iz:Iyi.' ~ T. :1 .~t~:iv~ .'~ ~ ~ r ii' i::~. . L.,:2,'~ .1, '.. V
200 180 160 140 120 100 
80 60 40 20 0 ppm
20 0 ppm 160 140 120 100 80 60 40
91.7.
91_
Me
90 0
89 - N -3
(*)-S4 O ---88-
g7 130.0
87 -148286 1711.1 1461.8 1033.46
-1251.28
85 .. 1691.4
3774.1-
65.85
%T 84 371 5 1640.53 1 1413.77
3697- 8 2924.14 1630.93
3683 f.'1599.12
83- 3663 7
3639.? 7 1754.00
3582.98
811
80.
79.
78_
77.0.-
4000.0 3000 2000 1500 1000 400.0
cm-I
SAMPLE DEC. & VT
dfrq 125
solvent Benzene dn
dpwr
dof 14
dm
ACQUISITION dmm
sfrq 499.757 dmf 1
tn Hi dseq
at 3.278 dres
np 40960 homo
sw 6248.0 PROCESSING
fb not used wtfile
bs 16 proc
tpwr 56 fn 6
pw 8.2 math
dl 1.000
tof 357.5 werr
nt 64 wexp
ct 32 wbs
alock n wnt
gain not used
FLAGS
ii n
in n
dp y
hs nn
DISPLAY
sp -250.7
wp 6247.9
vs 235
sc 0
wc 250
hzmm 24.99
is 33.57
rfl 250.9
rfp 0
th 7
ins 1.000
nm cdc ph
.677
C13
34
98.1
nnn
w
0000
1.0
n
ft
5536
. f
TBSO
N-
72 07O 0
Li 11 11 1 A hI
11 10 8 7 6 4 3 2 1 ppm
L - - a---Ll ak-
SAMPLE
solvent Benzene
ACOUISITION
sfrq 125.796
tn C13
at 1.736
np 104808
sw 30188.7
fb not used
bs 4
ss 1
tpwr 54
pw 6.9
dl 4.000
tof 565.8
nt 100000
ct 7260
alock n
gain not used
FLAGS
i1 n
in n
dp y
hs nn
DISPLAY
sp -2514.6
wp 30188.2
vs 1584
sc 0
wc 250
hzmm 120.75
is 500.00
rfl 18666.4
rfp 16151.4
th 20
ins 1.000
ai ph
DEC. & VT
dfrq 500
dn
dpwr
dof -5
dm
dmm
dmf
dseq
dres
homo
PROCESSING
lb
Wtfile
proc
fn 13
math
werr
wexp
wbs
Wnt
.233
H1
44
00.0
y
w
1000
1.0
n
0.30
ft
1072
f
TBSO
NQ
72 O--- O
________________________It 
____I ~ ~ 0 1I 160 - IIIIIaI I.IIII 140 1 2011 100II, 80 II  ITII IIII II40 III 201- 1... 0 ppm-j-T- I I.I200 180 160 140 120 100 80 40 20 0 ppm
103.4
400.0
cm-1
SAMPLE
solvent Benzene
ACQUISITION
sfrq 499.749
tn "IH
at 3.001
np 63050
sw 10504.2
fb not used
bs 1
tpwr 56
pw 8.9
dl 2.000
tof 1519.5
nt 16
ct 16
alock n
gain not used
FLAGS
11 n
in n
dp y
hs nn
DISPLAY
sp -249.9
wp 6246.8
vs 151
sc 0
wc 250
hzmm 24.99
is 33.57
rfl 1233.8
rfp 0
th 7
ins 100.000
nm cdc ph
dfrq
dn
dpwr
dof
dm
DEC. & VT
125.673
C13
30
0
dm
dmf i
dseq
dres
homo
PROCESSING
wtfile
proc
fn 13
math
werr
wexp
wbs
wnt
0000
1.0
n
ft
1072
f
1I 10 9 8 I 6 I 4 I 2 1 ppm I , I I I I I I I . . . . I -
OHC
TBSO
N
73 Oz(-
3 2 1 PPM
J--
11 10 9 8
SAMPLE
sn1vent Benzene
ACQUISITION
sfrq 125.797
tn C13
at 1.736
np 113086
sw 32573.3
fb not used
bs 4
ss 1
tpwr 53
pw 6.9
dl 0.763
tof 1820.5
nt le+09
ct 18872
alock n
gain not used
FLAGS
il n
in n
dp y
hs nn
DISPLAY
sp -2454.7
wp 32572.8
vs 191
sc 0
wc 250
hzmm 130.29
is 500.00
rf1 15106.2
rfp 12651.0
th 20
ins 128.390
ai ph
DEC. & VT
dfrq 500
dn
dpwr
dof -5
dm
dmm
dmf I
dseq
dres
homo
PROCESSING
lb
wtfile
proc
fn 13
math
werr
wexp
wbs
wnt
.233
HI
37
00.0
y
w
0000
1.0
n
0.30
ft
1072
f
220 200 180 160 140 120 100 80
OHC
TBSO '
73 O O
60 40 20 0 PPM
92.0
90 .-.
384
88 381
37!
3
86_
84.
82-
%T 80-
78.
76-
74.
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70
69.0
4000.0 3000 2000 1500 1000
cm-1
400.0
SAMPLE
solvent Benzene
ACQUISITION
sfrq 499.757
tn H1
at 3.278
np 40960
sw 6248.0
fb not used
bs 16
tpwr 56
pw 8.2
dl 0
tof 356.7
nt 64
ct 32
alock n
gain not used
FLAGS
11 n
In n
dp y
hs nn
DISPLAY
sp -250.8
wp 6247.9
vs 151
sc 0
wc 250
hzmm 24.99
is 33.57
r1l 251.0
rfp 0
th 7
ins 1.000
nm cdc ph
DEC. & VT
dfrq 125
dn
dpwr
dof 149
dm
dmm
dmf 1
dseq
dres
homo
PROCESSING
wtfile
proc
fn 6
math
werr
wexp
wbs
wnt
.677
C13
34
98.1
nnn
w
0000
1.0
n
ft
5536
f
(*)-65
I ~ I A ~ J~ ~ ~Jd4~ 1 .1
I1 I0 I  I 5 4 3 2 1 ppm V 1 I I I I I I i I I I I a I I8711 10 43 2 1 PPM
SAMPLE
solvent Benzene
ACQUISITION
sfrq 125.798
tn C13
at 1.735
np 109304
sw 31496.1
fb not used
bs 8
ss 1
tpwr 54
pw 6.9
dl 5.000
tof 2416.2
nt 500000
ct 7232
alock n
gain not used
FLAGS
il n
in n
dp y
hs nn
DISPLAY
sp -1317.9
wp 31495.6
vs 30872
sc 0
ch wc 250
hzm 125.98
Is 500.00
rfl 17469.7
rfp 16151.4
th 3
ins 1.000
at ph
DEC. & VT
dfrq 500
dn
dpwr
dof 
-5
dmn
dmm
dmf
dseqdres
homo
PROCESSING
lb
wtfile
proc
fn 13
math
werr
wexp
wbs
wnt
.233
H1
44
00.0
y
w
8000
1.0
n
2.00
ft
1072
f
I I 
- I I IIm- -F I I I I . . I I , , 1 - - -220 200 180 160 140 
120 100
60 40 20 PPm
(*)-65
120 100
FW ww, w1foork RAN go PIR MP PJA I $No- bfO
-"Z 1-11L: = =
220 200 180 160 140 n n
L.. ...I. -
H O
H* H
TBSO H'
(*)-65 N O
O
3426.52
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95
90
85
80
75
T
70
65
60
55
50
1407.99
3000 2000 1500 1000
cm-1
1014.36
45.3 .j
4000.0 400.0
SAMPLE
solvent CDC13
ACQUISITION
sfrq 499.749
tn HI
at 3.277
np 65536
sw 9998.8
fb not used
bs 1
tpwr 56
pw 8.2
dl 0
tof 1498.1
nt 16
ct 16
alock n
gain not used
FLAGS
11 n
In n
dp y
hs nn
DISPLAY
sp -250.0
wp 6246.8
vs 151
Sc 0
wc 250
hzmm 24.99
is 33.57
rfl 4638.1
rfp 3633.1
th 7
ins 1.000
nm cdc ph
DEC. & VT
dfrq 125.
dn
d pwr
dof 149
dm
dmm
dmf 1
dseq
dres
homo
PROCESSING
wtfile
proc
fn 6
math
werr
wexp
wbs
wnt
.674
C13
34
98.1
nnn
w)000
1.0
n
ft
5536
f
0 Me
Me- NHBoc
(+)-(S)-76
1 1 8 6 I I 3 I Ippm . I I I I I I I I I I I I I I I I I
A.jUA 
I
11 10 9 8 6 5 4 3 2 1 PPM
SAMPLE
solvent CDCI3
file exp
ACQUISITION
sfrq 125.676
tn Cis
at 3.000
np 226304
sw 37718.1
fb not used
bs 16
ss 1
tpwr 58
pw 7.5
dl 3.000
tof 615.5
nt 3500
ct 1712
alock n
gain not used
FLAGS
11 n
in n
dp y
hs nn
DISPLAY
sp -2513.8
wp 32672.3
vs 1230
sc 0
wc 250
hzmm 130.69
is 500.00
rfl 16013.3
rfp 9705.0
th 3
ins 1.000
ai cdc ph
DEC. & VT
dfrq 499.
dn
dpwr
dof
dm
dmm
dmf 1
dseq
dres
homo
DEC2
dfrq2
dn2
dpwr2
dof 2
dm2
dmm2
dmf2 1
dseq2
dres2
homo2
DEC3
dfrq3
dn3
dpwr3
dof3
dm3
dmm3
dmf3
dseq3
dres3
homo3
PROCESSING
lb
wtfile
proc
fn 13
math
werr
wexp
wbs
wnt
.756
H1
34
0
yyy
w
000
1.0
n
0
1
0
n
c
0000
0 Me
MeA NHBoc
(+)-(S)-76
1
0
n
c
0000
1.0
n
1.00
ft
1072
f
200~~L 180 -I60 L4 12 100 80d I 402Ipm
220 200 180 160 140 120 100 80 60 40 20 0 PPM
O Me
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90_ (+)-(S)-76
80-70- "2285.25
70-
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94 0\
2
50 44.36 7 2.12
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40 781.88
30. 106. 25.18 600.23
20. 1031
3350.86
10- 29 3.47 390.
%T 0 .. 454.44 1080.85
2974.76 1249.24
-10 1710.26 1522.82 1172.02 442,671365.74 416.22
-20.
-301
-401
-50.
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-70.
-80.
-89.8
4000.0 3000 2000 1500 1000 400.0
cm-1
SAMPLF
solvent LUnes I3
ACQUISITION -
sfrq 499.749
tn HI
at 3.277
np 65536
sw 9998.8
fb not used
bs 1
tpwr 56
pw 8.2
dl 0
tof 1498.1
nt 16
ct 16
alock n
gain not used
FLAGS
il n
in n
dp y
hs nn
DISPLAY
sp -1005.7
wp 9998.4
vs 151
sc 0
wc 250
hzmm 40.00
is 4.20
rfl 4639.1
rfp 3633.1
th 7
ins 1.000
nm cdc ph
DEC. & VT
dfrq 125.
dn
dpwr
dof 149
dm
dmm
dmf 1
dseq
dres
homo
PROCESSING
wtfile
proc
fn 6
math
werr
wexp
wbs
wnt
.674
C13
34
98.1
nnn
w
000
1.0
n
ft
5536
f
2 -0 ppm
C1- Me
H +
'N
IO
LLAAK
16
I . 1 I I I . . , . 1 1 3 1 ' 1 1 . I I I I I I | a ' I I I I ' I I | ' ' I ' I ' ' ' I I ' ' ' ' I ' ' ' ' 1I
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SAMPLE
Solvent CDC13
file exp
ACQUISITION
sfrq 125.796
tn C13
at 1.736
np 131010
sw 37735.8
fb not used
bs 8
ss 1
tpwr 53
pw 6.9
dl 0.763
tof 631.4
nt 10000
ct 10000
alock n
gain not used
FLAGS
11 n
in n
dp y
hs nn
DISPLAY
sp -2516.4
wp 32706.1
vs 15554
sc 0
wc 250
hzmm 130.82
ca is 500.00
rf1 16005.9
rfp 9715.0
th 4
ins 1.000.
ai ph
DEC. & VT
dfrq 500.
dn
dpwr
dof -5
dm
dimn
dmf
dseq
dres
homo
PROCESSING
lb
wtfile
proc
fn 13
math
werr
wexp
wbs
wnt
233
HI
37
00.0
y
w0000
1.0
n
0.30
ft
1072
f
00 180 160 140 120 100 80 60 a ppm
Cl- Me
H, +N
Me5
(-)-(2S)-64
:7- '777-7777- -o7
220 2 40 20
98.3. Cl- Me
H,+95 .
90 Me(-)-(25)-64
85 -
/ 238. 3.90
I ~p041 114. 850.90
.1 .5 762.8
75-/ 1457 .44 1038.10 748.46
70- j059.1 1386.46
65 k! 1685.762638.86
60 2936.10
60
3406.00
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50_
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. 25-
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4000.0 3000 2000 1500 1000 400.0
cm-1
Injection Date Seq. Line : 1
Sample Name Location : Vial 51
Acq. Operator Inj : 1
Inj Volume : 1 pl
Acq. Method
Last changed
Analysis Method
Last changed
MWD1 A, Sig=220,16 Ref=360,100
mAU.
14-
12-
10-
8-
6-
4-
2-
0- - .
-2
15 16 17 18
S, S Whelk-0
0 HN
Ph
19 20 21
Area Percent Report
Sorted By : Signal
Multiplier : 1.0000
Dilution : 1.0000
Use Multiplier & Dilution Factor with ISTDs
Signal 1: MWD1 A, Sig=220,16 Ref=360,100
Peak RetTime Type Width Area Height Area
# [min] [min) [mAU*s] (mAU] %
---- I ------- ---- I------ I-------- I-------- ------
1 19.526 PB 0.7477 504.22922 8.01823 100.0000
Totals : 504.22922 8.01823
Results obtained with enhanced integrator!
*** End of Report ***
164
22 23 mi
Injection Date Seq. Line : 1
Sample Name Location : Vial 51
Acq. Operator Inj : 1
Inj Volume :1 Ipl
Acq. Method
Last changed
Analysis Method
Last changed
S, S Whelk-0
MWD1 A, Slg=220,16 Ref=360,100
mAUl
o HN
Phj-
19
Area Percent Report
Sorted By : Signal
Multiplier : 1.0000
Dilution 1.0000
Use Multiplier & Dilution Factor with ISTDs
Signal 1: MWD1 A, Sig=220,16 Ref=360,100
Peak RetTime Type Width Area Height Area
# (mini [min] [mAU*sI [mAUI %
1-7.41P I --------PB I 21- -  -------1 17.641 PB 0.8517 2181.38892 36.47622 100.0000
Totals : 2181.38892 36.47622
Results obtained with enhanced integrator!
*** End of Report ***
165
Injection Date Seq. Line : 1
Sample Name Location : Vial 51
Acq. Operator Inj : 1
Inj Volume : 1 pl
Acq. Method
Last changed
Analysis Method
Last changed
R, R Whelk-0
Area Percent Report
Sorted By
Multiplier
Dilution
Use Multiplier &
: Signal
: 1.0000
: 1.0000
Dilution Factor with ISTDs
Signal 1: MWD1 A, Sig=220,16 Ref=360,100
Peak RetTime Type Width Area Height Area
# (min] [min] [mAU*s] [mAU] %
-- -I ------- I------I---------- I------
1 20.335 VV 0.8630 3016.49365 42.44931 100.0000
Totals : 3016.49365 42.44931
Results obtained with enhanced integrator!
*** End of Report.***
166
Injection Date Seq. Line : 1
Sample Name Location : Vial 51
Acq. Operator Inj : 1
Inj Volume : 1 pl
Acq. Method
Last changed
Analysis Method
Last changed
R, R Whelk-O
MWD1 A, Sig=220,16 Ref=360,100
mAU
14
12
10
8
6
4
2
0
o HN
Ph
Area Percent Report
Sorted By : Signal
Multiplier : 1.0000
Dilution : 1.0000
Use Multiplier & Dilution Factor with ISTDs
Signal 1: MWD1 A, Sig=220,16 Ref=360,100
Peak RetTime Type Width Area Height Area
# [min] (min] [mAU*s] (mAU] %
S I -- V -- I 8------.I-------- I--- 0 -
1 19.389 VB 0.8069 537.40503 8.15439 100.0000
Totals : 537.40503 8.15439
Results obtained with enhanced integrator!
* End of Report *
167
SAMPLE_
solvent Benzene
ACQUISITION
sfrq 499.749
tn Hi
at 3.277
np 65536
sw 9998.8
fb not used
bs 1
tpwr 56
pw 8.2
dl 0
tof 1498.1
nt 16
ct 16
alock n
gain not used
FLAGS
i1 n
in n
dp y
hs nn
DISPLAY
sp -250.1
wp 6246.7
vs 151
sc 0
wc 250
hzmm 24.99
is 33.57
rIl 1002.6
rfp 0
th 7
ins 1.000
nm cdc ph
DEC. & VT
dfrq 125.674
dn C13
dpwr 34
dof 1498.1
dm nnn
dmm w
dmf 10000
dseq
dres 1.0
homo n
DEC2
dfrq2 0
dn2
dpwr2 1
dof2 0
dm2 n
dm2 c
dmf2 200
dseq2
dres2 1.0
homo2 n
DEC3
dfrq3 0
dn3
dpwr3 1
dof3 0
dm3 n
dm,3 c
dmf3 200
dseq3
dresS 1.0
homoS n
PROCESSING
wtfile
proc ft
in 65536
math f
werr
wexp
wbs
wnt
63 Ont-2-epi-63
I
I I I
9 8 7 6 5
-V- F I I I I I I I I r V-- I I I I I I j I I I I I I I I I I =
3 2 1PPM11 10
SAMPLE DEC. & VT
dfrq 500.233
Solvent Benzene dn H1
file exp dpwr 37
ACQUISITION dof -500.0
sfrq 125.793 dm y
tn C13 dmm w
at 1.737 dmf 10000
np 104492 dseq
sw 30075.2 dres 1.0
fb not used homo n
bs 4 PROCESSING
ss 1 lb 0.30
tpwr 53 wtfile
pw 6.9 proc ft
di 0.763 fn 131072
tof -1947.9 math f
nt 1e+06
ct 2164 werr
alock n wexp
gain not used wbs
FLAGS wnt
il n
in n
dp. y
hs nn
DISPLAY
sp -4970.9
wp 30075.2
vs 1612
sc 0
wc 250
hzmm 43.79
- is 500.00
C rfl 21122.3
rfp 16151.4
th 6
ins 1.000
ai ph
.~..1A.
.8 .6 14 12 10 80 60 40 20 0. -2 .pp ..... m.II.I.II
.,Me
ent-2-epi-63
180 160 140 20 0 -20 PPM120 100 80 60 40
95.6 BSOH +OTBS
H H
85 O NO
80 63 ent-2-ep63
75.
70.
65.
1.766 -1 
3 1 . 1 . 65 .3 2
60- 1659.
146 5.40
551472. .49 .30
%T 50 1446.
1 3.85
1309. 1094.2 81.55
45- 1614.89 1277. 5 1038. 3
1406.49 1015.28
40 1259.11214.80
2 5.53 838.6535.
30 2928.78 1756.10
25.
20.
15.
10.1
4000.0 3000 2000 1500 1000 400.0
cm-1
SAMPLE
solvent Benzene
ACQUISIll u
sfrq 499.748
tn H1
at 3.001
np 37494
sw 6247.6
fb not used
bs 4
tpwr 56
pw 8.9
di 2.000
tof 359.2
nt 128
ct 32
alock n
gain not used
FLAGS
11 n
in n
dp y
hs nn
DISPLAY
sp -250.3
wp 6247.5
vs 165
sc 0
wc 250
hzmm 24.99
is 33.57
rfl 250.4
rfp 0
th 7
ins 100.000
nm cdc ph
DEC. & VT
dfrq 125
dn
dpwr
dof
dm
dmm
dmf 1
dseq
dres
homo
PROCESSING
wtfile
proc
fn 13
math
werr
wexp
wbs
wnt
Me.673
C13
30
0
nnn
w
0000
1.0
n
ft
1072
f
wft
11 10 9 8 7 6 5 4 3 2 1
I I I I
PPM
SAMPLE
solvent Benzene
ACQUISITION
sfrq 125.793
tn C13
at 1.735
np 83834
sw 24154.6
fb not used
bs 8
ss 1
tpwr 53
pw 6.9
dl 0.763
tof -1947.9
nt 100000
ct 1336
alock n
gain not used
FLAGS
11 n
in n
dp y
hs nn
DISPLAY
sp -1029.4
wp 22790.9
vs 1474
sc 0
wc 250
hzmm 91.16
is 500.00
rfl 18162.3
rfp 16151.4
th 20
ins 1.000
ai ph
DEC. & VT
dfrq 500
dn
dpwr
dof -5
dm
dmm
dmf 1
dseq
dres
homo
PROCESSING
lb
wtfile
proc
in 13
math
werr
wexp
wbs
wnt
.23
H3
00.
00c
1.
TBSO /H
H HH
NH
Me NH
79 = 0
- -1- .LJ 7-I'W" ".lW- FYr -1
60 140 120 100 
60 20 0 ppm' I ' ' ' V'
1 100
'' 
' ' ' ' ' 
' '
10
I ' ' I ' ' ' ' I ' '- ' ' 1 ' ' ' I
 140 120 60 20 0 ppm
TBSO / IH Liz
HHH
HH
me N H HN H
89.4 - O9 0 = ent-2-ep-
851
80-
3397.27 131. 29.02
75- 669.1
040.
1446.32 985.09 760.41
70_ 1 12. 2
62.14 1098.15
1212.12 F81.55
65_
1407.69
60-/
%T 1649.85 865.37
55 2856.02 
1254.00 841.14
50_
2928.10
45.
1757.88
40.
35.
31.0.
4000.0 3000 2000 1500 1000 400.0
cm-1
SAMPLE DEC. & VT
dfrq 125.673
solvent Benzene dn C13
dpwr 30
ACQUISITION
sfrq 499.748
tn Hi
at 3.001
np 37494
sw 6247.6
fb not used
bs 4
tpwr 56
pw 8.9
dl 2.000
tof 358.6
nt 128
ct 24
alock n
gain not used
FLAGS
11 n
in n
dp y
hs nn
DISPLAY
sp -250.4
wp 6247.5
vs 186
sc 0
wc 250
hzmm 24.99
is 33.57
rfl 250.4
rfp 0
th 7
ins 1.000
nm cdc ph
dof
dm
dmm
dmf 1
dseq
dres
homo
PROCESSING
wtfile
proc
fn 13
math
werr
wexp
wbs
wnt
nnn
w
0000
1072
f
HO
H&
H
H. H-
H H HMe
(-)-81,36%
I I ' ' I I ' ' ' I 9 ' ' I ' I j I
8 7 6 5 4 3
-I--------t-- 1 JIIlIflIIlJIIIijIiIIjiJl 1 I
' ' ' ' I ' ' ' ' I ' ' ' ' I ' '
2 1 PPM
-- -1 0 ' ' ' I
Current Data Parameters
EXPNO 1
PROCNO 1
F2 - Acquisition Parameters
Date 20060131
Time 7.54
INSTRUM spect
PROBHD 5mm BBO BB-1
PULPROG zgpg30
TD 65536
SOLVENT C6D6
NS 13187
DS 4
SWH 24875.621 Hz
FIDRES 0.379572 Hz
AQ 1.3173236 sec
RG 8192
DW 20.100 usec
DE 6.00 usec
TE 300.0 K
D1 2.00000000 sec
dlI 0.03000000 sec
d12 0.00002000 sec
NUC1
P1
PL1
SFO1
CPDPR
NUC2
PCPD2
PL2
PIgg2
PLj
SFOR2
F2 -
SI
SF
WDW
SSB
LB
GB
PC
ID NM
Cx
FlP
F1
F2P
F2
PPMC
HZCM
CHANNEL fl
13C
15.25
3.00
100.6237959
usec
dB
MHz
======= CHANNEL f2
G2 waltz16
1H
107.50 usec
0.00 dB
24.00 dB
24.00 dB
400.1316005 MHz
Processing parameters
32768
100.6127290 MHz
EM
0.
R4
1.00 Hz
0
1.40
plot parameters
20.00
233 .616
23504.72
-13.625
-1370.90
12.36206
1243 .78113
cm
ppm
Hz
ppm
Hz
ppm/cm
Hz/cm
V, ,I I' I VF1, 1 1 - I 11
170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 ppm
(-)-81, 36%
I 1 11 I I1.,1 1 i. 1. 1
II 1. 1 hi
1.1. .11 1 .. 1. I I ME ELUILL 11
'1 11 , I I - '.If - . I 11 p r fp*il v I wlij 11-- rill -iirl rr fi- I i qrirv rr- 1 It Ipl, I I if r r 4 11- -I , v
...........
4 UI L 1.1 . IIJ
(-)-81, 36%
86.
84
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80-
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76.
74.
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66-
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62.
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58.
56_
54.3 _-
3800.0
1413.11
600.0
88.5
3429.84
3000 2000 1500 1000
cm-I
SAMPLE
solvent Benzene
ACQUISITION
sfrq 499.748
tn H1
at 3.001
np 37494
sw 6247.6
fb not used
bs 4
tpwr 56
pw 8.9
dl 2.000
tof 358.6
nt 128
ct 32
alock n
gain not used
FLAGS
11 n
in n
dp y
hs nn
DISPLAY
sp -250.4
wp 6247.5
vs 350
Sc 0
wc 250
hzm 24.99
is 33.57
rfl 250.4
rfp 0
th 7
ins 1.000
nm cdc ph
DEC. & VT
dfrq 125
dn
- dpwr
- -lof
dm
dm.
dmf 1
dseq
dres
homo
PROCESSING
wtfile
proc
fn 13
math
werr
wexp
wbs
wnt
.673
C13
30
0
nnn
w
0000
1.0
n
ft
1072
f
OH
HH
H
H N MeN H
(+)-82, 34%
9 8 7 6 5 4 3 2 1 PPM11 10
SAMPLE
solvent Benzene
ACQUISITION
sfrq 125.795
tn C13
at 1.735
np 89854
sw 25890.0
fb not used
bs 8
ss 1
tpwr 53
pw 6.9
dl 0.763
tof 159.9
nt le+06
ct 21176
alock n
gain not used
FLAGS
il n
in n
dp y
hs nn
DISPLAY
sp -771.2
wp 25889.6
vs 5499
sc 0
wc 250
hzmm 103.56
is 500.00
rfl 16923.0
rfp 16151.4
th 15
ins 1.000
al ph
DEC. & VT
dfrq 500.
dn
dpwr
dof -5
dm
dmm
dmf 10
dseq
dres
homo
PROCESSING
lb
wtfile
proc
fn 13
math
werr
wexp
wbs
wnt
.233
H 1
37
30.0
y
w
000
1.0
n
3.30
ft
1072
f
(+)-82, 34%
d L.J
60 40 20 ppm180 160 140 100
91.5 N
90- N T9tme
CN}=O H
(+)-82, 34%
2360.39 3.79
9 0.18
7393
80- 3053. 573.93
1665.84
75 3424.42 1372.3 135.62 0.69
1481.69 761.
1445. 222.49 038.42
%T 70 - 1279.77 1101.36
734.34
1415.94
65-
2 5.68
60
55-
2925.82
1742.64
49.7-
3800.0 3000 2000 1500 1000 600.0
cm-1
SAMPLE
solvent Benzene
ACQUISITION
sfrq 499.748
tn H1
at 3.001
np 37494
sw 6247.6
fb not used
bs 4
tpwr 56
pw 8.9
dl 2.000
tof 359.1
nt 128
ct 72
alocc n
gain not used
FLAGS
11 n
in n
dp y
hs nn
DISPLAY
sp -250.3
wp 6247.5
vs 452
sc 0
wc
hzmm
is
rf1
rfp
th
ins
nm cdc
250
24.99
33.57
250.4
0
7
1.000
df rq
dn
dpwr
dof
dm
DEC. & VT
125.673
C13
30
nnn
dmm w
dmf 10000
dseq
dres 1.0
homo n
PROCESSING
wtfile
proc ft
fn 131072
math f
werr
wexp
wbs
wnt wft
11 10 5 4 3 2 1 ppm
HO
(-)-83
. I I I
9 8 7 6
SAMPLE
solvent Benzene
ACQUISITION
sfrq 125.794
tn C13
at 1.736
np 82982
sw 23894.9
fb not used
bs 8
ss 1
tpwr 53
pw 6.9
dl 0.763
tof -693.5
nt 1e+07
ct 19184
alock n
gain not used
FLAGS
il n
in n
dp y
hs nn
DISPLAY
sp -625.9
wp 23894.5
vs 9178
sc 0
wc 250
hzmm 95.58
is 500.00
rfl 16777.7
rfp 16151.4
th 20
ins 1.000
ai ph
DEC. & VT
dfrq 500
dn
dpwr
-of -5
Im
dmm
dmi 1
dseq
dres
homo
PROCESSING
lb
wtfile
proc
fn 13
math
werr
wexp
wbs
wnt
.233
H1
37
00.0
y
w
0000
1.0
n
0.30
ft
1072
f
HOH
HH
Me N
() -
(-)-83
I11 -L .. 1. . .-.~ I
180 10 14 120 00 8 60' 
40 20 'pm
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Pulse Sequence: gCOSY "- H
Solvent: Benzene
Ambient temperature
H. HINOVA-500 N
PULSE SEQUENCE: gCOSY H H 'Relax. delay 1.000 sec Me NCz
Acq. time 0.238 sec Me
Width 4293.7 Hz
2D Width 4293.7 Hz -)8
26 repetitions (-)-83
128 increments
OBSERVE H1, 499.7446815 NHz
DATA PROCESSING
Sq. sine bell 0.119 sec F2
F1 DATA PROCESSING
Sq. sine bell 0.030 sec (PP *
FT size 2048 x 2048
Total time 0 min, -1 sec
a
1 - S , '
.. u a a
3-- U e000
4-
- 0
5-
U a
6
7 r
Ga
8 7 6 5 4 3 2 1
F1 (ppm)
Pulse Sequence: HSQC
Solvent: Benzene
Ambient temperature
User:
INOVA-500
PULSE SEQUENCE; HSQC
Relax. delay 1.000 sec
Acq. time 0.099 sec
Width 4186.7 Hz
2D Width 23255.8 Hz
32 repetitions
2 x 256 increments
OBSERVE H1, 499.7446815 MHz
DECOUPLE C13, 125.6718434 MHz
Power 52 dB
on during acquisition
off during delay
GARP-1 modulated
DATA PROCESSING
Gauss apodization 0.113 sec
F1 DATA PROCESSING
Sq. sine bell 0.022 sec
Shifted by -0.022 sec
FT size 2048 x 2048
Total time 6 hr, 52 min, 23 sec
100 80
F1 (ppm)
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F2 -
SI
SF
WDW
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GB
PC
Fl -
SI
MC2
SF
WDW
SSB
LB
GB
8.0
ppm
Processing parameters
2048
600.4650000 MHz
SINE
2
0.00 Hz
0
1.00
Processing parameters
1024
TPPI
600.4650000 MHz
SINE
2
0.00 Hz
54
(-)-83 "
F2 - Acquisition Parameters
Date 20060124
Time 11.39
INSTRUM spect
PROBHD 5 mm CPTXI Z-G
PULPROG noesyph
TD 1024
SOLVENT C6D6
NS 32
DS 16
SWH 4807.692 Hz
FIDRES 4.695012 Hz
AQ 0.1066500 sec
RG 64
DW 104.000 usec
DE 6.00 usec
TE 295.0 K
dO 0.00009267 sec
Dl 0.80000001 sec
D8 0.40000001 sec
INO 0.00020800 sec
MCREST 0.00000000 sec
MCWRK 0.80000001 sec
======== CHANNEL fl ========
NUC1 1H
P1 8.90 usec
PLi -6.00 dB
SF01 600.4674019 MHz
Fl - Acquisition parameters
NDO 1
TD 512
SF01 600.4674 MHz
FIDRES 9.390024 Hz
Sw 8.007 ppm
FnMODE TPPI
7 6
0 .3a
d
\ }\ 
ROESY
4 3 2 1
HO
HH
I 
H
SMe
(-)-83
F2 - Acquisition Parameters
Date_. 20060124
Time 17.45
INSTRUM spect
PROBHD 5 mm CPTXI Z-G
PULPROG roesyph
TD 1024
SOLVENT C6D6
NS 32
DS 16
SWH 4807.692 Hz
FIDRES 4.695012 Hz
AQ 0.1066500 sec
RG 64
DW 104.000 usec
DE 6.00 usec
TE 295.0 K
dO 0.00009433 sec
Dl 0.80000001 sec
d12 0.00002000 sec
INO 0.00020800 sec
MCREST 0.00000000 sec
MCWRK 0.80000001 sec
00
ppm
-0.5
-1.0
-1.5
-2.0
-2.5
-3.0
-3.5
-4.0
-4.5
-5.0
-5.5
-6.0
-6.5
-7.0
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-8.0
ppm
CHANNEL fI ========
1H
8.90 usec
400000.00 usec
-6.00 dB
15.20 dB
600.4674019 MHz
Fl - Acquisition parameters
NDO 1
TD 512
SF01 600.4674 MHz
FIDRES 9.390024 Hz
Sw 8.007 ppm
FnMODE TPPI
F2 -
SI
SF
WDW
SSB
LB
GB
PC
Fl -
SI
MC2
SF
WDW
SSB
Processing parameters
2048
600.4650000 MHz
SINE
2
0.00 Hz
0
1.00
Processing parameters
1024
TPPI
600.4650000 MHz
SINE
2
0.00 Hz
NUC1
P1
P15
PL1
PLO
SF01
7 6 5
HO
H. H
N89.3 H 'Cbz' H
me N
85 (-)-83
55.
50-
45.
40
38.51.
4000.0 3000 2000 1500 1000
cm-1
400.0
SAMPLE
solvent Benzene
ACQUISITION
sfrq 499.748
tn HI
at 3.001
np 37494
sw 6247.6
fb not used
bs 4
tpwr 56
pw 8.9
dl 2.000
tof 358.9
nt 128
ct 32
alock n
gain not used
FLAGS
11 n
in n
dp y
hs nn
DISPLAY
sp -250.3
wp 6247.5
vs 1609
Sc 0
wc 250
0g bzmm 24.99
is 33.57
rfl 250.4
rfp 0
th 7
ins 100.000
nm cdc ph
dfrq
dn
dpwr
DEC. & VT
125.673
C13
30
dof 0
dm nnn
dmm w
dmf 10000
dseq
dres 1.0
homo n
PROCESSING
wtfile
proc ft
fn 131072
math f
werr
wexp
wbs
wnt wft
OH
H H ,
H4
HH
H Cbz' H M
N =o
(+)-2-epi-83
11 10 9 8 7 6 5 4 3 2
F~V~E
1 V
1 ppm
expi s2pul
SAMPLE
date Jan 31 2006
solvent Benzene
ACQUISITION
sfrq 125.794
tn C13
at 1.737
np 81258
sw 23391.8
fb not used
bs 8
ss 1
tpwr 53
pw 6.9
d1 0.763
tof -1079.9
nt 1e+06
ct 19784
alock n
gain not used
FLAGS
i n
in n
dp y
hs nn
DISPLAY
sp -762.5
wp 23391.5
vs 9421
sc 0
wc 250
hzmm 93.57
is 500.00
rfl 16914.-
rfp 16151.-
th 2,
ins 1.009
ai ph
JA~I- ,.. 1.
DEC. & VT
dfrq 500.233
dn H1
dpwr 37
dof -500.0
dm y
dmm w
dmf 10000
dseq
dres 1.0
homo n
PROCESSING
lb 0.30
wtfile
proc ft
In 131072
math f
werr
wexp
wbs
wnt
OH
HH , HHH
H 
.'H
H Cbz H Me
-"'=o H
(+)-2-epr-83
120 100 80 60 4 2 ppm
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0 0 PPM160 140
Pulse Sequence: gCOSY
Solvent: Benzene
Ambient temperature
INOVA-500
PULSE SEQUENCE: gCOSY
Relax. delay 1.000 sec
Acq. time 0.241 sec
Width 4247.2 Hz
20 Width 4247.2 Hz
24 repetitions
128 increments
OBSERVE H1, 499.7446814 MHz
DATA PROCESSING
Sq. sine bell 0.120 sec
F1 DATA PROCESSING
Sq. sine bell 0.030 sec
FT size 2048 x 2048
Total time 0 min, -1 sec
OH
H
H 
-H
H CbzH Me
CN 
0 H
(+)-2-ep83
-I
8 7 6 5 4 3 2
F1 (ppm)
A A ........... ..   
Pulse Sequence: HSQC
Solvent: Benzene
Ambient temnera+ure
User:
INOVA-500
PULSE SEQUENCE: HSOC
Relax. delay 1.000 sec
Acq. time 0.099 sec
Width 4406.3 Hz
2D Width 22598.9 Hz
32 repetitions
2 x 256 increments
OBSERVE H1, 499.7446817 MHz
DECOUPLE C13, 125.6721325 MHz
Power 52 dB
on during acquisition
off during delay
GARP-1 modulated
DATA PROCESSING
Gauss apodization 0.107 sec
F1 DATA PROCESSING
Sq. sine bell 0.023 sec
Shifted by -0.023 sec
FT size 2048 x 2048
Total time 6 hr, 52 min, 27 sec
OH
H,H H,
HH
H Cbz''H MeN Gb'HH
0
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Processing parameters
2048
600.4650000 MHz
SINE
2
0.00 Hz
0
1.00
Processing parameters
1024
TPPI
600.4650000 MHz
SINE
2
0.00 Hz
0
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I
H H
H N C
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F2 - Acquisition Parameters
Date._ 20060127
Time 15.57
INSTRUM spec t
PROBHD 5 mm CPTXI Z-G
PULPROG noesyph
TD 1024
SOLVENT D20
NS 24
DS 16
SWH 4807.692 Hz
FIDRES 4.695012 Hz
AQ 0.1066500 sec
RG 128
DW 104.000 usec
DE 6.00 usec
TE 295.0 K
dO 0.00009267 sec
Dl 0.69999999 sec
D8 0.40000001 sec
INO 0.00020800 sec
MCREST 0.00000000 sec
MCWRK 0.69999999 sec
======== CHANNEL fl
NUC1 1H
P1 8.90 usec
PL1 -6.00 dB
SF01 600.4674019 MHz
Fl - Acquisition parameters
NDO 1
TD 480
SF01 600.4674 MHz
FIDRES 10.016026 Hz
SW 8.007 ppm
FnMODE TPPI
, ,
. . . . . . . . . . . . . . . . . . . . . . . . . . . . .
- 08,
08. 0U
PPM
'Ili
8 7 6
IAh
ROESY
4 3 2 1
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H HAH HH 
-H'
H .H* M
HN Cbz' H Me
1+)-2-epi-83
1z - Acquisition Parameters
Date_ 20060127
Time 19.54
INSTRUM spect
PROBHD 5 mm CPTXI Z-G
PULPROG roesyph
TD 1024
SOLVENT C6D6
NS 24
DS 16
SWH 4807.692 Hz
FIDRES 4.695012 Hz
AQ 0.1066500 sec
RG 128
DW 104.000 usec
DE 6.00 usec
TE 295.0 K
dO 0.00009433 sec
D1 0.69999999 sec
d12 0.00002000 sec
INO 0.00020800 sec
MCREST 0.00000000 sec
MCWRK 0.69999999 sec
ppm
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F1 - Acquisition parameters
NDO 1
TD 480
SF01 600.4674 MHz
FIDRES 10.016026 Hz
Sw 8.007 ppm
FnMODE TPPI
F2 -
S1
SF
WDW
SSB
LB
GB
PC
F1 -
SI
MC2
SF
WDW
SSB
LB
GB
Processing parameters
2048
60.0.4650000 MHz
SINE
2
0.00 Hz
0
1.00
Processing parameters
1024
TPPI
600.4650000 MHz
SINE
2
0.00 Hz
0
NUC1NuiP1
P15
PL11
SF01
CHANNEL fl ========
1H
8.90 usec
400000.00 usec
-6.00 dB
15.20 dB
600.4674019 MHz
OH
95 MeS HN CbzH
90 L 0
(+)-2-epi-B 3
3423.46
2 4.51
2927.43
1690.88
48.6
4000.0 3000 2000 1500 1000
cm-1
1094.90
698.16
400.0
SAMPLE
solvent Bent-t..
ACQUISITION
sfrq 499.748
tn HI
at 3.001
np 37494
sw 6247.6
fb not used
bs 4
tpwr 56
Pw 8.9
dl 2.000
tof 361.0
nt 128
ct 72
alock n
gain not used
FLAGS
il n
in n
dp y
hs nn
DISPLAY
sp 
-250.4
wp 6247.5
vs 989
sc 0
wc 250
hzum 24.99
is 33.57
rfl 250.5
rfp 0
th 7
ins 1.000
nm cdc ph
DEC. & VT
dfrq 125
dn
- dpwr
dof
dm
dmm
dmf 1
dseq
dres
homo
PROCESSING
wtfile
proc
fn 13
math
werr
wexp
wbs
wnt
.673
C13
30
0
nnn
w
0000
1.0
n
ft
1072
f
wf t
11. 10 9 8 7 
6 5
4 3 2 1 PPM
(-)-84
 10 9 8 7 6 5
SAM4PLE
solvent Benzent
ACQUISITION
sfrq 125.798
tn C13
at 1.737
np 103480
sw 29795.2
fb not used
bs 8
ss 1
tpwr 53
pw 6.9
dl 0.763
tof 2763.3
nt le+06
ct 17464
alock n
gain not used
FLAGS
i n
in n
dp y
hs nn
DISPLAY
sp -120.9
wp 29794.7
vs 7375
sc 0
wc 250
hzmm 119.18
is 500.00
rfl 16272.8
rfp 16151.4
th 5
ins 1.000
ai ph
DEC. & VT
dfrq 500.233
dn Hi
dpwr 37
dof -500.0
dm y
dmm w
dmf 10000
dseq
dres 1.0
homo n
PROCESSING
lb 0.30
wtfile
proc ft
fn 131072
math f
werr
wexp
wbs
wnt
hi. I... ... .j~. ., .I.L. .. .. ..i I... .IJIdLdJ J,.LJJ
(-)-84
.iImIJ.ILUJJL.dL.i...IIIJLd.....L. ~'~.k..I..tkjduj.IIia,1. J1~ .1,11,. ~.4..L. 4 IaJ Li
... 'A__________ __LA.__.__ J _
ZZO~ 1 200. 180r 10 141010 8,0 0,p
L-1-A AL.11,ji,W1W. 014-JUJIul k-JiLt- aiLl., -a.1 m,.-.jJh6- j i I
220 200 180 160 140 120 100 80 40 20 PPM
3000 2000 1500 1000
cm-1
4000.0 400.0
SAMPLE DEC. & VT
dfrq 125.673
solvent Benzene dn C13
dpwr 30
dof 0
dm nnn
dmm w
ACQUISITION dmf 10000
sfrq 499.748 dseq
tn H1 dres 1.0
at 3.001 homo n
np 37494 PROCESSING
sw 6247.6 wtfile
fb not used proc ft
bs 4 fn 131072
tpwr 56 math f
pw 8.9
dl 2.000 werr
tof 361.1 wexp
nt 128 wbs
ct 56 wnt wft
alock n
gain not used
FLAGS
ii n
in n
dp y
hs nn
DISPLAY
sp -250.3
wp 6247.5
vs 151
sc 0
c wc 250C hzmm 24.99
is 33.57
rfl 250.4
rfp 0
th 7
Ins 1.000
nm cdc ph
OH H
H *H'
H H
H bz HN H
(+)-2-epj-83
11 10 9 8 7 6 5 4 3 2 1 ppm
SAMPLE
solvent Benzene
ACOUISITION
sfrq 125.798
tn C13
at 1.735
np 100196
sw 28880.9
fb not used
bs 8
ss 1
tpwr 53
pw 6.9
dl 0.763
tof 2391.4
nt 100000
ct 16160
alock n
gain not used
FLAGS
il n
in n
dp y
hs nn
DISPLAY
sp -35.7
wp 28880.4
vs 8233
sc 0
wc 250
hzmm 115.52
is 500.00
rfl 16187.5
rfp 16151.4
th 20
ins 1.000
al ph
DEC. & VT
dfrq 500
dn
dpwr
dof -5
dm
dmm
dmf
dseq
dres
homo
PROCESSING
lb
wtfile
proc
fn 13
math
werr
wexp
wbs
wnt
.233
H1
37
00.0
y
w
0000
1.0
n
0.30
ft
1072
f
OH
H H
H
(+)-2-epi-83
. 2 -0 I8 1I 14 120 100 80I.,, IIIIIII .,,IIII - IIIIII IIIIIII
20 ppm
220 20 0 180 16 0 140 120 10 0 80 6 0 40
90.2
89-
88
87-
86-
85
84 _
83_
%T 82
81.
80-
79-
78_
77
76_
74.6-_
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SAMPLE DEC. a VT
. dfrq 125.673
solvent Benzene dn C13
dpwr 30
dof 0
dm nnn
dvm w
HO
H
H
NH
Me O
ACQUISIlium dmf X0000
sfrq 499.748 dseq (-)-galbulimima alkaloid 13 (2)
tn H1 dres 1.0
at 3.001 homo n
np 37494 PROCESSING
sw 6247.6 wtftle
fb not used proc ft
bs 4 fn 131072
tpwr 56 math f
pW 8.9
dl 2.000 werr
tof 361.3 wexp
nt 1024 wbs
ct 76 wnt wft
alocc n
gain not used
FLAGS
11n
in n
dp y
hs nn
DISPLAY
sp -250.3
wp 6247.5
vs 163
S c 0
wc 250
hzmm 24.99
Is 33.57
rfl 250.4
rfp 0
th 7
ins 1.000
rm cdc ph
11 10 9 8 7 6 5 4 3 2 1 ppm
SAMPLE
solvent Benzene
ACQUISITION
sfrq 125.797
tn C13
at 1.735
np 96070
sw 27681.7
fb not used
bs 8
ss 1
tpwr 53
pw 6.9
dl 0.763
tof 1796.2
nt 120000
ct 32744
alock n
gain not used
FLAGS
il n
in n
dp y
hs nn
DISPLAY
sp -30.6
wp 27681.2
vs 8161
sc 0
wc 250
hzmm 110.73
is 500.00
rfl 16182.4
rfp 16151.4
th 11
ins 1.000
al ph
DEC. & VT
dfrq 5
dn
dpwr
dof
dm
dmm
dmf
dseq
dres
homo
PROCESSI
lb
wtfile
proc
fn
math
werr
wexp
wbs
wnt
00
-5
.233
H1
37
00.0
10000
1.0
n
NG
0.30
ft
131072
f
(-)-galbulimima alkaloid 13 (2)
I I J -,- FA.4~.1 "7,i
20 18 160 14 I2 10 80 60 IIII
40 20 ppm140 120 10 0 80 6 0
-- I .. .- - I - .3 . - - I -
20 0 180 16 0
Pulse Sequence: gCOSY
PULSE SEQUENCE: gCOSY
Relax. delay 1.000 sec
Acq. time 0.213 sec
Width 4801.9 Hz
2D Width 4801.9 Hz
16 repetitions
128 increments
OBSERVE H1, 499.7446819 MHz
DATA PROCESSING
Sq. sine bell 0.107 sec
F1 DATA PROCESSING
Sq. sine bell 0.027 sec
FT size 2048 x 2048
Total time 0 min, -1 sec
(-)-galbulimima alkaloid 13 (2)
-4
j
F2 -
(ppm)
1. 0-
1 . 5-
2.0-
2.5-
3.0-
3.5
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S
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Pulse Sequence; HSQC
Solvent: Benzene
Ambient temperature
sqPer: 1-14-87
PULSE SEQUENCE: HSQC
Relax. delay 1.000 sec
Acq. time 0.100 sec
Width 4542.4 Hz
2D Width 26490.1 Hz
36 repetitions
2 x 300 Increments
OBSERVE H1, 499.7446838 MHz
DECOUPLE C13, 125.6740716 MHz
Power 52 dB
on during acquisition
off during delay
GARP-1 modulated
DATA PROCESSING
Gauss apodization 0.104 sec
F1 DATA PROCESSING
Sq. sine bell 0.019 sec
Shifted by -0.019 sec
FT size 2048 x 2048
Total time 9 hr, 2 min, 7 sec
(-)-galbulimima alkaloid 13 (2)
120 110 100 90 80 70 60 50 40 30 20 10
F1 (ppm)
1 0 ppm
Me
20
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(-)-galbulimima alkaloid 13 (2)
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1646.10
3000 2000
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1500 1000 400.0
SAMPLE
solvent Benzene
ACQUISITION
sfrq 499.748
tn H1
at 3.001
np 37494
sw 6247.6
fb not used
bs 4
tpwr 56
pw 8.9
d1 2.000
tof 360.8
nt 1024
ct 112
alock n
gain not used
FLAGS
11 n
in n
dp y
hs nn
DISPLAY
sp -250.3
wp 6247.5
vs 141
sc 0
wc 250
hzmm 24.99
is 33.57
rf1 250.4
rfp 0
th 7
ins 3.000
nm cdc ph
DEC. & VT
dfrq 125
dn
dpwr
dof
JM
Jm
dmf
dseq
dres
homo
PROCESSING
wtfile
proc
fn 13
math
werr
wexp
wbs
wnt
.673
C13
30
0
nnn
w
0000 (+)-2-pi-16-oxohimga|ine
(2-epi-21)
1072
f
11 10 9 
3 2 1 ppmS I I 5
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I
SAMPLE DEC. & VT
dfrq 500.233
solvent Benzene dn H1
dpwr 37
dof -500.0
-dm y
dmm w
ACQUISITION dmf 10000
sfrq 125.797 dseq
tn C13 dres 1.0
at 1.736 homo n
np 97624 PROCESSING
sw 28119.5 lb 0.30
fb not used wtfile
bs 8 proc ft
ss 1 fn 131072
tpwr 53 math f
pw 6.9
dl 0.763 werr
tof 2069.0 wexp
nt le+06 wbs
ct 60256 wnt
alock n
gain not used
FLAGS
i n
in n
dp y
hs nn
DISPLAY
sp 22.6
wp 28119.1
vs 10530
sc 0
wc 250
hzmm 112.48
is 500.00
rfl 16129.2
rfp 16151.4
th 6
ins 1.000
ai ph
OH
H
-H
Ne
H MHO H
(+)-2-epi-16-oXOhimgaline
(2-epi-21)
220 200 180 160 140
1-1-blih-11- '116
w NNW wmo
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Pulse Sequence: gCOSY
Solvent: Benzene
Ambient temperature
PULSE SEQUENCE: gCOSY
Relax. delay 1.000 sec
Acq. time 0.227 sec
Width 4507.6 Hz
20 Width 4507.6 Hz
64 repetitions
128 increments
OBSERVE H1, 499.7446840 MHz
DATA PROCESSING
Sq. sine bell 0.113 sec
F1 DATA PROCESSING
Sq. sine bell 0.028 sec
FT size 2048 x 2048
Total time 0 min, -1 sec
(+)-2-epi-1 6-oxohimgaline
(2-epi-21)
F2
(ppm]
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Pulse Sequence: HSQC
Solvent: Benzene
Ambient temperature
PULSE SEQUENCE: HSOC
Relax. delay 1.000 sec
Acq. time 0.227 sec
Width 4507.6 Hz
20 Width 27662.5 Hz
32 repetitions
2 x 256 increments
OBSERVE H1, 499.7446840 MHz
DECOUPLE C13, 125.6746698 MHz
Power 52 dB
on during acquisition
off during delay
GARP-1 modulated
DATA PROCESSING
Gauss apodization 0.105 sec
F1 DATA PROCESSING
Sq. sine bell 0.019 sec
Shifted by -0.019 sec
FT size 2048 x 2048
Total time 7 hr, 27 min, 44 sec
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F2 - Acquisition Parameters
Date_ 20090221
Time 17.40
INSTRUM spect
PROBHD 5 nm CPTXI 1H-
PULPROG zg30
TD 65536
SOLVENT C6D6
NS 26
DS 2
SWH 12376.237 Hz
FIDRES 0.188846 Hz
AQ 2.6477449 sec
RG 57
Dw 40.400 usec
DE 6.00 usec
TE 305.0 K
D1 1.00000000 sec
TDO 1
-- ------ CHANNEL fl ======
NUCl 1H
P1 11.00 usec
PL1 4.00 dB
SF01 600.1337060 MHz
F2 - Processing parameters
SI 65536
SF 600.1300681 MHz
WDW EM
SSB 0
LB 0.30 Hz
GB 0
PC 1.00
(-)-Himbadine (4)
94 3 2 1 ppm11 10 9
.I .I I . I I . . . I I . I
F2 - Acquisition Parameters
Date_ 20070421
Time 18.37
INSTRUM spect
PROBHD 5 mm ONP 1H/13
PULPROG zgpg30
TD 65536
SOLVENT C6D6
NS 37286
DS 2
SWH 20964.361 Hz
FIDRES 0.319891 Hz
AQ 1.5630836 sec
RG 2048
DW 23.850 usec
DE 6.00 usec
TE 293.2 K
Dl 2.00000000 sec
dl 0.03000000 sec
DELTA 1.89999998 sec
TOO 1
- CHANNEL fl=
NUC1 13C
P1 9.38 usec
PL1 0.00 dB
SFO1 100.6241820 MHz
======== CHANNEL f2 =======
CPDPRG2 waltz16
NUC2 1H
PCPD2 90.00 usec
PL2 0.00 dB
PL12 16.10 dB
PL13 19.00 dB
SF02 400.1316005 MHz
F2 - Processing parameters
SI 65536
SF 100.6127122 MHz
WDW EM
SSB 0
LB 1.00 Hz
GB 0
PC 1.40
(-)-Himbadine (4)
200 190 180 170 160 150 140 130 120 110 100 90
I I
70 60
50 I I
50 40 30 ppm
%wo^w*% Ml a ft R. -__ I -Iowa - __ 1 11 - .1 -0 - - I I - 11 -1 IM.- U I L-4111 L
.I1
80
F2 - Acquisition Parameters
Date_ 20090220
Time 18.43
INSTRUM spect
PROBHD 5 rsu CPTXI 1H-
PULPROG zg30
TO 65536
SOLVENT CDC13
NS 63
DS 2
SWH 12376.237 Hz
FIDRES 0.188846 Hz
AQ 2.6477044 sec
RG 40.3
DW 40 .400 usec
DE 6.00 usec
TE 305.0 K
Dl 1.00000000 sec
TOO 1
======== CHANNEL fl ========
NUC1 1H
P1 11.00 usec
PL1 4.00 dB
SF01 600.1337060 MHz
F2 - Processing parameters
SI 65536
SF 600.1300277 MHz
WDW EM
SSB 0
LB 0.30 Hz
GB 0
PC 1.00
(-)-Himbadine (4)
3 2 ppm
89.4. N.M
88. Me 0
86_ (-)-Himbadine (4) 803.98
84
1 42. 2 732.88
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ACQUI
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sw
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tof
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alock
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SPLAY
-250.4
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0
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33.57
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PROCESSING
wtfile
proc
fn 26
math
werr
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w
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DEC. & VT
dfrq 500.233
solvent CDC13 dn H1
dpwr 37
dof -500.0
dm y
dmm w
ACQUISITION dmf 10000
sfrq 125.796 dseq
tn C13 dres 1.0
at 1.735 homo n
np 87286 PROCESSING
sw 25157.2 lb 0.30
fb not used wtfile
bs 4 proc ft
ss 1 fn 131072
tpwr 53 math f
pw 6.9
dl 0.763 werr
tof 630.8 wexp
nt le+06 wbs
ct 20704 wnt
alock n
gain not used
FLAGS
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rf 1
rfp
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ai
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Appendix B.
Spectra for Chapter II
226
Current Data Parameters
NAME
EXPNO
PROCNO
F2 - Acquisition Parampt-s
Date_
Time
INSTRUM spect
PROBHD 5 nun QNP 1H/13
PULPROG zg30
TD 65536
SOLVENT CDC13
NS 16
DS 2
SWH 8278.146 Hz
FIDRES 0.126314 Hz
AQ 3.9584243 sec
RG 203.2
DW 60.400 usec
DE 6.00 usec
TE 293.2 K
D1 1.00000000 sec
TDO 1
NUC
P1
PLI
SFO1
F2 -
SI
SF
WDW
SSB
LB
GB
PC
CHANNEL fl ========
1H
14.00 usec
0.00 dB
400.1324710 MHz
Processing parameters
65536
400.1300178 MHz
no
0
0.00 Hz
0
1.00
8 7 6 3 2 1 ppm
OH
(-)-S2 ONHPh
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Current Data Parameters
NAME
EXPNO
PROCNO
F2 - Acquisition Paranptors
Date_.
Time
INSTRUM spect
PROBHD 5 min QNP 1H/13
PULPROG zgpg30
TD 65536
SOLVENT CDC13
NS 128
DS 2
SWH 23980.814 Hz
FIDRES 0.365918 Hz
AQ 1.3664756 sec
RG 2580.3
DW 20.850 usec
DE 6.00 usec
TE - 294.2 K
D1 2.00000000 sec
dll 0.03000000 sec
DELTA 1.89999998 sec
TDO 1
======== CHANNEL fl ========
NUCI 13C
P1 9.38 usec
PL1 0.00 dB
SFO1 100.6228298 MHz
= CHANNEL f2
CPDPRG2 waltz16
NUC2 1H
PCPD2 90.00 usec
Oo PL2 0.00 dB
PL12 16.10 dB
PL13 19.00 dB
SF02 400.1316005 MHz
F2 - Processing parameters
SI 65536
SF 100.6127509 MHz
WDW no
SSB 0
LB 0.00 Hz
GB 0
PC 1.40
OH
(-)-S2 ONHPh
I I
I 1 1
140 120 100 80 60
I I 1. .11I .
I I
40 20 0 ppm
OH
(-)-S2 ONHPh
Area Percent Report
Sorted By : Signal
Multiplier 1.0000
Dilution : 1.0000
Use Multiplier & Dilution Factor with ISTDs
Signal 1: MWD1 E, Sig=215,16 Ref=360,100
Peak RetTime Type Width Area Height Area
# [min] [min] [mAU*s] [mAU] %-
---- I------- ------- I-------- I--------I------I
1 18.029 MM 1.3433 4183.07324 51.89904 99.4174
2 22.153 MM 1.0577 24.51239 3.86262e-1 0.5826
Totals : 4207.58564 52.28530
Results obtained with enhanced integrator!
Summed Peaks Report
Signal 1: MWD1 E, Sig=215,16 Ref=360,100
229
OH
(-)-S2 ONHPh
Area Percent Report
Sorted By Signal
Multiplier 1.0000
Dilution : 1.0000
Use Multiplier & Dilution Factor with ISTDs
Signal 1: MWD1 E, Sig=215,16 Ref=360,100
Peak RetTime Type Width Area Height Area
# [min] [min] [mAU*s] [mAU] %
---- I------- ------- I-------- I-------I------I
1 18.118 MM 0.5225 65.04629 2.07490 0.5432
2 22.017 MM 0.9094 1.19103e4 218.27008 99.4568
Totals : 1.19753e4 220.34498
Results obtained with enhanced integrator!
Summed Peaks Report
Signal 1: MWD1 E, Sig=215,16 Ref=360,100
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1500
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solvent CDC13
ACQUISITION
sfrq 500.435
tn i1
at 4.999
np 120102
sw 12012.0
fb not used
bs 2
tpwr 56
pw 8.0
dl 0.100
tof 3003.2
nt 16
ct 10
alock n
gain not used
FLAGS
il n
in n
dp y
hs nn
DISPLAY
sp -250.2
wp 6255.3
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is
rfl
rfp
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PROCESSING
wtfile
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Current Data Parameters
NAME
EXPNO
PROCNO
F2 - Acquisition Parameters
Date_
Time
INSTRUM spect
PROBHD 5 mm QNP 1H/13
PULPROG zgpg30
TD 65536
SOLVENT CDC13
NS 64
DS 4
SWH 23980.814 Hz
FIDRES 0.365918 Hz
AQ 1.3664756 sec
RG 1824.6
DW 20.850 usec
DE 6.00 usec
TE 292.2 K
D1 2.00000000 sec
dl 0.03000000 sec
DELTA 1.89999998 sec
TDO 1
======== CHANNEL fl --------
NUCI 13C
Pl 9.38 usec
PL1 0.00 dB
SFO1 100.6228298 MHz
CPDPRG2
NUC2
PCPD2
PL2
PL12
PL13
SF02
F2 -
SI
SF
WDW
SSB
LB
GB
PC
CHANNEL f2 ========
waltz16
1H
90.00 usec
0.00 dB
16.10 dB
19.00 dB
400.1316005 MHz
Processing parameters
32768
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Current Data Parameters
NAME
EXPNO
PROCNO
F2 - Acquisition Parameters
Date_
Time
INSTRUM spect
PROBHD 5 mm CPTXI 1H-
PULPROG zg30
TD 65536
SOLVENT CDC13
NS 16
DS 2
SWH 12376.237 Hz
FIDRES 0.188846 Hz
AQ 2.6477044 sec
RG 4
DW 40.400 usec
DE 6.00 usec
TE 293.0 K
D1 1.00000000 sec
TDO 1 -
NUC1
Pl
PL1
SFO1
F2 -
SI
SF
t'- WDW
w SSB
LB
GB
PC
OTBS
(+)-25 OH
CHANNEL fl ========
1H
11.00 usec
4.00 dB
600.1337060 14Hz
Processing parameters
65536
600.1300281 MHz
EM
0
0.30 Hz
0
1.00
- -I ....... ' I''  .. A .I....................
1 10 9 8 7 6 4 3 2 1 ppm
I..I I . . I . . I I . . I . I . I . T I I I I I I . I I I I I I I I . . I I . I . . I . I I . . I I . I . . . . . . I . I I I . . . . . . . . . I . . . . . . . . . I . . . . . . . I I .
Current Data Parameters
NAME
EXPNO
PROCNO
F2 - Acquisition Parameters
Date_
Time
INSTRUM spect
PROBHD 5 mm BBO BB-1H
PULPROG zgpg30
TD 65536
SOLVENT CDC13
NS 615
DS 2
SWH 23980.814 Hz
FIDRES 0.365918 Hz
AQ 1.3664756 sec
RG 18390.4
DW 20.850 usec
DE 6.00 usec
TE 294.2 K
D1 2.00000000 sec
dll 0.03000000 sec
DELTA 1.89999998 sec
TDO 1
CHANNEL fl
NUCl 13C
P1 8.75 usec
PL1 -3.00 dB
SFOl 100.6228298 MHz
======== CHANNEL f2 ========
CPDPRG2 waltzl6
NUC2 1H
PCPD2 90.00 usec
PL2 -1.00 dB
PL12 14.52 dB
PL13 18.00 dB
SF02 400.1316005 MHz
F2 - Processing parameters
SI 65536
SF 100.6127478 MHz
WDW no
SSB 0
LB 0.00 Hz
GB 0
PC 1.40
200 180 160
OTBS
(+)-25 OH
140 120 100 80 60
-L.Jk--# --- I I
I I
40 20 0 ppm
OTBS
(+)-25 OH
,\
3583.69
3446.43
3600 3200 1600 1400 1200.0
7
7." .
81.8..
73 -.
72 -
71
70-
69-
68
67-
66-
65.4
3077.91
1641.64
~2 5 .52
1257.24
1403.37
1472.39
4000.0 2800 2400 2000
cm-1
1800
1361.74
I
Current Data Parameters
NAME
EXPNO
PROCNO
F2 - Acquisition Parameters
Date_
Time
INSTRUM spect
PROBHD 5 mm CPTXI 1H-
PULPROG zg30
TD 65536
SOLVENT CDC13
NS 13
DS 2
SWH 12376.237 Hz
FIDRES 0.188846 Hz
AQ 2.6477044 sec
RG 5.7
DW 40.400 use
DE 6.00 use
TE 304.0 K
Dl 1.00000000 sec
TD0 1
======== CH
NUC1
P1
PLI
SFO1
F2 -
SI
SF
WDW
SSB
LB
GB
PC
OTBS
(-)-S3 OMe
NNEL f l ========
1H
11.00 usec
4.00 dB
600.1337060 MHz
Processing parameters
65536
600.1300278 ]MHz
EM
0
0.30 Hz
0
1.00
IA L -lii11..J I -I .......  
11 10. 9 ppm
c
c
8 
7
Current Data Parameters
NAME
EXPNO
PROCNO
F2 - Acquisition Parameters
Date_
Time
INSTRUM spect
PROBHD 5 nun QNP 1H/13
PULPROG zgpg30
TD 65536
SOLVENT CDC13
NS 30
DS 4
SWH 23980.814 Hz
FIDRES 0.365918 Hz
AQ 1.3664756 sec
RG 2580.3
DW 20.850 usec
DE 6.00 usec
TE 291.2 K
D1 2.00000000 sec
dll 0.03000000 sec
DELTA 1.89999998 sec
TDO 1
======== CHANNEL fl ========
NUCl 13C
P1 9.38 usec
PL1 0.00 dB
SF01 100.6228298 MHz
CPDPRG2
NUC2
PCPD2
PL2
PL12
PL13
SF02
F2 -
SI
SF
WDW
SSB
LB
GB
PC
OTBS
(-)-S3 OMe
CHANNEL f2 ========
waltz16
1H
90.00 usec
0.00 dB
16.10 dB
19.00 dB
400.1316005 MHz
Processing parameters
32768
100.6127499 MHz
EM
0
1.00 Hz
0
1.00
140 120 100 80 60
I III | I | | | || ,
200 180 160 40 20 0 ppm
90.
851
80-
75.
70
65
60
551-
50-
45_
40.
35
3853.72
3744.68
3078.24
OTBS:
(-)-S3 OMe
2858.71
2929.69
1700.07 1540.2 \
1684.2 1 506.+ 321.05 -
2360.87 1558.95
;18
1641.91 14 2.25
1388.49
1361.54
1463.28
1472.46
1256.20
7.51 j939.111 \
1005.79
. 910.34
1107.07
25
23.2 - - -- - -
4000.0 3600 3200 2800 2400 2000 1800 1600 1400 1200 1000 800 600 400.0
cm-1
95.8 
-Il!r
30 ..
667 .63
81 t.7
776.24
37.36-8
Current Data Parameters
NAME
EXPNO
PROCNO
F2 - Acquisition Parameters.
Date_.
Time
INSTRUM spect
PROBHD 5 mm QNP 1H/13
PULPROG zg30
TD 65536
SOLVENT CDC13
NS 13
DS 2
SWH 8278.146 Hz
FIDRES 0.126314 Hz
AQ 3.9584243 sec
RG 45.3
DW 60.400 usec
DE 6.00 usec
TE 291.2 K
Dl 1.00000000 sec
TDO 1
NUC
PLi
PL1
SFOl
F2 -
SI
SF
WDW
SSB
LB
GB
PC
OH
(+)-26 OMe
CHANNEL fl ========
1H
14.00 usec
0.00 dB
400.1324710 MHz
Processing parameters
65536
400.1300175 MHz
EM
0
0.30 Hz
0
1.00
ll............ - - IP A d A - 1 11 IIJI ......... 'Ii k
11 10 9 8 7 3 
2 1 ppm
3 21PPM8 711 10 9
Current Data Parameters
NAME
EXPNO
PROCNO
F2 - Acquisition Parameters-
Date_
Time
INSTRUM
PROBHD 5 nm QNP 1H/13
PULPROG zgpg30
TD 65536
SOLVENT CDC13
NS 21
DS 4
SWH 23980.814 Hz
FIDRES 0.365918 Hz
AQ 1.3664756 sec
RG 1824.6
DW 20.850 usec
DE 6.00 usec
TE 291.2 K
Dl 2.00000000 sec
dl 0.03000000 sec
DELTA 1.89999998 sec
TDO 1
NUCl
Pl
PL1
SFO1
CPDPRG2
NUC2
PCPD2
PL2
PL12
PL13
SF02
F2 - Pro
SI
SF
WDW
SSB
LB
GB
PC
OH
(+)-26 OMe
CHANNEL fl ========
13C
9.38 usec
0.00 dB
100.6228298 MHz
CHANNEL f2 ========
waltz16
1H
90.00 usec
0.00 dB
16.10 dB
19.00 dB
400.1316005 MHz
cessing parameters
32768
100.6127571 MHz
EM
0
1.00 Hz
0
1.00
200 180 160 .140 120 100 80 60 40 20 0 ppm
0001'7 009 008 0001 ON 001O71 0091 0081 000Z 0017Z 008Z 0 OOZE ONE 0O00t, I_ --- -
--I.- .---1 .-I-I-- --.-L ---- -I---- ---L --I -' --h611i
:UE601
I FIt'91
88'E611 g0fE ll L * I 9
~ L~8I 110000
\ -N / i 1 '8k 9 S i/Al
Fit4lZ
'9io9EZ
evOO~(
HO
~8.L99
£t't~O8
W 016
OE96
-09
Z9
-99
..8 9
-99
OL
98
8L
-06
t71' I Zt'f
89E~8~
1%
-CF/A
[6L 9L6Z
59LOE
DEC. & VT
dfrq 125.672
solvent CDC13 dn C13
dpwr 30
dof 0
dm nnn
ACQUISITION
sfrq 499.746
tn Hi
at 3.001
np 63050
sw 10504.2
fb not used
bs 8
tpwr 56
pw 8.6
dl 2.000
tof 1519.5
nt 16
ct 16
alock n
gain not used
FLAGS
SPLA
dmm
dmf 1
dseq
dres
homo
PROCESSING
wtfile
proc
fn 26
math
werr
wexp
wbs
wnt
Br Br
(-)-27 OMe
0000
1.0
n
ft
2144
f
wft
y
nn
Y
-249.9
6246.7
10
0
250
24.99
33.57
4865.6
3618.1
7
100.000
Iii ...1.....
11 10 9 7 5 3 2 
1 ppm
11
in
dp
hs
DI
sp
wp
vs
sc
wc
hzmm
is
rf 1
rfp
th
ins
al cdc
 9 7 6 3 2 1 PPM
date
solvent COC13
ACQUISITION
sfrq 125.672
tn C13
at 2.000
np 125588
sw 31397.2
fb not used
bs 8
tpwr 58
pw 6.7
d1 3.000
tof 0
nt 256
ct 160
alock n
gain not used
FLAGS
11 n
in n
dp y
hs nn
DISPLAY
sp -1329.0
wp 27683.3
vs 172
sc 0
wc 250
hzmm 110.73
is 500.00
ril 13468.0
rfp 9704.7
th 68
ins 100.000
al cdc ph
DEC. & VT
dfrq 499
dn
dpwr
dof
dm
dmm
dmf 1
dseq
dres
homo
PROCESSING
lb
wtfile
proc
fn 13
math
werr
wexp
wbs
wnt
Br Br
(-)-27 OMe
.744
H134
0
yyy
w
0000
1.0
n
1.00
ft
1072
f
120 100 80 60 40
ONO I , I- 
" A -1-i l II 1gl.4 gi p i~i III I i
20 0 PPM200 180 160 140
Vo'1
96.3
95
90
6.61
2979.7
822.22
2930.75
2340.9
2360.6
85 -
3853.72!
80- 3744.71:
3649.36 307
75..
70 .
65.
60
55
50
45
39.2
4000.0 3600 3200
Br Br
(-)-27 OMe
3 -
1343.24 1200.93
1734.06s 106.7
1700. 1 s1558.p5
3 1684.2 1540.45
4
1640.77 1458.43
1616.73
r4
993.2
68
843.49
2 I
912.13
782.33
- -_______ - --.
2800 2400 2000 1800 1600 1400 1200 1000 800
cm-I
667.86
-r - 400.0
600 400.0
1104.
DEC. & VT
dfrq 125.673
solvent CDC13 dn C13
dpwr 30
dof 0
ACQUISITION
sfrq 499.749
tn H1
at 3.001
np 63050
sw 10504.2
fb not used
bs 2
tpwr 56
pw 8.9
dl 2.000
tof 1519.5
nt 16
ct 8
alock n
gain not used
FLAGS
i n
in n
dp y
hs nn
DISPLAY
sp 
-249.9
wp 6246.8
vs 141
sc 0
wc 250
hzmm 24.99
is 33.57
rfl 4869.5
rfp 3618.2
th 7
ins 100.000
nm cdc ph
dm
dmm
dmf 1
dseq
dres
homo
PROCESSING
wtfile
proc
fn 13
math
nnn
w,
0000
TBSO
Me COMe
29 Br
ft
1072
f
werr
wexp
wbs
wnt wft
I1 1 0 I 8- , 6 5 4 I 2 1 p p m I . I I I - , . . I I
11 10 9 3P
Current Data Parameters
NAME
EXPNO
PROCNO
F2 - Acquisition Parameters
Date_
Time
INSTRUM spect
PROBHD 5 mm BBO BB-1H
PULPROG zgpg30
TD 65536
SOLVENT CDC13
NS 1024
DS 2
SWH 23980.814 Hz
FIDRES 0.365918 Hz
AQ 1.3664756 sec
RG 8192
DW 20.850 usec
DE 6.00 usec
TE 293.2 K
D1 2.00000000 sec
dl 0.03000000 sec
DELTA 1.89999998 sec
TDO 1
NUC1
P1
PL1
SFO1
CPDP
NUC2
PCPD2
PL2
PL12
PL13
SF02
F2 -
SI
SF
WDW
SSB
LB
GB
PC
TBSO
Me ObMe
29 Br
CHANNEL fl ========
13C
8.75 usec
-3.00 dB
100.6228298 MHz
CHANNEL f2 ========
RG2 waltz16
1H
90.00 usec
-1.00 dB
14.52 dB
18.00 dB
400.1316005 MHz
Processing parameters
65536
100.6127514 MHz
no
0
0.00 Hz
0
1.40
200 180 160 140 120 100 80 60 
0 ppm
A-1.1
200 160 140 120180 100 80 60 0 ppm
96-
94
92-
90_
88-
86
84
82
80.
78.4
76
74
72
70.
68
~1
,.1
8341.80
1367.83 834.80
1470.09 1253.171147.817I 775.76
2929.15
66.3
4500.0 4000 3000 2000 1500 1000 500 370.0
cm-I
98.1,
OU{
TBSO
Me / OMe
29 Br
Current Data Parameters
NAME
EXPNO
PROCNO TBSO
F2 - Acquisition Parameters
Date Me OMe
Time
INSTRUM spect N
PROBHD 5 rmn QNP 1H/13 S5PULPROG zg30
TD 65536
SOLVENT CDC13
NS 16
DS 2
SWH 8278.146 Hz
FIDRES 0.126314 Hz
AQ 3.9584243 sec
RG 101.6
DW 60.400 usec
DE 6.00 usec
TE 293.2 K
D1 1.00000000 sec
TDO 1
======== CHANNEL fl ========
NUCl 1H
P1 14.00 usec
PL1 0.00 dB
SF01 400.1324710 MHz
F2 - Processing parameters
SI 65536
SF 400.1300173 MSfz
WDW no
SSB 0
LB 0.00 Hz
GB 0
PC 1.00
11 10 9 8 7 6 5 4 3 2 1 ppm
Current Data Parameters
NAM4E
EXPNO
PROCNO
F2 - Acquisition Parameters
Date.
Time
INSTRUM
PROBHD 5 mm QNP 1H/13
PULPROG zgpg30
TD 65536
SOLVENT CDC13
NS 512
DS 2
SWH 23980.814 Hz
FIDRES 0.365918 Hz
AQ 1.3664756 sec
RG 8192
DW 20.850 usec
DE 6.00 usec
TE 293.2 K
D1 2.00000000 sec
dl 0.03000000 sec
DELTA 1.89999998 sec
TDO 1
======== CHANNEL fl ========
NUC1 13C
P1 9.38 usec
PL1 0.00 dB
SFO1 100.6228298 MH z
======== CHANNEL f2 ========
CPDPRG2 waltz16
NUC2 1H
PCPD2 90.00 usec
PL2 0.00 dB
PL12 16.10 dB
PL13 19.00 dB
SF02 400.1316005 MHz
F2 - Processing parameters
SI 65536
SF 100.6127511 MHz
WDW no
SSB 0
LB 0.00 Hz
GB 0
PC 1.40
TBSO
OMeMeN
N
S5 9
200 18 - 1 20 10 80 60 4 op
1.11I IIII I 1 -1
200 180 100 80 60 40160 140 120 PPM
1558.99
1653 61
1640.56 14.6
146B. 16
1472.29
1395.62
S5
O
201.421 i
0o23.71
5 11 50.7 9961.2t
1252.21 966.29
909.20
8167.2
t776.78
\ i
57.49
2954 1
2929.33
43.0 - -- , ---- ----- I-- - -- ,
4000.0 3600 3200 2800 2400 2000 1800 1600 1400 1200 1000 800 600 400.0
cm-I
2360 96
2341.10
834.661093.52
95.6
94]
92 ]
*gT
56
54..
52.
50.
48_
46-
1760.73
md,
Current Data Parameters
NAME
EXPNO
PROCNO
F2 - Acquisition Parameters
Date_
Time
INSTRUM spect
PROBHD 5 nun CPTXI 1H-
PULPROG zg30
TD 65536
SOLVENT CDC13
NS 11
DS 2
SWH 12376.237 Hz
FIDRES 0.188846 Hz
AQ 2.6477044 sec
RG 12.7
DW 40.400 usec
DE 6.00 usec
TE 304.0 K
Dl 1.00000000 sec
TDO 1
NUCl
PLi
PL1
SFOl
P2 -
SI
SF
t'Q WDW
SSB
LB
GB
PC
0
Me We
N(-)-S7-
0P
CHANNEL fl ========
1H
11.00 usec
4.00 dB
600.1337060 MHz
Processing parameters
65536
600.1300277 MHz
EM
0
0.30 Hz
0
1.00
II lilA III A ill
I 5 4
10 3 24 p
. . . . . . . I .I ..I ... . I . . I . . I I - I . I . I . I . I . I . . . . . . . . . . . I I , . . . , I . . i I . r--lI - I I I I I I I I I *
10 3  1PPM
Current Data Parameters
NAME
EXPNO
PROCNO
F2 - Acquisition Parameters
Date_
Time
INSTRUM spect
PROBHD 5 mm QNP 1H/13
PULPROG zgpg30
TD 65536
SOLVENT CDC13
NS 85
DS 4
SWH 23980.814 Hz
FIDRES 0.365918 Hz
AQ 1.3664756 sec
RG 1824.6
DW 20.850 usec
DE 6.00 usec
TE 291.2 K
Dl 2.00000000 sec
dll 0.03000000 sec
DELTA 1.89999998 sec
TDO 1
======== CHANNEL fl ========
NUC1 13C
P1 9.38 usec
PLi 0.00 dE
SFOl 100.6228298 MHz
======== CHANNEL f2 ========
CPDPRG2 waltzl6
NUC2 1H
PCPD2 90.00 usec
PL2 0.00 dB
PL12 16.10 dB
PL13 19.00 dB
SF02 400.1316005 MHz
F2 - Processing parameters
SI 32768
SF 100.6127562 MHz
WDW EM
SSB 0
LB 1.00 Hz
GB 0
PC 1.00
0
\ o~MeMe
N(-)-S7 
A0
- .--.--. 
.
200 180 160 140 120 
40 20 0 ppm
100 80 60180 160200 140 120 40 - 20 0 ppm
92_
90
88
86-
84-
82
80-
78-
76-
8
11/7.77 1031.33 911.37
202.69 977.09
36054
1100.99
.19 1256.41
1400.73
34.08
778.99
74
72
70
68-
T 66-
64
62.
60_
58.
56.
54-
52
50
48-
46-
44-
42
40.4 ..
4000.0 3600 3200 2800 2400 2000 1800 1600 1400 1200 1000 800 600 400.0
cm-I
(-)-S7
3583.84
2976. 6
2931.84
94.1 ,
69217
1603
1672.58
1756.45
Current Data Parameters
NAME
EXPNO
PROCNO
F2 - Acquisition Parameters
Date
Time
INSTRUM spect
PROBHD 5 mm CPTXI 1H-
PULPROG zg30
TD 65536
SOLVENT CDC13
NS 15
DS 2
SWH 12376.237 Hz
FIDRES 0.188846 Hz
AQ 2.6477044 sec
RG 6.3
DW 40.400 usec
DE 6.00 usec
TE 293.0 K
D1 1.00000000 sec
TDO 1
======== CHANNEL f1 ========
NUCI 1H
Pl 11.00 usec
PL1 4.00 dB
SFO1 600.1337060 MHz
F2 -
SI
SF
WDW
SSB
LB
GB
PC
TBSO
OMe
(-)-30
0
Processing parameters
65536
600.1300677 MHz
EM
0
0.30 Hz
0
1.40
ii II I III II I AAA .k.
111 7 6 
5 4 3 2 1 ppmI -
11 A I 41 11
7 6 5 4 3 2 1PPM
Current Data Parameters
NAME
EXPNO
PROCNO
F2 - Acquisition Parameters
Date-
Time
INSTRUM spect
PROBHD 5 mm QNP 1H/13
PULPROG zgpg30
TD 65536
SOLVENT CDC13
NS 40
DS 4
SWH 23980.814 Hz
FIDRES 0.365918 Hz
AQ 1.3664756 sec
RG 1625.5
DW 20.850 usec
DE 6.00 usec
TE 291.2 K
Dl 2.00000000 sec
dll 0.03000000 sec
DELTA 1.89999998 sec
TDO 1
NUC1
P1
PL1
SFO1
CPDP
NUC2
PCPD2
PL2
PL12
PL13
SF02
F2 -
SI
SF
WDW
SSB
LB
GB
PC
TBSO
OMe
(-)-30N
0.1
CHANNEL fl--------
13C
9.38 usec
0.00 dB
100.6228298 MHz
CHANNEL f2 ========
RG2 waltz16
1H
90.00 usec
0.00 dB
16.10 dB
19.00 dB
400.1316005 MHz
Processing parameters-
32768
100.6127104 MHz
EM
0
1.00 Hz
0
1.00
I III
I I I I
200 180 160 140 120 100 80 60 
40 20 0 ppm
160200 180 140 120 100 80 60 40 20 0 ppm
117.2.
110-
TBSO
100 OMe
95 (-)-30
90 _
85_
80--
70 - 1621.6 1463.31 0 0.60 59.93 1
65 1584.38 910.10
345. 8L I
%T 60 . 2 9.01 1395.45 1 1102.46 8 8 9
11254.1718.9
00 552 1317.82 1028.17 840.19
2930.96
50_
45-
40
35_
30
1760.01
25.
20.
15.
10
6.8.
4000.0 3000 2000 1500 1000 500 400.0
cm-1
DEC. & VT
date dfrq 125
solvent Benzene dn
dpwr
dof
dm
dum
ACQUISITION dmf
sfrq 500.435 dseq
tn HI dres
at 4.999 homo,
np 120102 PROCESSING
sw 12012.0 wtfile
fb not used proc
bs 8 fin 26:
tpwr 56 math
pw 8.0
dl 0.100 werr
tof 3003.2 wexp
nt 16 wbs
ct 16 wnt
alock n
gain not used
FLAGS
in n
dp y
hs nn
DISPLAY
sp -250.2
wp 6255.3
vs 14
sc 0
wc 250
hzmm 25.02
is 33.57
rfl 4065.7
rfp 3583.1
th 7
ins 100.000
ai cdc ph
.845
C13
30
OHC
TBSO
ONg
N
n
ft
2144
f
wf t
11 1bi ', . II 11 . .1 L II IA .-~ , k
11 10 9 8 7 6 5 4 
3 2 1 ppm
11 10 98
7  5 4 3 2 1PPM
date
%nivent Benzene
ACQUISITION
sfrq 125.795
tn C13
at 1.736
np 131010
sw 37735.8
fb not used
bs 8
ss 1
tpwr 53
pw 6.9
dl 0.763
tof 631.4
nt 12800
ct 1128
alock n
gain not used
FLAGS
il n
in n
dp y
hs nn
DISPLAY
sp -1911.2
wp 29007.8
vs 184
Sc 0
wc 250
hzmm 116.03
is 500.00
rfl 18876.7
rfp 12651.0
th 20
ins 1.000
ai ph
DEC. & VT
dfrq 500
dn
dpwr
dof -5
dmm
dmf 1
dseq
dres
homo
PROCESSING
lb
wtfile
proc
fn 13
math
werr
wexp
wbs
wnt
.229
Hl
37
00.0
y
w
0000
1.0
n
0.30
ft
1072
f
IJ4- OMe
N
( O-3
aao 1 11 11 160 1 140 .Z 1 801 60-T- 40- 20l 0- ppm III.I.I.I
W FM6~~~~ ~ ~ ~   I _- _-A ---. _ fPl- -_N 1 4 It A -6 W 0
200 180 160 140 120 100 80 60 40 20 0 PPM
(-)-31 0 I
V.'
839.88
1397.97
80
78
76
%T 74
72
70,
68
66.
64.
2931.03
3000. 2000 1500 1000
cm-1
87.1
84_
82
| I
1755.831
1693.88
62.4 4.
4000.0 500 400.0
Current Data Parameters
NAME
EXPNO
PROCNO
F2 - Acquisition Parameters
Date-
Time
INSTRUM spect
PROBHD 5 mm BBO BB-1H
PULPROG zg30
TD 65536
SOLVENT C6D6
NS 16
DS 2
SWH 8278.146 Hz
FIDRES 0.126314 Hz
AQ 3.9584243 sec
RG 128
DW 60.400 usec
DE 6.00 usec
TE 293.2 K
Dl 1.00000000 sec
TDO 1
NUC1
P1
PL1
SFO1
F2 -
SI
SF
WDW
SSB
LB
GB
PC
H O
H, H
TBSO H
HH
N OMe
(-)-32
CHANNEL fl ========
1H
15.07 usec
0.00 dB
400.1324710 MHz
Processing parameters
65536
400.1300444 MHz
no
0
0.00 Hz
0
1.00
I I I A .L
11 10 63 2 1 ppm
....... ........
7 
6
date
solvent Benzene
ACQUISITION
sfrq 125.796
tn Cis
at 1.736
np 131010
sw 37735.8
fb not used
bs 8
ss 1
tpwr 53
pw 6.9
dl 0.763
tof 631.4
nt 2560
ct 296
alock n
gain not used
FLAGS
11 n
in
dp
hs
sp
wp
vs
sc
wc
hzmm
is
rf 1
rfp
th
ins
ai
DEC. & VT
dfrq 500.233
dn H1
dpwr 37
dof -500.0
dmn y
dmm w
dmf 10000
dseq
dres 1.0
homo n
PROCESSING
lb 0.30
wtfile
proc ft
fn 131072
math f
werr
wexp
wbs
wnt
n
y
nn
DISPLAY
-1887.5
28933.0
119
0
250
115.73
500.00
18876.6
12651.0
20
1.000
H O
H*, H
TBSO H
H HA H
N OMe
0=V
(-)-32
140 120 . .0 11 080m
L I - , .I - - - . 1.1 1, . , --.- I li .. - 11. . ,,i - i. - - - - J - 61, L 1
20 0 180 160 60 40 . 20. . O PPM
88.9
88
87
86
85.
84_.
83-
82-
81-
2 62.74
2929.69
H O
H, H
TBSO H
H
H ;- H
N OMe
O -32
)7 
ji ri
1383.61 1092-58
831.60
- ----- - -,--- -- -, . - --- , --
3600 3200 2800 2400 2000 1800 1600 1400 1200 1000 800 600 400.0
cm-1
1627.
1 3.07
1749.65
80J
72.
70.7 +
4000.0
Current Data Parameters
NAME
EXPNO-
PROCNO TBSO
F2 - Acquisition Parameters
Date_
Time N OMe
INSTRUM spect O
PROBHD 5 mm CPTXI 1H-
PULPROG zg30
TD 65536 (+)-S8
SOLVENT C6D6
NS 16
DS 2
SWH 12376.237 Hz
FIDRES 0.188846 Hz
AQ 2.6477044 sec
RG 18
DW 40.400 usec
DE 6.00 usec
TE 304.0 K
Dl 1.00000000 sec
TDO 1
======== CHANNEL fl ========
NUCl 1H
Pl 11.00 usec
PL1 4.00 dB
SF01 600.1337060 MHz
F2 - Processing parameters
SI 65536
SF 600.1300679 MHz
WDW EM
SSB 0
LB 0.30 Hz
GB 0
PC 1.00
11 10 9 8 7 6 5 4 3 2 1 ppm
date
solvent Benzene
ACQUISITION
sfrq 125.796
tn C13
at 1.736
np 131010
sw 37735.8
fb not used
bs 8
ss 1
tpwr 53
pw 6.9
dl 0.763
tof 631.4
nt 25600
ct 1168
alock n
gain not used.
FLAGS
11 n
in n
dp y
hs nn
DISPLAY
sp -1887.5
wp 28933.0
vs 471
sc 0
wc 250
hzmm 115.73
is 500.00
rfl 18876.6
rfp 12651.0
th 20
ins 1.000
ai ph
DEC. & VT
dfrq 500
dn
d pwr
dof -5
dm
dmm
dmf 1
dseq
dres
homo
PROCESSING
lb
wtfile
proc
fn 13
math
werr
wexp
wbs
wnt
.233
Hi
37
00.0
y
w
0000
1.0
n
0.30
ft
1072
f
H O
H iH
TBSO H
H
H HH 1
N OMe
(+)-S8
180 160 140 iZO 100 80 
40 - 20 0 ppm
200 120 100 80 40 . 20 0 PPM160 140
90
89-
88-
871
86-
85
84
83-
82
81_
80 .
79
78-
77
76
75
74
73-
72
71-
70 -
H O
TBSO
H
H H
NH OMe
(+)-S8
(
~58.20
II
Ii
2930.59
f Iv
1553.34 1130.14
v I,
1472.14
1629.61 10.1
1001.11
1254.60
1224.28 1093.88
1363 .17
4 VI
780.76
836.94
1 ?23.07
17591.28
69.2 -
4000.0 3600 3200 2800 2400 2000 1800 1600 1400 1200 1000 800 600 400.0
cm-i
91.4.
7
Current Data Parameters
NAME
EXPNO
PROCNO
F2 - Acquisition Parameters
Date_
Time
INSTRUM specc
PROBHD 5 mm CPTXI 1H-
PULPROG zg3o
TD 65536
SOLVENT C6D6
NS 16
DS 2
SWH 12376.237 Hz
FIDRES 0.188846 Hz
AQ 2.6477044 sec
RG 22.6
DW 40.400 usec
DE 6.00 usec
TE 300.0 K
D1 1.00000000 sec
TDO 1
NUl
P1
PL1
SF01
F2 -
SI
SF
ch WDW
00 SSB
LB
GB
PC
H H
0
H aN OMe
(-)-33
CHANNEL fl ========
1H
11.00 usec
4.00 dB
600.1337060 MHz
Processing parameters
65536
600.1300667 MHz
no
0
0.00 Hz
0
1.00
I IiI I. I .. ...... ..... . A A '4 I
I - - I I I I I
3 2 1 ppm11 10 8 7 6 5
Current Data Parameters
NAME
EXPNO
PROCNO
F2 - Acquisition Parameters
Date_
Time
INSTRUM spect
PROBHD 5 mm CPTXI 1H-
PULPROG zgpg30
TD 65536
SOLVENT CDC13
NS 256
DS 4
SWH 35971.223 Hz
FIDRES 0.548877 Hz
AQ 0.9110004 sec
RG 14596.5
DW 13.900 usec
DE 6.00 usec
-TE 300.0 K
D1 2.00000000 sec
dl 0.03000000 sec
DELTA 1.89999998 sec
TDO 1
======== CHANNEL fl
NUCl 13C
P1 15.00 usec
PLI 1.60 dB
SF01 150.9178988 MHz
======== CHANNEL f2 ========
CPDPRG2 waltz16
a NUC2 1H
PCPD2 70.00 usec
PL2 4.00 dB
PL12 22.84 dB
PL13 22.84 dB
SF02 600.1324005 MHz
F2 - Processing parameters
SI 65536
SF 150.9027231 MHz
WDW EM
SSB 0
LB 1.00 Hz
GB 0
PC 1.00
H
N OMe
(-)-33
I I I I.~. ~.
i"k.ii 11i1 Lr.'f1 IL .JLI .~ .....ij.- -,w6LI- A:
- I
I I I
40 20 0 ppm
-- w-, ---r r - - - . - r
120140 100 60200 180 160
HHN OMe
(-)-33
95.3-
94-
93 -
92.
91-
90-
89-
88-
87-
86-
85
FVK\
I I
If
1'
V
1383.81
'I I ~.
'I
1082.62
1500 1000 500 400.0
cm-I
2360.23
2 30
2931.09
V
84 -
83-
82-
81-
80 -
79
78
77
74.9.1-
4000.0 3000 2000
lit
1i 6.48
1741.42
Current Data Parameters
NAME
EXPNO
PROCNO
F2 - Acquisition Parameters
Date-_
Time
INSTRUM spect
PROBHD 5 un CPTXI 1H-
PULPROG zg30
TD 65536
SOLVENT C6D6
NS 16
DS 2
SWH 12376.237 Hz
FIDRES 0.188846 Hz
AQ 2.6477044 sec
RG 32
DW 40.400 usec
DE 6.00 usec
TE 293.0 K
Dl 1.00000000 sec
TDO 1
NUCl
Pl
PL1
SFO1
F2 -
SI
SF
t'Q WDW
S SSB
LB
GB
PC
HO H0H H
H
N
H H'Cbz'H OMeMe N
0- -0
H--38
CHANNEL fl ========
1H
11.00 usec
4.00 dB
600.1337060 MHz
Processing parameters
65536
600.1300681 MHz
EM
0
0.30 Hz
0
1.00
IL
I~~~~ 7 6 3 2 1 ppm .I..I.I. I.IIII... II -3 2 1PPM
date
solvent Benzene
ACQUISITION
sfrq 125.795
tn C13
at 1.736
np 131010
sw 37735.8
fb not used
bs 8
ss 1
tpwr 53
pw 6.9
dl 0.763
tof 631.4
nt 128000
ct 3064
alock n
gain not used
FLAGS
il n
in n
dp y
hs ,nn
DISPLAY
sp -1960.7
wp 29007.8
vs 1238
sc 0
wc 250
hzmm 116.03
is 500.00
rfl 18876.7
rfp 12651.0
th 20
ins 1.000
ai ph
DEC. & VT
rq 500.229
dn Hi
dpwr 37
dof -500.0
dm y
dmm w
dmi 10000
dseq
dres 1.0
homo n
PROCESSING
lb 0.30
wtfile
proc ft
fn 131072
math f
werr
wexp
wbs
wnt
HO
H HH
HH
H- H
N.N -
MH 'CbZ H OMeMe N
H-3
180 140 120 ' 100 80 60 40 20 0 ppm
kALLk"
100 160
HO
H HH
HH
H., H
H HO H
H N.H 'Cbz H OMe
Me O (--3
96.1 =
94-
92.
90
88
86
84
82
80-
78
76
74
72
70,i
68
66.
64
62
60
58
55.4.
4000.0
2932.49
2360.02
3000 2000 1500
cm-1
149721
882.92
I i :10772
12P3.51 1040.64|
HI 978.10
1454. 1198A7
7
1156.1
1 46.
1391 .32
1315.40
1083.63
1000 500 400.0
- c:\peldata\spectra\groups\movass1\junqi\jq4-139.sp
1689.36
174i 0
3414.39
Current Data Parameters H " H
NAME
EXPNO * * H
PROCNO , H
H
F2 - Acquisition Parameters H'
Date N
Time H Z ~ii
-rie-H Cbz -H OMe
INSTRUM spect Me 0
PROBHD 5 mm CPTXI 1H-
PULPROG zg30 (.).3 
-TD 65536
SOLVENT C6D6
NS 16
DS 2
SWH 12376.237 Hz
FIDRES 0.188846 Hz
AQ 2.6477044 sec
RG 50.8
DW 40.400 usec
DE 6.00 usec
TE 293.0 K
Dl 1.00000000 sec
TDO 1
======== CHANNEL fl ========
NUCl 1H
Pl 11.00 usec
PLI 4.00 dB
SFO1 600.1337060 MHz
F2 - Processing parameters
SI 65536
SF 600.1300702 MHz
WDW no
SSB 0
LB 0.00 Hz
GB 0
PC 1.00
11 10 9 8 7 6 5 4 3 2 1 ppm
date
solvent Benzene
ACQUISITION
sfrq 125.795
tn C13
at 1.736
np 131010
sw 37735.8
fb not used
bs 8
ss 1
tpwr 53
pw 6.9
dl 0.763
tof 631.4
nt 12800
ct 1808
alock n
gain not used
FLAGS
11 n
in n
dp y
hs nn
DISPLAY
sp -1887.0
wp 28932.4
vs 147
sc 0
wc 250
hzmm 115.73
is 500.00
rfl 18876.7
rfp 12651.0
th 20
ins 1.000
ai ph
DEC. & VT
dfrq 500.229
dn Hi
dpwr 37
dof -500.0
dm y
dmu w
dmf 10000
dseq
dres 1.0
homo n
PROCESSING
lb 0.30
wtfile
proc ft
fn 131072
math f
werr
wexp
wbs
wnt
-
1-8 162 0 01 8 1 6 01 4 01 2 '1 00" " 8 0 i i 6 0 ' ' ' ' i ' ' ' 
' ' 2 '*' p p m
(-)-39
I I 1 1
140 120
I I I | I I
100 80 6.0
I I | II . i
Aff, 20 . a- PPM
87.1-
86 4
85.
84.
83-
82181 _
80 -
79-_
78-.
77-_
76
75
74-
73-
72
711
70
69
68
67
66.
65 1
64_
63.2
4000.0
2279.60
2932.69
1465
184.13
1497. 4
1439
14
jI/~ 124
3i.6
14.84
1346.
13 16.68
696.94
I 101.92
156.44 986.92
4.811
1187.93
1%
1113. 5
1088.43
1738.77;
1689.82
3000 2000 1500 1000 500 400.0
cm-I
(-)-39
[I
3583.73
3429.51
Current Data Parameters
NAME
EXPNO
PROCNO
F2 - Acquisition Parameters
Date_
Time
INSTRUM spect
PROBHD 5 mm CPTXI 1H-
PULPROG zg30
TD 65536
SOLVENT CDCl3
NS 16
DS 2
SWH 12376.237 Hz
FIDRES 0.188846 Hz
AQ 2.6477044 sec
RG 28.5
DW 40.400 us.ec
DE 6.00 usec
TE 293.0 K
Dl 1.00000000 sec
TDO 1
NUC1
P1
PL1
SFO1
F2 -
SI
SF
WDW
SSB
LB
GB
PC
(+-1
CHANNEL fl ========
1H
11.00 usec
4.00 dB
600.1337060 Miz
Processing parameters
65536
600.1300667 MHz
EM
0
0.30 Hz
0
1.00
I 1 5 4 I..II.I.. ." I. 2.I .II.... 1-.IIII.I. p pmI. I--- - l.. III.I  -10 --[L 2 1 PPM5 4
date
solvent Benzene
ACQUISITION
sfrq 125.795
tn C13
at 1.736
np 131010
sw 37735.8
fb not used
bs 8
ss 1
tpwr 53
pw 6.9
dl 0.763
tof 631.4
nt 128000
ct 1768
alock n
gain not used
FLAGS
il n
In n
dp y
hs nn
DISPLAY
sp -1264.3
wp 27669.1
vs 983
sc 0
wc 250
hzmm 110.68
is 500.00
rfl 22374.3
rfp 16151.2
th 20
Ins 1.000
al ph
DEC. & VT
dfrq 500
dn
dpwr
dof -5
dm
dim.
dmif 1
dseq
dres
homo
PROCESSING
lb
wtfile
proc
fn 13
math
werr
wexp
wbs
wnt
.229
H1
37
00.0
y
w
0000
1.0
n
0.30
ft
1072
IF
H H
HH
- y H
H- O 00
H \1H OMeMeCbz 0 H
(+)-41
L.
0 ppm12 100 80 . . 60 40 20
~I. I I.tj .'~ .~7 .L 1 ......liilllij i "06" L- 1.
200 180 160 140
100.3-
95 -
90 -
85 _
80.-
75--
70-
1954.43
3477.63 1
3060I6
3033. 5
2814.14
1723.A8
1692.2932.35
1 5 .84
1497.55
1266.0
1448.6f : I
1244.83
1414.j4
1391.8d 117
96 58
1595.83
1344.95
1312.32
9
9.85
5.41 t .92
854. 2
22.09
13 .9 838.55
1027.87
965.14 771.4
48.64
735.99
1119.87
35j
32.1
4000.0 3000 2000
(+)-41
%T 65
60 1
cm-I
1500 1000 500 400.0
date
solvent Benzene
ACQUISITION
sfrq 500.435
tn H1
at 4.999
np 120102
sw 12012.0
fb not used
bs 4
tpwr 56
pw 8.0
dl 0.100
tof 3003.2
nt 128
ct 20
alock n
gain not used
FLAGS
11 n
in n
dp
hs
DI
sp
wp
vs
sc
wc
hzmm
is
rf 1
rfp
th
ins
al cdc
dfirq
dn
dpwr
dof
dm
DEC. & VT
125.845
C13
30
dimm
dmf
dseq
dres
homo
PROCESSING
wtfile
proc
fn 26
math
werr
wexp
wbs
wnt
nnn
c
200
1.0
n
ft
2144
f
wf t
y
nn
SPLAY
-250.2
6255.3
60
0
250
25.02
33.57
4065.7
3583.1
7
100.000
H HO H
HH
SH
H-
H O''R HOMe
0Me OMe R = Cbz
(-)-44
i.i
I I--.I I I I I . I I a I I I . . I I T
11 10 9 8 7 6 1 ppm
date
solvent Benzene
ACQUISITION
sfrq 125.795
tn C13
at 1.736
np 131010
sw 37735.8
fb not used
bs 8
ss 1
tpwr 53
pw 6.9
dl 0.763
tof 631.4
nt 10000
ct 1535
alock n
gain not used
FLAGS
i1 n
in n
dp y
hs nn
DISPLAY
sp -1314.4
wp 27768.1
vs 392
sc 0
wc 250
hzmm 111.07
is 500.00
rfl 22374.9
rfp 16151.2
th 20
ins 1.000
ai ph
DEC. & VT
dfrq 500.
dn
dpwr
dof -5
dm
dim.
dmf 1
dseq
dres
homo
PROCESSING
lb
wtfile
proc
fn 13
math
werr
wexp
wbs
wnt
.229
H1
37
00.0
y
w
0000
1.0
n
0.30
ft
1072
f
I J
H HO H#HH
SH
H'- \
HO'R OH OeOMMe OMe R = Cbz
(-)-44
I00 1 1 14 I2 I00 80 60 40 20I II I 0 ppm
1 77 Zj-
60 40 20 0 ppm
i 
i i ' ' '
| | 
| |
140
I~~~ ~ ~ I I I -
120 100 802 00 180 16.0
70.5
65
60_
5 5
-
50-
45-
12.8 .
1000
(..)-44
4 8t
90.8
75.96 4.8'A,
--.23.09
807.0$
9?0.12 772.5
72.39 698.67
735.26
5.6k
0 11026. 83
.83
|'
1111.19
1085.33
%T 40
35
30-
25.
20-
15.
3439.82
~8j6.01
2.i
2927.56
1733.6J
1675.24
4000.0 3000 2000 1500
cm-1
500 400.0
DEC. & VT
date dfrq 125.845
solvent Benzene dn C13
dpwr 30
dof 0
dm nnn
dmm c
ACQUISITION dmf 200
sfrq 500.435 dseq
tn HI dres 1.0
at 4.999 homo n
np 120102 PROCESSING
sw 12012.0 wtfile
fb not used proc ft
bs 4 fn 262144
tpwr 56 math f
pw 8.0
dl 0.100 werr
tof 3003.2 wexp
nt 128 wbs
ct 24 wnt wft
alock n
gain not used
FLAGS
11 n
in n
dp y
hs nn
DISPLAY
sp -250.2
wp 6255.3
vs 60
sc
wc
hzmm
is
rf1
rfp
th
ins
at cdc
0
250
25.02
33.57
4068.0
3583.1
7
100.000
I ]J I
TMSO AHH
H OMe
MeOMe0
,(-)-S9
I'~~* I
11 10 8 6 
5 4 3 2 1 ppm
, 
.
9 8 32 1 ppm
date
solvent benzene
ACQUISITION
sfrq 125.796
tn C13
at 1.737
np 104492
sw 30075.2
fb not used
bs 4
ss 1
tpwr 53
pw 6.9
dl 0.763
tof 1771.3
nt le+07
ct 23884
alock n
gain not used
FLAGS
1i n
In n
dp y
hs nn
DISPLAY
sp -1255.0
wp 27743.0
vs 1986
sc 0
wc 250
hzmm 110.97
is 500.00
rfl 17404.7
rfp 16149.2
th 20
ins 1.000
ai ph
DEC. & VT
dfrq 500
dn
dpwr
dof -5
dm
dimm
dmf 1
dseq
dres
homo
PROCESSING
lb
wtfile
proc
fn 13
math
werr
wexp
wbs
wnt
.229
H1
37
00.0
y
w
0000
1.0
n
0.30
ft
1072
f
(-)"S9
I I
140 120 100 80 60 40 20 0 ppm
7-1-,-
11111111200 180 160
84.1
80- 'M''p H
H- \NN0
H 'HH OMe75- OH0Me OMe
70 - ~-
65-
752.66
1 .44-
I 1374.84 163354 8 .
60
1447.46
1296.p551 1277.41 892.341
o8.95,
"1673.58 1250.86
85.09 1161.11 842.1750- 1112.64
1741.23
45
2927.37
40
35
29.9 -
4000.0 3000 2000 1500 1000 500 400.0
cm-1
Current Data Parameters
NAME H
EXPNO HH
PROCNO , H
F2 - Acquisition Parameters H-
Date-
Time H
INSTRUM spect O 'H H OMe
PROBHD 5 mm CPTXI 1H- Me 0
PULPROG zg30 OMe .
TD 65536
SOLVENT C6D6 (-)-21
NS 8
DS 2
SWH 12376.237 Hz
FIDRES 0.188846 Hz
AQ 2.6477044 sec
RG 50.8
DW 40.400 usec
DE 6.00 usec
TE 304.0 K
Dl 1.00000000 sec
TDO 1
======== CHANNEL fl ========
NUCl 1H
P1 11.00 usec
PL1 4.00 dB
SFO1 600.1337060 MHz
F2 - Processing parameters
SI 65536
SF 600.1300659 MHz
WDW EM
SSB 0
LB 0.30 Hz
GB 0
PC 1.00
. . . . . . . . . i , . . . . . . . . ... . . . . . . i . . . . . . . . . i ., , - - - - - - .-- - - - - -.-.-- - ' ' ' ' ' '.'' ' ' ' ' ' ' '.'' ' ' ' ' ' ' '... . ' ' ' ' ' ' ' '. ' ' ' ' ' ' ' ' '. ' ' ' ' '
11 10 9 8 7 6 5 4 3 2 1 ppm
date
solvent Benzene
ACQUISITION
sfrq 125.795
tn C13
at 1.735
np 91936
sw 26490.1
fb not used
bs 8
ss 1
tpwr 53
pw 6.9
dl 0.763
tof 1250.7
nt 100000
ct 15240
alock n
gain not used
FLAGS
i1 n
in n
dp y
hs nn
DISPLAY
sp 19.1
wp 26489.7
vs 1857
sc 0
wc 250
hzmm 105.96
is 500.00
rfl - 16132.5
-rfp 16151.2
th 20
ins 1.000
at ph
dfrq
DEC. & VT
500.229
dn Hi
dpwr 37
dof -500.0
dm y
dmm w
dmf '10000
dseq
dres 1.0
homo n
PROCESSING
lb 0.30
wtfile
proc ft
fn 131072
math f
werr
wexp
wbs
wnt
(-)-21
I I I d L IL -I.
aaa 180 160 140 120 100 
60 40 20 ppmV I I I I 1 1 7 1 1 1 1 1 1 1 1 1 1 . . . . . . . . . . . . . . - . I I .
200 180 . 160 60 40 2 0 PPM140 120 100
1375.53
1209.06
1460.20 1260.57 ,f032.17
1110.75
1500 1000
(-)-21
72.6
%T 60
58
56
54
3583.73
,3457.15
800.33
670.72
1735.84
2 50.67
2921.26
52 A
50
48.5-
4000.0 3000 2000
cm-I
500 400.0
Current Data Parameters
NAME
EXPNO
PROCNO
F2 - Acquisition Parameters
Date-
Time
INSTRUM spect
PROBHD 5 mm CPTXI 1H-
PULPROG zg30
TD 6ssu
SOLVENT
NS
DS 2
SWH 12376.237 Hz
FIDRES 0.188846 Hz
AQ 2.6477044 sec
RG 57
DW
DE
TE
Dl
TDO
HO H
H
H- \
N
H OMe
Me OMe
(+)-46
40.400 usec
6.00 usec
293.0 K
1.00000000 sec
======== CHANNEL fl ========
NUCl 1H
Pl 11.00 usec
PL1 4.00 dB
SFO1 600.1337060 MHz
F2 -
SI
SF
t'J WDW
00 SSB
LB
GB
PC
Processing parameters
65536
600.1300696 MHz
EM
0
0.30 Hz
0
1.00
... .. . . . I - I
11 2 1 ppm
I
date
solvent Benzene
ACQUISITION
sfrq 125.796
tn C13
at 1.735
np 96238
sw 27729.6
fb not used
bs 8
ss 1
tpwr 53
pw 6.9
dl 0.763
tof 1722.0
nt le+06
ct 23576
alock n
gain not used
FLAGS
11 n
in n
dp y
hs nn
DISPLAY
sp -131.2
wp 27656.0
vs 1496
sc 0
wc 250
hzmm 110.62
Is 500.00
rfl 16280.8
rfp 16149.2
th 20
Ins 1.000
ai ph
DEC. & VT
dfrq 500
dn
dpwr
dof -5
dm
dmm
dmf 1
dseq
dres
homo
PROCESSING
lb
wtfile
proc
fn 13
math
werr
wexp
wbs
wnt
.229
H1
37
00.0
y
w
0000
1.0
n
0.30
ft
L072
f
H HO
A l H H
H
N
H O H OWeMe~me OMe
(+)-46
180 160 140 120 .. 041000...p
"'1 1 - wa- 0, 1- 1, 1 NOW d
I . I I I I I I I I I I I I I I I I -- T- I I . - I I . I I I I . - . I I I , 9 F . I . . I I . I I I I I-T I I - - I I I I I I . I I , I I
80 6  .200 . 4 0. . 20 Pppm
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16.61348.25
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801.75
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3000 200000.0
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1500 1000 500 400.0
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40
Current Data Parameters
NAME
EXPNO
PROCNO
F2 - Acquisition Parameters
Date-
Time
INSTRUM spect.
PROBHD 5 mm CPTXI 1H-
PULPROG zg30
-TD 65536
SOLVENT CDC13
NS 24
DS 2
SWH 12376.237 Hz
FIDRES 0.188846 Hz
AQ 2.6477044 sec
RG 40.3
DW 40.400 usec
DE 6.00 usec
TE 293.0 K
Dl 1.00000000 sec
TDO 1
NUCl
P1
PLI
SFO1
F2 -
SI
SF
WDW
SSB
LB
GB
PC
H HO
H
H
N AH H
H M OMeH
Me OMeOH
(+)-47
CHANNEL f1 ========
1H
11.00 usec
4.00 dB
600.1337060 MHz
Processing parameters
65536
600.1300284 MHz
EM
0
0.30 Hz
0
1.00
10
10 
ppm-- I-....I.. I....
k)
ul-
I I
PPM
date
solvent
dfrq
CDCl3 dn
dpwr
dof
dm
dim.
ACQUISITION dmf
sfrq 125.796 dseq
tn C13 dres
at 1.735 homo
np 96404
sw 27777.8 lb
fb not used wtfi
bs 8 proc
ss 1 fn
tpwr 53 math
pw - 6.9
dl 0.763 werr
tof 1845.7 wexp
nt 100000 wbs
ct 24792 wnt
alock n
gain not used
FLAGS
i1 n
in n
dp y
hs nn
DISPLAY
sp -93.2
wp 26499.4
vs 2637
sc 0
wc 250
hzmm 106.00
is 500.00
rfl 9808.5
rfp 9714.9
th 11
ins 1.000
ai ph
DEC. & VT
500
-5
1
PROCESSING
le
131
200 180 160 140 iza 100 80 ppm40 20
.229
H 1
37
00.0
y
w
0000
1.0
n
).30
ft
1072
f
(+)-47
, I
200O 180 10 0 80160 140 120 .'
H HO H
'OHH H H
0 x H OMe
Me OMeOH
(+)-47
3496.33
83.7
822
80- I,
\ 8 I
1458.81
1733.1
1689.71
78.
76-
74
72_
70
68.
66-
64..
62
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58-
56.
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51.4
4000.0 3000 2000
cm-1
1500 1000
724.89
1 4.5 
83. 9
82.61
0.20
1281. 6 1080.83
1262.73
2930.94
500 400.0
Current Data Parameters
NAME H
EXPNO
PROCNO
F2 - Acquisition Parameters
Date
Time
INSTRUM spect
PROBHD 5 nn CPTXI 1H-
PULPROG zg30 OM6
TD 65536
SOLVENT CDC13
NS 16
DS 2 (-)-himandrine (3)
SWH 12376.237 Hz
FIDRES 0.188846 Hz
AQ 2.6477044 sec
RG 45.3
DW 40.400 usec
DE 6.00 usec
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